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ABSTRACT
Eps 15 homology (EH) domain-containing proteins have been implicated in diverse 
intracellular signalling pathways, such as endocytosis, actin cytoskeleton organization, 
nucleo-cytosolic shuttling and mitogenic signalling. However, the extent of the protein- 
protein interactions mediated by the EH domain at the level of a whole organism has not 
yet been addressed. This project aims to gain an overview of the EH network in a model 
system, C. elegans, by identifying interactors of all EH-domain containing proteins present 
in C. elegans. Five genes encode EH proteins in the C. elegans genome and the isolated 
EH domains were used to screen a C. elegans cDNA library using the Yeast Two Hybrid 
system. The validation of the putative interactions was carried out by in vitro pull-down 
assays. The biological relevance of the interactions was tested genetically using C. elegans 
as a model system. The genetic interactions were monitored using available mutants for 
four of the five EH encoding genes, in which the genes of the putative interactors were 
knocked-down by RNA interference. A total of 26 proteins were found to interact 
physically and genetically with at least one EH protein. Most of the interactions identified 
are novel and highlight new pathways in which the EH network is involved. The results of 
this study indicate that the EH complexes can be found in various intracellular 
compartments, holding together a network of adaptor proteins involved in all the major 
processes of the protein sorting events during intracellular signalling.
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I. INTRODUCTION
In the first part of the introduction, the identification of the EH domain, its structure and its 
interacting motif will be discussed. Four major EH-domain containing protein families have 
been identified to date, namely; the Eps 15 family, the Intersectin family, the EHD family and 
the Reps family. Each EH protein family will be introduced by exploring the current 
knowledge of the family members found across the species from yeast to mammals.
The subsequent part of the introduction will focus on the experimental approaches that were 
taken in this study. This project aimed to perform a genome-wide screening to identify the 
interactors of all Caenorhabditis elegans (C. elegans) EH proteins, using the Yeast Two 
Hybrid (Y2H) technique. The interactions discovered through the Y2H screenings were 
validated by in vitro binding, followed by genetic studies using C. elegans. Therefore, the first 
section in the experimental approaches will elaborate on several reasons why C. elegans is an 
ideal model system for this study. Secondly, the advantages and disadvantages of the Y2H 
system will be examined, especially in the context of genome-wide screenings.
The final part of the introduction will aim to summarize the existing picture of the EH 
network, and how this project can contribute to analyse the EH network in a whole organism.
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1. The Eps15 Homology (EH) Domain
1.1. Identification of the evolutionarily-conserved EH domain
The Epsl5 Homology (EH) domain was first identified as a repeated domain present in 
the N-terminal portion of Epsl5 (Epidermal growth factor receptor pathway substrate 
#15), a substrate of the tyrosine kinase domain of the epidermal growth factor receptor 
(EGFR) [1].
The EH domain is a protein-protein interaction domain of about 70 amino acids (Figure 
A), present in 3 copies at the N-terminal portion of Eps 15 and EPS 15 Related protein 
(EPS15R). The EH domain has been conserved through evolution, as sequences 
homologous to this domain are found in the genome of Saccharomyces cerevisiae, 
Caenorhabditis elegans, Drosophila melanogaster, Mus musuculus, and Homo sapiens 
[2]-
Apart from a few EH proteins that do not appear to have obvious homologues in other 
species, such as yeast EH proteins YKR019cp/Irs4p and YJL083wp, and the 
mammalian y-Synergin (even though putative homologues in C. elegans and other 
species have been identified recently, as described in the following section 2.5), most of 
them were found to belong to four major families of EH proteins. The main EH 
proteins families are: the Eps 15 family, the Intersectin family, the EHD (Eps 15- 
Homology-Domain containing proteins) family and the Reps (RalBPl-Associated 
Eps 15 homology proteins) family. The structures of these major families of EH 
proteins are shown in Figure B. (For more detailed descriptions of other EH proteins 
found in yeast, refer to the review by Santolini et.al. [3])
Figure A The conserved sequences o f Eps 15 Homology Domains in Eps 15 and EpslSR 
(The figure was modified from article by Wong et.al. [4])
Epsl5-/Epsl5R-EHl: the amino acid sequences of the first EH domains of Eps 15 and Epsl5R 
Eps 15-/Eps 15R-EH2: the amino acid sequences of the second EH domains o f Epsl5 and 
Epsl5R
Epsl5-/Epsl5R-EH3: the amino acid sequences third EH domains of Epsl5 and Epsl5R.
The Consensus sequence of EH domain; a: acidic residue, b: basic residue, cj>: hydrophobic 
residue and any residue.
1 70
E p s l 5 —E H l GNPVYEKYYRQVDTGNTGRVLASDAAAFLKKSGLPDLILGKIWDLADTDGKGILNKQEFFVALRLVACAQ 
E p s l5 R - E H l  GNSLYESYYKQVDPAYTGRVGASEAALFLKKSGLSDIILGKIWDLADPEGKGFLDKQGFYVALRLVACAQ
1 70
E p s l 5 —EH2 DKAKYDAIFDSLSPVNGFLSGDKVKPVLLNSKLPVDILGRVWELSDIDHDGMLDRDEFAVAMFLVYCALE 
E p s l5 R -E H 2  EKAKFDGIFESLLPINGLLSGDKVKPVLMNSKLPLDVLGRVWDLSDIDKDGHLDRDEFAVAMHLVYRALE
. 1  ' ' .  70
E p s l 5 —EH3 EKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTGLPSTLLAHIWSLCDTKDCGKLSKDQFALAFHLISQKL 
E p s  15R -E H 3 DKMRFDEIFLKTDLDLDGYVSGQEVKEIFMHSGLTQNLLAHIWALADTRQTGKLSKDQFALAMYFIQQKV
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1.2 The structure of EH domain
The NMR structure of the second EH domain of Eps 15 revealed that it consists of four 
alpha helices; aA, aB, aC, and aD, where aA  and aB are connected by a p-sheet, and 
aC  and aD are connected by another P-sheet that is positioned in an anti-parallel 
manner with respect to the first p-sheet [5] (Figure C). The EH domain was found to 
contain two EF-hand motifs, a motif which acts as a calcium-binding region. Even 
though calcium-binding often acts as a regulatory mechanism for various proteins, the 
addition of calcium did not alter the ability of the EH domains to interact with proteins 
significantly [4]. In addition, it was shown that the EF-hands of Eps 15 display different 
affinities and positions for calcium-binding [5]. Therefore calcium-binding to the EH 
domain is suggested to have a structural role. The structures of various EH domains 
have been solved to date, such as the EH domain of POB1 [6] and Repsl [7, 8], the first 
EH domain of Eps 15 [9] and the third EH domain of Eps 15 [10]. These studies 
demonstrated that all EH domains share the same conformation.
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Figure B The Structures o f EH domain-containing proteins found conserved through 
evolution. (Adapted from the review by Santolini et al. [3])
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1.3 Motifs that bind to the EH domain
A tripeptide motif of NPF (asparagine-proline-phenylalanine) was highlighted as the 
common interaction motif as a result of a screening of a random phage-displayed 
peptide library using the GST-fusion proteins of the EH domains of Eps 15 and Epsl5R 
[11]. The NPF motif was found in 46 out of 48 peptides that interacted with the EH 
domains, whereas the remaining two peptide sequences selected by the EH domain of 
Epsl5R contained either NHF (asparagines-histidine-phenylalanine) or HPF (Histidine- 
proline-phenylalanine). In this study, it was also shown that a single EH domain is 
sufficient to mediate protein-protein interactions [11].
Further investigation on the EH-interacting regions using eleven different EH domains 
confirmed the NPF tripeptide (Class I) as the most common interactive motif in addition
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to two more classes of peptides [11]. Class II peptides identified from the phage-display 
experiments with various EH domains contain dipeptide motif FW (phenylalanine- 
tryptophan) or WW (tryptophan-tryptophan), and a tripeptide motif of SWG (serine- 
tryptophan-glycine). The third class of EH interacting motifs were tripeptides: HSF 
(histidine-serine-phenylalanine) or HTF, (histidine-threonine-phenylalanine). These 
motifs are recognized exclusively by the first EH domain of a yeast EH protein, End3p
[12].
Figure C Structure and Asn-Pro-Phe (NPF) binding pocket o f  the Eps 15 homology 
domain (Taken from the article by de Beer et al. [5])
A: The best-fit superposition of the backbone atoms (N, Ca, and C') in the secondary 
structure elements of the 20 structures with the lowest nuclear Overhauser effect 
energies
B: The ribbon diagram of the structure closest to the average of the 20 structures 
depicted in A.
C: The amino acid sequence alignment of the three EH domains of human Eps 15.
The yellow spheres in the three dimensional structures (A & B)indicate the position of 
the calcium ions (Ca2+) in the EF-hand-like calcium-binding pockets. The pink arrows 
pointing to the residues in the amino acid sequence (C) indicate the NPF-motif binding 
residues.
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Structural studies confirmed that NPF peptides bind the hydrophobic surface in the EH 
domain [5], and that the type I p-tum conformation of NPF peptides is buried in 
between two a-helices of the EH domain [7]. The specificity of the interaction mediated 
by the hydrophobic pocket of the EH domain was further demonstrated when the 
disruption of the hydrophobic surface by a point mutation was shown to alter the 
interaction affinity [10].
To date, several interactors of EH domains that contain the NPF motifs have been 
identified, such as Hrb, Hrb-related protein Hrb-l, Numb and Numb-related protein, 
Numb-1 [11], Epsin [13-16], TTP [17]. Most of the interactors that have been 
characterized to date are summarized in Table A, which was taken from the review by 
VoXoetal [18].
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2. The EH network
The function of the EH network can be better appreciated by considering the properties 
of EH-containing proteins and their interactors. The EH network was first implicated in 
the process of endocytosis at the plasma membrane. Some EH-containing proteins were 
also involved in intracellular trafficking, whilst some others play a role in the regulation 
of actin cytoskeleton organization. Finally, on the basis of known interactions, the EH 
proteins may also participate in different processes, such as mitogenic signalling, cell 
proliferation and nuclear shuttling.
Numerous studies of each family of EH-domain-containing proteins in mammalian 
cells, as well as in Xenopus laevis (X. laevis), Drosophila melanogaster (D. 
melanogaster) and in C. elegans, have provided insights into a network of protein 
interactions that are implicated in diverse intracellular signalling pathways. The 
following sections on the EH-containing protein families will describe their functions 
and highlight the networks in which these proteins are engaged.
2.1 Epsl5 family
2.1.1 In trod uction  o f  th e  Ep s15 fam ily
The Eps 15 protein was identified in a screening for substrates of the EGFR tyrosine 
kinase domain as well as of another tyrosine kinase receptor, platelet-derived growth 
factor receptor (PDGFR). [1]. A screening of the mouse keratinocyte cDNA library 
with the EH-domain containing region of Epsl5 identified an Epsl5-related gene, 
Epsl5R, which has been mentioned in Section 1.1 [4]. As evident from the sequence 
alignment shown in Figure A, the portion of Eps 15R which contains the EH domains
shares 70% identity with Epsl5 [4]. The homologue of mammalian Eps 15 has been 
identified also in yeast (edel), C. elegans (EHS-1) [3, 19] and in D. melanogaster 
(dEps-15) [20]. In yeast, edelp is involved in fluid-phase endocytosis and the clathrin- 
dependent endocytosis; EHS-1 and dEps-15 are expressed mainly in neurons, where 
they play a role in synaptic vesicle recycling [19, 20], a specialized form of clathrin- 
dependent endocytosis.
The structure of Eps 15 and Epsl5R consists of three main regions. The N-terminal 
portion contains three EH domains, the central region of a-helix forming a coiled-coil 
region, followed by a C-terminal region containing repeated motifs of the tripeptide 
sequence DPF (aspartic acid-proline-phenylalanine). In addition, a proline-rich region 
[1, 4, 21] and two short sequences defined as Ubiquitin-interacting-motif (UIM) 
domains, which are able to bind monoubiquinated proteins were identified (Refer to 
Figure D) [22]. The EH domains of Epsl5 were shown to interact with NPF-containing 
proteins such as Epsin, Numb and Hrb. The DPF motifs were found to interact with 
clathrin assembly adaptor proteins such as AP-2, whereas the coiled-coil region is 
thought to play a role in homo- or hetero-dimerization. The interactors of Eps 15 will be 
described in detail in the following sections that are divided according to the functions 
or the processes, in which Eps 15 and the interactors are involved in.
2.1.2 E p s 15 and c lath rin -d ep en dent en d ocytosis
The DPF repeats in the C-terminal region of Eps 15 were found to be responsible for the 
interaction with the a-subunit of AP-2 [23, 24], an adaptor complex able to interact 
directly with clathrin during vesicle formation [25-28]. Immuno-electron microscopy 
data revealed that Eps 15 is localized to the rim of budding clathrin-coated vesicles at
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the plasma membrane [29] and then released from the forming vesicle when the 
clathrin coat is assembled [30].
The importance of the EH domains in the function of Eps 15 in the clathrin-coat 
assembly and the endocytosis was demonstrated by the study of a deletion mutant of 
Eps 15, which lacked the second and the third EH domains. Transient overexpression of 
this construct was disrupted the localization of Epsl5, as well as the distribution of AP- 
2 and clathrin and Dynamin at the plasma membrane. The cells expressing the mutant 
Eps 15 lacking the EH domains was also shown to have reduced the internalization of 
transferrin, which is used as a marker for" clathrin dependent endocytosis [31]. The 
complex of Eps 15 and AP-2 was also shown to interact with Epsin, an adaptor protein 
involved in the clathrin-coated assembly [13].
Figure D. The Structure o f Eps 15 and EpslSR. (Adapted from the figures taken from 
the articles by Salcini A.E., et al. [11] and Polo S., et al. [22])
EH1 EH2 EH3 a-hclix DPF repeats uim
motifs
E pslSR
EH! EH2 EH3 a-hclix DPF repeats u im
motifs
In addition to the interaction with the clathrin-assembly adaptors such as AP-2 and 
Epsin, Eps 15 also interacts with dynamin [19, 31, 32], a GTPase that is required for the 
vesicle fission during endocytosis [33, 34]. Benmerah et ah showed that dynamin is no 
longer localized in puctate pattern in the plasma membrane region, when the dominant 
negative form of Epsl5 is expressed [31]. More recently, the homologues of Epsl5 and 
Dynamin in C. elegans, ehs-1 and dyn-1 respectively, were also shown to interact
genetically [19]. In the same study [19], the physical interaction between Epsl5 and 
Dynamin I and II was demonstrated in vitro.
2.1.3 E p sl5  in  syn aptic  v e sic le  recyclin g
Eps 15 is enriched at the presynaptic nerve terminals, which is the site of a specialized 
form of clathrin-dependent endocytosis [13]. Eps 15 has been shown to interact with 
API80, which is a Vesicle recycling at the synapses uses the molecular mechanisms of 
the clathrin-dependent endocytosis. Eps 15 has been reported to undergo a stimulation- 
dependent dephosphorylation at nerve terminals [35]. Dephosphorylated Epsl5 was 
shown to bind to the a-adaptin appendage domain with higher affinity, suggesting that 
the dephosphorylation leads to an increased efficiency of the synaptic vesicles 
membrane internalization [35]. Furthermore, the study of ehs-1 (strain okl46), the 
Epsl5 mutant in C. elegans, showed that the mutants suffered a temperature sensitive 
locomotion defect, which was attributed to the presynaptic neurotransmission defect 
[19]. The analysis of dEpsl5 homologue in Drosophila also revealed a function in the 
nervous system [20].
2.1.4 E p s 15 and non-clathrin  en d ocytosis
Eps 15 and the aforementioned interactor, Epsin, both contain the Ubiquitin-Interacting
Motif (UIM), which binds to ubiquitin moiety. Upon the EGF stimulus, EGFR is
monoubiquitinated on multiple sites and the UIM domain of Eps 15 was shown to bind
to the monoubiquitinated EGFR [36]. The UIM domains of Eps 15 participate in the
mechanism of coupled-monoubiquitination, as these domains mediate the interaction
between the ubiquitinated proteins and Eps 15, which is often ubiquitinated itself. The
UIM domains of Eps 15 are thought to interact with ubiquitinated EGFR, which was
implicated in the mechanism by which the dosage of EGF influences the internalization
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pathway of EGFR. In the presence of low level of EGF (1.5 ng/tnl), EGFR is localized 
to the clathrin-dependent endocytosis, where EGFR is tyrosine-phosphorylated and is 
capable of downstream signalling. In comparison, in the presence of high EGF 
concentration (20 ng/ml), EGFR is ubiquitinated and distributed equally between the 
clathrin-coated pits and the caveolae [37-40].
2.1.5 O ther fun ctions o f  E p sl5
Prior to the screenings carried out by this project, several proteins had been found to 
interact with the EH domains of Eps 15. Numb and Numb-1 were identified in a 
screening of an expression library with the EH domains of Epsl5 [11]. Numb was 
originally identified in D. melanogaster [41]. Both Numb and its related protein, 
Numb-like (Numb-1), are asymmetrically localized and involved in cell-fate 
determination of progenitor cells during neurogenesis [42] and myogenesis [43]. Numb 
contains an NPF motif in its C-terminus, through which it binds to the EH domain of 
Epsl5 [11]. In its N-terminus, Numb contains a PTB domain that has been 
demonstrated to bind to a membrane-associated receptor, Notch [44, 45], which is also 
involved in the decision of the cell-fate. The interaction between Eps 15 and Numb, and 
its link to Notch via Numb suggests that Eps 15 is also implicated in the cell-fate 
determination during development [46, 47].
The same screening that identified Numb and Numb-1 as the interactors of Eps 15, also
identified Hrb and its related protein Hrb-1 as interactors of the EH domains of Eps 15
[11]. Hrb is also known as Rev-interacting protein. Rev is an HIV-1 protein, containing
a zinc-finger domain in the N-terminal portion and four NPF motifs in its C-terminus
[3]. Hrb has been shown to act as a cofactor of Rev, which is involved in the nucleo-
cytosolic shuttling of the viral transcripts in HIV-infected cells. Another known
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interactor of Epsl5, epsin has been reported to undergo nucleo-cytosolic shuttling, 
together with several other endocytic proteins [48-50].
2.2 Intersectin family
2.2.1 In trod uction  on  the In tersectin  fam ily
Two genes (Intersectin 1 and 2) encoding similar proteins were identified in mammals 
and were found conserved throughout evolution. Clear homologues has been found in 
lower eukaryotes such as Drosophila {Dap 160) and C. elegans (itsn-1). In yeast, a 
putative Intersectin homologue can be identified in panl, which is an EH domain- 
containing protein, and shares with the Intersectin proteins a role in actin organization. 
Intersectin was first identified when the cDNA library of X  laevis oocytes was screened 
with an SH3 peptide ligand. The Xenopus gene was identified to contain two EH 
domains in its N-terminus, a central coiled-coil region, and five SH3 domains in the C- 
terminus [14].
The EH domains of Intersectin bind NPF motif-containing proteins, such as Epsin, 
Hrb/Hrb-1 and Numb [14, 51], which interact also with the EH domains of Epsl5 (Refer 
to Section 2.1.2 and 2.1.5). In addition, a component of recycling vesicles, Secretory 
Carrier Membrane Protein 1 (SCAMPI), which also contains NPF motifs, was recently 
discovered to interact with the EH domains of Intersectin [52]. The SH3 domains of 
Intersectin interact with several proteins, such as the Son-of-Sevenless, Dynamin, and 
Synaptojanin [14]. When the mouse Intersectins (initially called Esel & 2) were 
identified, the coiled-coil region of the Esel was reported to interact with the coiled-coil 
region of Epsl5 by a Yeast Two Hybrid approach [53]. Many interactions mediated by 
the different domains of Intersectin suggest diversity in their functions. Each
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intracellular process, in which Intersectin and its interactors are implicated, will be 
discussed in later sections.
In addition, the mammalian Intersectin proteins contain isoforms with extra C-terminal 
regions due to alternative splicings. The extended isoforms, which are more neuronal 
specific, contain a Dbl homology (DH) domain, a Pleckstrin homology (PH) domain 
and a C2 domains [53-56] (Figure E). The DH and PH domains specific to the 
m am m alian long isoforms have been shown to play a role in actin cytoskeleton 
organization, which will be discussed later, in Section 2.2.4.
2.2.2 In tersectin  and clathrin-dependent en d ocvtosis
The interactions with endocytic proteins, such as Dynamin, Epsl5, epsin and Synaptojanin
[14], strongly implicate Intersectin in endocytosis. At first, the role of Intersectin was
suggested to take place mainly in clathrin-dependent endocytosis [14, 56]. Indeed,
overexpression of wild type Intersectin proteins was sufficient to reduce the internalization
of transferrin and EGF. Accordingly, mammalian Intersectins were found targeted to
clathrin-coated pits and the importance of the interactions mediated by the SH3 domains of
Intersectin in clathrin-coated vesicle formation has also been shown [57].
Figure E. The structures o f Intersectin long and short isoforms. (Adapted from the 
review by Santolini et al. [3])
Intersectin 
(short isoform)
Intersectin 
(long isoform)
EH EH Coiled-coil SH3 SH3 SH3 SH3 SH3
EH EH Coiled-coil SH3 SH3 SH3 SH3 SH3 DH PHI C2
EH EpstS Homology (EH) domain DH Dbl homology domain
C-c CoiEed-ooil region PH Pleckstrin homology domain
SH3 Src Homology 3 (SH3) domain C2 Ca2+-activated membrane binding domain
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2.2.3 In tersectin  in  syn ap tic  v e s ic le  recyclin g
The function of Intersectin at the level of presynaptic termini is better appreciated in 
lower organisms such as Drosophila and C. elegans. Drosophila homologue, Dap 160, 
was identified as a membrane-associated neuronal protein that interacts with dynamin 
[58]. Further studies on Dap 160 revealed that it acts as a scaffolding protein required for 
synaptic development and synaptic vesicle retrieval [59, 60]. A recent report 
demonstrated that Dap 160 plays its role in scaffolding structure together with Eps-15 at 
the site of synaptic vesicle endocytosis [61]. Furthermore, the Intersectin homologue 
studied in lamprey eel showed that it negatively regulates the level of dynamin 
redistributed at the periactive zone, and that Intersectin may play a role in the fission of 
vesicles [62].
A recent study of Intersectin in C. elegans also demonstrated ITSN-1 as a neuronal 
protein, with a role in synaptic transmission. In addition, the study on itsn-1 has shed 
light for the first time on a possible antagonistic relationship between itsn-1 and ehs-1 
on the dynamin-regulated pathways [63]. As Intersectin, Epsl5 and Dynamin interact 
with each other to orchestrate the clathrin-dependent endocytosis, the antagonism 
uncovered by the genetic studies in C. elegans suggest a complex mechanism by which 
the endocytic process is controlled by these proteins.
2.2.4 In tersectin  and actin  cv tosk e leton  organ ization
The DH domain of the Intersectin long isoform has been found to specifically act as a
guanine nucleotide exchange factor for Cdc42, but not for Racl or RhoA [64, 65].
Intersectin was shown to interact with Wiskott Alrich Syndrome Protein (WASP) or
Neural-WASP (N-WASP), which participate in the Arp2/3 complex mediated-actin
polymerization [64, 66]. Recently, Numb was also identified as an interactor of
Intersectin, and the presence of Numb was shown to enhance the Cdc42 GEF activity of
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Intersectin [51]. Numb, a protein that determines cell-fate is involved in the neurite 
outgrowth during the early stages of the neuronal development. Numb plays a role in 
the formation of dendritic spines in the later stages of the neuronal development. Numb 
is thought to activate the GEF activity of Intersectin to promote the actin cytoskeleton 
re-arrangement mediated by the Cdc42, which is required during the morphogenesis of 
the dendritic spines. In addition, the PH domain of the Intersectin was also shown to act 
together with the DH domain in the regulation of the GTPase activity [67].
2.2.5 In tersectin  and exocvtosis
In agreement with the ability of Intersectin-1 long isoform to activate Cdc42, Intersectin 
was found to play a role in the Cdc42-mediated exocytic pathways [68]. In further 
support of its role in exocytosis, rat Intersectins EHSH1 and EHSH2 were shown to 
interact with an exocytic protein, SNAP-25 (Synaptosomal associated protein of 25kD) 
in yeast two hybrid screens [54]. SNAP-25 was originally identified as a synaptosomal 
protein [69]. It was later discovered as a protein targeted by the Botulinum neurotoxin 
type-B, indicating that it is a component of the core complex in the docking of vesicles 
to the plasma membrane during exocytosis [70].
Another interactor of Intersectin involved in exocytosis, is SCAMPI, a secretory 
protein also implicated in endocytosis, that binds to Intersectin’s EH domains [52]. The 
fact that Intersectin-1L plays a role in the actin cytoskeleton organization required 
during exocytosis implies that Intersectin is an adaptor protein, which coordinates the 
membrane trafficking of both endocytosis and exocytosis.
2.2.6 In tersectin  and m itogen ic  sign alling
In addition to interactions with endocytic proteins such as Dynamin, the SH3 domains
28
of Intersectin also mediate the interactions with several proteins that regulate cellular 
signaling pathways. For example, Intersectin forms complexes with the guanine 
nucleotide exchange factor, Sos, to stimulate Ras activation specifically on 
endomembrane compartments [71, 72]. More recently, it was shown that Intersectin 
associates with the Cbl, an E3 ligase of EGFR, and this association promotes the 
receptor ubiquitylation and degradation [73].
In addition, Intersectin expression was sufficient to induce an oncogenic transformation 
of rodent fibroblasts. The overexpression of the tandem EH domains of Intersectin was 
found to be sufficient to activate the Elk-1 transcription factor in a MAPK-independent 
manner [74]. Furthermore, Intersectin cooperated with epidermal growth factor to 
potentiate Elk-1 activation.
The function of Intersectin-L in cell growth signalling was further investigated when the 
substrate of its GEF activity, Cdc42, was implicated in cell transformation. It was 
reported that the mutated Cdc42 (Cdc42 (F28L)), which is constitutively active, 
activated c-Jun Kinase (JNK) and induced transformation of the cultured fibroblast cells 
[75]. Various portions of Intersectin-L are able to transform cultured cells and 
mutational studies on the DH and the SH3 domains indicated that both regions are 
required for the activation of JNK and PI3K (Phophatidyl-inositol-3 Kinase) [76]. The 
study suggested a complex interplay between the activation of the pathways of Ras and 
Cdc42 in the cell proliferation control. Together, these data suggest that Intersectin links 
endocytosis with regulation of pathways important for cell growth and differentiation.
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2.2.7 O ther fu n ction s o f  In tersectin
Recently, Intersectin was found localized at the caveolar-neck in endothelial cells. The 
study demonstrated that Intersectin is required for an efficient fission of caveolae, 
suggesting that, through its interaction with dynamin, it also plays a role in clathrin- 
independent but dynamin-dependent internalization [77].
As mentioned earlier in the introduction section 2.2.1, the EH domain of the Xenopus 
Intersectin was shown to interact with Hrb and Hrbl, The interactions with Hrb/Hrb-1, 
which were previously described as interactors of the EH domain of Epsl5, suggesting 
a possible role for Intersectin in nucleo-cytosolic shuttling [14].
Intersectin was also found to play a role in cell survival. Decreasing Intersectin 
expression dramatically increased apoptosis in both neuroblastoma cells and primary 
cortical neurons [78] and in endothelial cells [79]. A yeast two-hybrid analysis 
identified class II phosphoinositide 3'-kinase C2beta (PI3K-C2beta) as an Intersectin- 
binding protein, suggesting that Intersectin may regulate a PI3K-C2beta-AKT survival 
pathway.
2.3 Reps family
2.3.1 In troduction  on  the Reps fam ily
The Reps family is composed of two closely related proteins, Repsl and Reps2/POBl 
(Figure F). Repsl was first identified as a human gene, encoding for an interactor of 
RalBPl, (RalBPl-Eps homology domain protein 1) [80], but homologous proteins have 
been identified in Drosophila and C. elegans. Reps family proteins contain one EH 
domain, a proline-rich domain, and the RalBPl binding domain. The EH domain of
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P0B1 interacts with an EH protein, Epsl5, and an endocytic adaptor protein, Epsin, that 
also interacts with Epsl5 and Intersectin (See Sections 2.1.2 and 2.2.2). The interaction 
with another EH protein mediated by an EH domain has so far been observed only for 
POB1, and the nature of this interaction will be discussed in the following section 2.3.2. 
In addition to endocytic interactors, Reps/POBl family is likely to participate in various 
processes that involve RalBPl. RalBPl binds specifically to GTP-bound form of Ral 
proteins, which are a family of multifunctional small GTPases in mammalian cells, 
regulating processes as diverse as membrane transport, apoptosis, transcription, cell 
migration, cell proliferation and oncogenesis [81]. In agreement with the role of RalBPl 
in oncogenesis, POB1 expression was found to be downregulated during the 
progression of prostate cancer. It was suggested that POB1 is involved in growth factor 
signalling through Ral, and the decreased level of POB 1 leads to the loss of control of 
cell proliferation in tumorigenic cells [82].
Figure F. The structures o f Repsl and POB1. (Taken from the review by Santolini et al.
[3])
EHRepsl PxxP
EHPOB1 PxxP
RalBPl binding domainEH domainEH
Proline-rich domain Coiled-coil regionPxxP
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2.3.2 R ep sl/P O B l in  en d ocytosis
Both Repsl and Reps2/POBl are tyrosine-phosphorylated upon EGF stimulation, 
leading to the interaction between these proteins and the EGFR [80, 83]. Moreover, 
overexpression of the EH domain of POB 1 leads to a decreased internalization of EGFR 
and Tn snl in receptor, suggesting that POB 1 regulates receptor internalization and that 
the EH domain is important for this function. Pull-down experiments using a GST- 
fusion protein of the EH domain of POB1 from the bovine brain membrane extracts 
identified Epsl5 and Epsin [15]. Interestingly, in the report by Nakashima et al, the 
binding of the EH domain of POB1 to Epsl5 C-terminal region suggested that the 
POB1 EH domain is capable of binding to a region not containing NPF motifs [15]. 
Indeed, the EH domain of POB1 was shown to recognize the DPF motifs, many of 
which are present in the C-terminal region of Epsl5 [84].
During the mitotic phase, Epsin, POB1 and Epsl5 are serine- phosphorylated and this 
phosphorylation inhibits the complex formation, suggesting that the complex is 
involved in the specific control of endocytosis during the mitosis [85].
2.3.3 R ep sl/P O B l and R ecycling
Repsl also plays a role in endosomal recycling, as suggested by its interaction with a 
member of the Rabl 1-binding protein family, Rabll-FIP2 [86]. Rab proteins such as 
Rab4 and Rabll, orchestrate the protein sorting into the endocytic recycling 
compartments (ERC) at the early endosomes, and out of the ERC at the plasma 
membrane. Rabl 1-FIP2 is one of the Rabl 1-binding effector proteins that function with 
the Rab proteins in the endosomal recycling. It also interacts with Myosin Vb [87], and 
it was shown to associate with the endosomal membrane [88]. Interestingly, Rabll- 
FIP2 also interacts with another EH protein family, the EHD family of proteins that are
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mainly implicated in the endocytic recycling and endosomal transport [89]. This will be 
discussed later in the section on the EHD family, in Section 2.5.2.
2.3.4 R ep sl/P O B l and cell m igration
An additional function of POB 1 is indicated by the interaction between the third proline- 
rich region in the C-terminal domain to the SH3 domain of AS API, a mouse homologue 
of a human protein PAG2, a paxillin-associated protein, which inhibits the fibronectin- 
dependent migration and paxillin recruitment to focal contacts. The study suggested a 
role o f POB 1 in cell migration through its interaction with PAG2 [90].
2.4 EHD family
2.4.1 In trod uction  on  the EHD fam ily
The main feature of the EHD family of proteins is that they all contain a C-terminal EH 
domain rather than an N-terminal one, like the Epsl5 and Intersectin families (Figure 
B). The EHD family has been found to be conserved in nematode, fly, mouse and 
human, and one EHD1 gene in the human malaria parasite, Plasmodium falciparum has 
also been reported [91]. The EHD1 gene has been studied as a candidate gene found in 
the locus of two different pathologies, the Multiple Endocrine Neoplasia 1 (MEN1) [92] 
and Bardet-Biedl Syndrome (BBS 1) [93, 94].
Following the identification of EHD1, three other members of the mammalian EHD
family have been identified, namely EHD2, EHD3 and EHD4 [95]. As indicated in
Figure B, EHD proteins also contain a coiled-coil domain in the central region, as well
as a nucleotide-binding region near the N-terminus [96]. Numerous studies have
indicated that the nucleotide-binding is a crucial mechanism in the function of the EHD
proteins. For example, the homo-/hetero-oligomerization of the EHD proteins that is
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mediated by the coiled-coil region was shown to be an ATP-dependent process [97, 98]. 
Similarly, the association with membrane structure was shown to be nucleotide- 
dependent [99]. This will be discussed in the section 2.4.4.
2.4.2 EHD protein s and recyclin g
The EHDs share many common features with the dynamin superfamily, such as a low 
affinity for nucleotides, ability to tubulate liposomes in vitro, oligomerization around 
lipid tubules in ring-like structures and stimulated nucleotide hydrolysis in response to 
lipid binding [100]. As previously mentioned in the section 2.1.2, dynamin is a GTPase 
that allows the fission of the neck of vesicles at the membrane. Despite the similarities 
between EHD proteins and dynamin, numerous studies on EHD proteins have revealed 
that they are involved in the recycling of endocytic compartments rather than the fission 
of vesicles during endocytosis.
An in vivo assay of yolk-protein uptake in C. elegans demonstrated that the C. elegans 
homologue of EHD1, RME-1, is involved in the recycling of vitellogenin receptors 
internalized by clathrin-dependent endocytosis [99]. A recent report in C. elegans 
showed that RME-1 interacts with ALX-1, a member of Alix/Brolp family that 
interacts with the endosomal ESCRT complex-I and -HI. The interaction between RME- 
1 and ALX-1 is required for the recycling from the endosomes to the plasma membrane 
[101].
Studies on mammalian EHD proteins also revealed that they play a role in the 
trafficking of endocytic recycling compartments (ERC). The receptors that have been 
shown to be recycled to the plasma membrane in a EHD 1-dependent manner are: 
transferrin receptors [102], cystic fibrosis transmembrane conductance regulator [103],
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the insulin-regulated GLUT4 [104, 105], and AMPA-type glutamate receptors at the 
post-synaptic membranes [106].
To date, EHD1, EHD2 and EHD3 were shown to interact with the Rab-binding 
proteins, providing a physical link to the Rab family of proteins that coordinate the 
sorting of proteins in the ERC. As briefly mentioned in the section 2.3.3, EHD1 and 
EHD3 interact with an effector protein of Rabll, Rabll-FIP2 [89]. In addition to 
Rabll-FIP2, the EH domains of the mammalian EHD1 and EHD2 interact with the 
NPF motifs of Rabenosyn-5 [107], which forms a complex with Rab 4 or Rab5 GTPase 
proteins and hVPS45 [108, 109].
Syndapins, which are interactors of Dynamin and N-WASP, and play a role in 
endocytosis, vesicle recycling, and actin organization [110, 111], were also shown to 
interact with the EHD proteins. The EH domains of four EHD proteins (EHD1, EHD3, 
EHD4 and C. elegans RME-1) interact with the NPF motifs present in Syndapin I and 
Syndapin II [112].
Furthermore, EHD1 was found localized on tubular structures that associate with ADP- 
ribosylation factor 6 (Arf6), which mediates the internalization of Major 
Histocompatibility Complex 1 (MHC-I) via lipid raft [98]. Other EHD proteins were 
also found to play a role in the Arf-6-mediated endosomal transport of non-clathrin 
endocytic compartments. For example, the EHD protein homologue in Drosophila, 
dEHD, and the mammalian EHD4 were both shown to interact with Numb [113], an 
NPF-containing protein that interacts also with Epsl5 and Intersectin (Refer to the 
Sections 2.1.5 and 2.2.4). The interaction between EHD4 or dEHD and the NPF-motifs 
in the C-terminal of Numb was shown to be induced at sites of Arf6-mediated endocytic
recycling [113]. Moreover, EHD4 was shown to co-localize with the markers of early 
endosomes, such as Rab5 and early embryonic antigen 1 (EEA1), and the endosomes in 
which EHD4 was localized were Arf6-containing endosomes [113]. Furthermore, a very 
recent report on EHD1 and EHD4 implicates both EHD proteins in the early endosomal 
transport of the clathrin-independent endocytic compartments [114].
2.4.3 EHD p rotein s and v e s ic le  fu sion
EHD1 interacts with a SNARE protein SNAP-29 [115, 116]. SNAP-29 and EHD1 were 
found in a complex with Insulin-like Growth Factor 1 Receptor (IGFR) and were thus 
implicated in the regulation of the IGF-signalling pathway [115]. However, SNAP-29 
has been reported as a general SNARE protein implicated in synaptic transmission [117, 
118] and it was shown to inhibit the disassembly of SNARE complex [119]. Taking 
into consideration that SNAP-29 shares 39% sequence similarity to neuronal specific 
SNARE protein SNAP-25, and 35% similarity to ubiquitous SNAP, SNAP-23 [115], 
the interaction between SNAP-29 and EHD1 may participate in the vesicle fusion 
events both at the synapse and at the endocytic sites in non-neuronal cells.
2.4.4. EHD protein s and m em brane rem od ellin g
Recently, EHD2 was shown to interact with membrane phospholipids, implicating the 
EHD proteins in the induction of membrane curvature [100, 120]. As mentioned earlier 
briefly in the introduction, the nucleotide-binding domain of EHD is required for the 
oligomerization of the proteins. In turn, the oligomerization of EHD proteins uncovers a 
highly curved membrane-binding domain. In agreement with this model, the mouse and 
C. elegans EHD1 were shown to bind and hydrolyse ATP, and the interaction with ATP 
was shown to be a prerequisite for EHD to bind to the endosomal membrane [121].
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The interactions between EHD1 or EHD3 and the NPF motifs of endosomal recycling 
proteins such as Rabll-FIP2, Rabenosyn-5 and Syndapins (See Section 2.4.2), were 
shown to be reduced when the nucleotide-binding to the p-loop of the EHD proteins 
was impaired [89]. A study with the mutated oligomerization domain of EHD 1 and 
EHD3 demonstrated that oligomerization is also required for the interaction between the 
EH domain of the EHD proteins and NPF motifs [89]. The nucleotide-binding and the 
oligomerization of EHD proteins are required for the EHD binding to the membrane. 
These data together suggest that the EHD proteins are localized at the endosomal 
membranes when they interact with NPF-containing proteins, thereby recruiting the 
interactors to the endosomal or synaptic vesicle recycling compartments.
2.4.5 EHD protein s and actin  cy tosk eleton
The interaction of EHD proteins with Syndapin I and II, which were described in the 
previous section 2.4.2, implicates the EHD proteins in the actin cytoskeleton 
organization. Syndapins are thought to act as the link between the endocytosis and actin 
remodelling [111]. The EH domain of EHD2 was shown to interact with the NPF motif 
of EHBP1 (EHD2-Binding Protein 1) [122]. EHD2 and EHBP1 were shown to function 
in the endocytosis of receptors such as GLUT4 and transferrin in adipocytes. More 
interestingly, EHD2 and EHBP1 were demonstrated to regulate actin cytoskeleton 
organization through an acidic region and a CH (Calponin Homology) domain, 
respectively. The acidic region adjacent to the EH domain in EHD2 has been suggested 
to act as an Arp2/3-binding motif, emphasizing the link between the endocytosis and the 
actin rearrangement by the complex of EHD2 and EHBP1. Syndapins, which have been 
described previously in this section as binding partners of EHD proteins [112], were 
suggested as the coordinators of the machinery for the actin nucleation events at various 
stages of endocytosis [123].
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2.4.6 EHD and endosom al sign alling
An implication of EHD proteins in the endosomal signalling comes from the studies on 
an EHD family protein, Pincher, which is most similar to the EHD5. Pincher acts in the 
Nerve Growth Factor (NGF)-induced pinocytosis of TrkA receptor, and it is involved in 
retrograde signalling of Trk-signalling endosomes [124]. Retrograde transport of the 
neurotrophic signal, such as NGF activation of TrkA, is a critical process in promoting 
the cell survival of neurons. In neurons, receptors such as TrkA, are activated by 
neutrophins at the axonal terminal. The activated receptors'-are internalized and are 
transported in endosomes rapidly to the cell bodies, utilizing the transport through the 
cytoplasm that is motored by dynein [125].
As the receptors internalized via clathrin-dependent pathway are usually destined for 
degradation or recycling to the plasma membrane, the internalization of the 
neurotrophin receptors is thought to occur via clathrin-independent pathways, in order 
to transport the signal. Neutrophin signalling in neurons is a critical process for 
maintaining the cell survival, and the failure of such process is thought to be the cause 
of the loss of neurons observed in the patients with neurodegenerative diseases. The 
implication of the EH proteins and their interactors in the neurodegenerative diseases 
will be discussed at length in the Discussion (Section 16.2).
2.5 y-Synergin
y-synergin is an EH domain-containing protein, which was found as an interactor of y-
adaptin, a subunit of the adaptor protein complex-1 (AP-1). AP-1 is a complex of
adaptor proteins that orchestrates the clathrin-coat assembly at the Trans Golgi Network
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(TGN) [126]. y-synergin was found associated with AP-1 in the cytosol, on the 
membranes of the TGN, and in the clathrin-coated vesicles [127]. The structure of y- 
synergin consists of an EH domain and the y-binding domain in the central region of the 
protein, as illustrated in Figure G. The alternative splice sites (AS) and the copies of the 
DDFD/EXF motifs (D), will not be discussed here as they are not crucial for the 
function as an EH protein.
The EH domain of y-synergin interacts with an NPF-containing protein SCAMPI [128], 
which was initially implicated in exocytosis. It also interacts with Intersectin, as 
described in the section 2.2.6. The transmembrane protein SCAMPI is suggested to act 
as the docking site for the cytosolic y-synergin at the membrane of the TGN.
Figure G. The structure o f gamma-synergin
(a) the alignment of the EH domain of y-synergin with the other EH domains (b).
(Taken from Figure 3 of the article by Page et al. [127])
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In addition, y-synergin was recently found in a stable complex with Aftiphilin and p200 
that assists the function of AP-1 [129]. The targeting of y-synergin to the TGN is 
thought to be mediated via the signal sequence found in the y-adaptin of AP-1 [130]. y- 
synergin was also shown to interact with the ears of Golgi-localized, y-ear containing,
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ARF-binding proteins (GGAs), a family of monomeric adaptor proteins that contain the 
C-terminal regions homologous to y-adaptin [131-134].
In comparison to the other EH proteins, the various interactors of y-synergin that have 
been identified to date implicated its function specific to the assembly of the clathrin- 
coated vesicles at the TGN, a crucial process in protein secretion. The specific function 
may rise from the fact that y-synergin is an EH protein specific to mammals, although 
putative homologues have been identified in the other species, characterized to date. 
Moreover, the protein structure of y-synergin consists of only two domains, the EH 
domains and the y-binding domain, whereas the other EH proteins contain binding sites 
for diverse proteins . The predicted C. elegans homologue of y-synergin encoded by the 
gene R10E11.6 has remained an uncharacterized gene to date. Y2H screenings in this 
study searched the C. elegans genome for any interactors of the putative EH domain of 
R10E11.6.
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3. Experimental Approach
3.1 Introduction
The current knowledge of the EH domain-containing proteins (EH proteins) and their 
interactors illustrates that the proteins in the EH network are involved not only in 
endocytosis, hut in various intracellular processes. In order to better understand the 
extent of the network of different intracellular signalling pathways mediated by the EH 
proteins, this project was designed as a genome-wide screening of interactors of EH 
proteins in a model system, C. elegans.
The nematode was chosen for several reasons. For example, the C. elegans genome 
contains single non-redundant homologues of each four major EH protein families. C. 
elegans has also been established as an ideal organism for in vivo genetic studies, which 
were carried out subsequent to the Y2H screenings. The advantages of using C. elegans 
as a model system will be explored in detail in the following section.
The aim of this study was to identify all putative interactors of EH proteins in the whole 
genome of the model system. Therefore, the EH domains of each EH protein present in 
the C. elegans genome were cloned as separate baits for Y2H screenings against a G. 
elegans cDNA library.
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3.2 Yeast Two Hybrid Screenings
3.2.1 In troduction  to  the Y2H system
Y2H system is a widely used technique to test the interaction between two moieties. It 
utilizes the yeast genetic system to select the cDNAs (“preys”) that encode the proteins 
that bind to the target, or the “bait” proteins. The bait is usually cloned in-frame with 
the DNA binding domain (BD) whereas the prey cDNA is cloned in-frame with the 
transcription activation domain (AD), to express two recombinant proteins in yeast 
(Figure H). When the prey that is expressed in-frame with the AD interacts with the 
bait protein, the complex of the hybrid proteins form a functional transcriptional 
activator.
In this study, the hybrid proteins with the GAL4-DBD and GALA-AD were used. The 
genome of the strain Mav203 of S. cerevisiae, which was used in this study, contains 
three reporter genes with the GAL4-promoter region. Transcription activation of the 
reporter genes such as URA3 and HIS3 are monitored by growth in the selective 
medium lacking uracil and/or histidine, In comparison, the activation of the third 
reporter gene, LacZ, is detected by an assay called the X-gal assay, in which the (3- 
galactosidase encoded by LacZ catalyses the reaction of X-gal, resulting in the colour 
change from white to blue yeast cells.
3.2.1 A dvantages o f  the Y2H system
The strongest advantage of the Y2H system is that the bait can be designed to contain a 
limited fragment of a protein, such as a specific domain, as seen in this study. A bait 
engineered to contain mutations of interest can also be tested in comparison to the 
interaction mediated by the wild type bait. For example, Naslavsky et al. mutated the
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critical residue of the nucleotide-binding domain of EHD1 and EHD3 (G65R) and 
tested the oligomerization of EHD1 and EHD3 by Y2H [89].
Figure H. Yeast Two Hybrid system for detecting protein interactions.
(1) The interaction surfaces on bait in the recombinant protein 1 (Hybrid 1) and the 
prey in the recombinant protein 2 (Hybrid 2) interact to form a complex. (2) The DBD 
binds to the upstream activating sequence (UAS) of the reporter gene. (3) The AD 
stimulates the assembly of the transcription initiation complex at the promoter region of 
the reporter gene. (4) The transcription of the reporter gene is activated.
Hybrid 1 ~ Hybrid 2
1 .  i n t e r a c t i o n
2. DBD binding to the UAS
3. Assem biyof 
Transcription initiation 
complex
4. Expression of 
the reporter gene
P r o m o t e r  ' e g  o n R e p o r t e r  g e n e
The technique of cDNA library preparation has enabled the application of the Y2H 
system a genome-wide screenings. Furthermore, the possibility to use the cDNA library 
as the prey allows the identification and the cloning of the putative interactor directly 
from the plasmid purified. The use of yeast system also allows an easy handling and 
maintains a low cost, even with large-scale transformations, such as that needed in 
screenings. For the analysis of two candidate interactors, only a small amount of DNA, 
lng of each recombinant construct, is sufficient to obtain several clones to be tested for 
the expression of the reporter genes, providing a quick and easy method.
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In comparison to Y2H, interactors identified by other biochemical approaches, such as 
co-immunoprecipitation coupled with the protein identification by mass spectrometry, 
may be biased, depending on the sample preparation. In the case of co- 
immunoprecipitation, the representation of proteins found in the sample can be affected 
by several factors. For example, the protein population purified from cell lysates may 
vary due to the endogenous level of expression, the conditions of cell lysis buffer and 
the sensitivity of the instrument used for the identification of the protein mixture. By 
expressing putative interactors in yeast, even weak or transient interactions can be 
detected by Y2H system. ~
3.1.2 D isad vantages o f  Y2H system
On the other hand, Y2H system has a major disadvantage that interactions shown by the 
system may be false positives. When the hybrid proteins are expressed in yeast, they are 
confined in a small space, enabling proteins to interact even though they are often not 
localized together in a physiological condition. For example, a nuclear protein may 
interact with a plasma membrane protein, simply because they contain sequences that 
are “sticky”. The intracellular localization and the expression pattern in tissues should 
be considered when analyzing the interactions identified by the Y2H system.
Therefore, different methods to detect protein-protein interactions should be used to 
complement each other. Y2H system is more suitable for a large-scale screening to fish 
out putative interactors from a mixed population of proteins expressed by cDNA library. 
The interactions identified in the Y2H should be validated by in vitro pull-down assays, 
or by a method that better reflects the endogenous interactions, such as co- 
immunoprecipitation.
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3.2 C. elegans as a model system
C. elegans is a favourite model organism for genetic studies, such as the one carried out 
in this project. The main benefit of C. elegans for this study is that the EH protein 
families were represented by one non-redundant homologue in its genome. For instance, 
C. elegans contain one Epsl5 homologue (EHS-1) and one Intersectin homologue (ITSN- 
1), whereas S. cerevisiae EH proteins such as Panlp, End3p and Edelp do not contain the 
other non-EH domains to match as the clear homologues of the mammalian Epsl5 and 
Intersectin. Instead, each mammalian EH protein family contains different members, as 
described for each family in the Section 2 of the introduction.
C. elegans was an appropriate model system to study the EH network also for the fact 
that there are mutant strains available for ehs-1 [19], itsn-1 [63], and rme-1 [99], and a 
recently discovered reps-1. The reported phenotypes of the EH mutants allowed the 
monitoring of genetic interactions with the putative interactors identified in the Y2H 
system.
In addition to the advantages specific to this project in using C. elegans, there are 
numerous advantages of C. elegans as a model system per se. First of all, C. elegans 
provides several practical advantages in laboratories. They are small (approximately 
1mm in length) and easy to cultivate, and E. coli, on which they feed, and the medium 
required for cultivation, are cheap. Moreover, the organism is transparent, allowing the 
cells of interest to be studied under the microscope in vivo..
The short life cycle is another factor that facilitates the cultivation of C. elegans in 
laboratory. C. elegans reach adulthood at an optimum temperature of 25°C in 3 days. 
Cultures of C. elegans can be maintained at a temperature from the range of 12°C to
25°C. This allows an additional benefit as the growth rate of the cultured nematodes can 
be increased or decreased depending on the temperature. The oocytes are self-fertilized in 
the spermateca in the hermaphrodite nematodes, the embryos develop in eggs until the 
eggs are laid. Worms of larval stage 1 (LI) hatch from the eggs, and develop through 
various larval stages from the LI to L2, to L3 and to L4, until the worms reach the 
adulthood. Hermaphrodites can produce offspring also by mating with males, which are 
formed by stress-induced mutations. Therefore, a cultured strain of C. elegans can be 
induced to form males, which can then be used as means of crossing strains.
The ability to synchronize the growth of C. elegans was another useful characteristic, in 
the genetic studies carried out during this project. In the experiments that monitored the 
genetic interaction in this study required hundreds of worms to have reached the same 
developmental stage. By starving the LI larvae that hatched from the eggs isolated from 
the hermaphrodite mothers and leaving the synchronized Lis to grow at a stable 
temperature provided young adult worms on the day of the experiment.
The vast collection of data already available from the past studies provides another 
advantage for the C. elegans community. The genome of C. elegans has been completely 
sequenced and the information is publicly available through a database called the 
Wormbase, accessed via the Internet at http://www.wormbase.org. The database contains 
not only sequence information, but also experimental data, such as the phenotypes 
observed of mutants or of knock-down animals during the RNAz screenings of the 
genome. The expression of the protein can be found as well, where available, and the 
alignments of sequences with the genes of other species can also be found. In addition, 
experimental reagents are also readily shared amongst the C. elegans community. For 
example, reagents such as mutants, and the Expression Sequenced Tags (ESTs) are
available through various laboratories, such as the C. elegans Gene Knockout 
Consortium, the National Bioresource Project-Japan and the Nematode Expression 
Pattern Database in the National Institute of Genetics in Japan. Furthermore, the genetic 
studies hy in vivo RNAz by feeding in the strains of the EH mutants were carried out 
using many of the C. elegans RNAz library, which contains the bacterial strains 
expressing the double-stranded RNA specific for 87% of the whole genome [135].
3.2.2. S tu d ies o f G enetic  in teraction s u sin g  aldicarb  
hvp er/hyp osensitive  m utants o f  C. elegans ~
The protein interactions identified in the Y2H screenings in this study were first studied
by in vitro pull-down assays for validation of the Y2H results. As a further step of 
validation, the genes encoding the EH interactors identified by the Y2H screenings were 
examined whether they genetically interact with the genes encoding the four EH proteins. 
However, it must be noted that the genetic interactions give an indication that the genes 
are involved in the same signalling pathways, do not validate the physical interaction 
between two proteins, such as that shown by the Y2H system or by the in vitro pull-down 
assays. The genes encoding the EH interactors were knocked-down by RNAz by feeding 
in the mutants of four EH genes, namely itsn-1, ehs-1, reps-1 and rme-1.
The mutants of two EH genes, itsn-1 and ehs-1 both display phenotypes different to that 
of the wild type N2 Bristol strain, when treated with a compound called aldicarb. The 
deletion mutant of ehs-1 (okl46) has been reported to be aldicarb resistant [19], whereas 
itsn-1 (ok268) is aldicarb hypersensitive [63].
Aldicarb, a compound commonly used as a pesticide is a competitive inhibitor of 
acetylcholine esterase. The structure of aldicarb mimics that of acetylcholine, as shown in 
the illustration below [136]:
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Inhibition of acetylcholine esterase results in the accumulation of acetylcholine in the 
synaptic cleft. At the level of a whole organism, for example in C. elegans, the 
accumulation of acetylcholine results in a paralysis that can be monitored by the 
insensitivity to touch stimuli. Therefore, in the genetic background of the ehs-1 mutant 
strain, a higher concentration of aldicarb, or a longer incubation time than that for the 
wild type, is required to reach the level of acetylcholine in the synaptic cleft that 
manifests in paralysis. In comparison, a lower concentration or a shorter incubation time 
is sufficient for itsn-1 worms to stop responding to the touch stimuli than that for the wild 
type.
The mutant strain of rme-1 (bl045) was characterized to have a defect in the endocytosis 
of yolk protein vitellogenin YP170 in the oocytes, as well as a reduced brood size, but no 
phenotype related to aldicarb treatment has been reported [99]. Therefore, the response to 
aldicarb by the rme-1 mutant and the recently found reps-1 mutant, which is yet 
uncharacterized, were also studied in this project.
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4. Summary of the Introduction
The EH domain, which has been shown to interact with NPF motif-containing proteins, 
was found conserved through evolution. The EH domain-containing proteins that are 
found across species are Epsl5 family, Intersectin family, EHD family, Reps/POB 
family, and y-synergin. Each family of the EH proteins interact with a number of 
interactors, through which they are involved in diverse intracellular trafficking, such as 
clathrin-dependent and -independent endocytosis, endosomal recycling, vesicle assembly 
at the TGN, and nucleo-cytosolic shuttling, Other intracellular processes such as actin 
cytoskeleton organization, cell fate determination and mitogenic signalling are also found 
under the EH network.
To date, the extensive picture of the EH network is made up of different studies, mainly 
overexpression studies in mammalian cell lines, that have shown the functions of the EH 
proteins or that of the EH interactors. This study aimed to dissect the EH network in C. 
elegans, by identifying the interactors of the EH domains and testing the biological 
relevance of the interactions in a whole organism. Furthermore, C. elegans give us the 
unique possibility to analyse the impact of the EH network in complex circuits such as 
synaptic transmission. The interactors identified in this study illustrate a network of 
proteins that span from the plasma membrane to the nucleus, participating in diverse 
trafficking and signalling events in non-polarized cells and polarized cells such as 
neurons.
H. MATERIALS AND METHODS
5. Materials
5.1 Medium for Escherichia. Coli
5.1.1 SOC m edium
20 g of tryptone, 5 g of yeast extract, and 0.5 g of NaCl was dissolved into 950 ml of 
CIH2 O. 10 ml of a 250 mM KC1 was added and the pH was adjusted to pH 7.0 with 
5N NaOH. The total volume of the solution was adjusted to 1 L with distilled water 
(CIH2 O) and the solution was sterilized by autoclaving. After the autoclavation, 5ml 
of sterile 2M MgCL and 20 ml of sterile 1M glucose were added.
5.1.2 LB m edium  (Luria B roth l
10 g of tryptone, 5 g of yeast extract, 10 g NaCl was added to 950 ml of dH20 and 
the pH was adjusted to pH 7.0 with 5N NaCl. The total volume was adjusted to 1 L 
with cfflbO. The medium was sterilized by autoclaving. The antibiotics, Ampicillin or 
Kanamycin, were added after the autoclaving to the final concentration of 50jig/ml to 
make a selective medium appropriate for the strain of E. Coli used. 15 g/L of 
Bactoagar was added and sterilized for preparations of solid LB medium
5.2 Medium and specific solutions for Saccharomyces 
Cerevisiae
5.2.1 YPD m edium
10 g of BactoYeast extract, 20 g of BactoPeptone and 20 g of dextrose were dissolved 
in 1 L of (IH2O. The medium was autoclaved for sterilization.
5.2.2 YPAD so lid  m edium
20 g of bactoagar was added to YPD medium and was sterilized by autoclaving.
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0.02 mg of adenine sulphate (Sigma-Aldrich) was added immediately after autoclaving. 
The medium was poured into plates and was left to solidify at room temperature. The 
plates were stored at room temperature.
5.2.3 S yn th etic  C om plete (SC) m ed ium
5.2.3.1 “Drop-out” mix of Amino Acids
3 g of each essential amino acids (purchased from Sigma-Aldrich) except for Leucine, 
Tryptophan, Histidine and Uracil were mixed. The container was wrapped with an 
aluminium foil to avoid damage by light, and was stored at room temperature.
5.2.3.2 SC medium (pH 5.9)
10 g of ammonium sulphate, 3.4 g of yeast nitrogen base (without amino acids) and 2.7 
g of amino acid “drop-out” mix were dissolved in CIH2 O to a final volume of 1 L. The 
pH was adjusted to pH 5.9 with ION NaOH, and the medium was sterilized by 
autoclaving. After the autoclaving, 80 ml of sterile 40% glucose was added.
Additional amino acids namely Uracil, Histidine, Leucine and Tryptophan, were 
dissolved in (IH2 O and sterilized by filtration through 0.22 pm filters and were added as 
necessary according to Table A shown below. 20 g of bactoagar per litre of SC medium 
was added to make a solid medium. The solid medium was stored at room temperature. 
Table A: Composition of the amino acids added to the selective SC medium
Amino Acid 
(AA)
Molarity (mM) Volume per L of 
medium (ml)
Final Cone, of AA 
(mM)
Uracil 10 16 0.16
Histidine 100 8 0.8
Leucine 100 8 0.8
Tryptophan 40 8 0.32
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5.233  lONNaOH
40 g of NaOH was dissolved in a total of 80 ml of dH20  by stirring continuously. The 
total volume was adjusted to 100 ml with dH20.5.2.4 Solutions for yeast transformation
5.2.4.1 50% PolyEthylene Glycol (PEG)
75 g of PEG was dissolved in 150 ml of dH20  and was filtered through 0.22 pm filter 
for sterilization.
5.2.4.2 lOx Lithium Acetate (LiAc)
10.2 g of LiAc was dissolved in a total volume of 100 ml in dH20  to give a 1M 
solution, and was autoclaved for sterilization.
5.2.4.3 PEG/LiAc
40 ml of 50% PEG and 5 ml of lOx TE buffer, and 5 ml of 1M LiAc were mixed to give 
a total of 50 ml of PEG/LiAc.
5.2.4.4 lx  TE/LiAc
1 ml of lOx TE buffer, 1 ml of 1M LiAc and 8 ml of sterile dH20  were mixed.
5.2.5.So lu tion s for X-gal assays
5.2.5.1 Buffer Z
16.1 g of Na2HP04 * 7H20, 5.5 g of NaH2P04 • H20 , 0.75 g of KC1, 0.246 g of 
MgS04 • 7H20  were dissolved in 1 L of autoclaved dH20 , and the solution was 
adjusted to pH7.0. The solution was filtered for sterilization.
5.2.5.2 X-gal in DMF (stock solution of 20mg/ml)
20 mg of X-gal (5-bromo-5-chloro-3-indolyl-D-galactoside) was dissolved in 1 ml of 
DMF (N, N-dimethyl formamide) and was stored in an eppendorf tube wrapped in foil 
at -20°C until use.
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5.2.5.3 X-gal Assay Buffer
250 ill of X-gal stock solution and 30 ul of p-mercaptoethanol were mixed in 5 ml of 
Buffer Z.
5.3. Medium and specific solutions used for Caenorhabditis 
elegans
5.3.1 NGM (liquid  and so lid  m edium )
4 g of Sodium Chloride (NaCl), 50 ml of Potassium phosphate (KH2PO4 ) at pH6.0, 3 g 
of Bactopeptone 21 g of Bacto-agar were dissolved and brought to a total volume of 1 L 
with dTLO. In the case of liquid medium, the bacto-agar was omitted. The solution was 
sterilized by autoclaving. After the sterilization, 1 ml of cholesterol solution in ethanol 
(5 mg/ml), 3 ml of sterile 1M Magnesium sulphate (MgS04), 3 ml of sterile 1M 
Calcium Chloride (CaCL) and 10 ml of sterile Trace Metal Solution were added. The 
liquid medium was kept at room temperature. Once the medium was solidified in plates, 
each plate was seeded with an overnight culture of E. Coli strain OP50 grown in LB. 
The seeded plates were incubated at 37°C to allow the bacterial lawn to grow on the 
surface. The plates were stored at 15°C.
5.3.1.1 Cholesterol 5mg/ml in ethanol
500 mg of cholesterol was dissolved in 400 ml of 100% ethanol, and the final volume 
was brought to 500 ml with 100% ethanol.
5.3.1.2 MgS04
1M solution of MgS04 was made in dELO and sterilized by autoclaving.
5.3.1.3 CaCI2
1M solution of CaC12 was made in dELO and sterilized by autoclaving.
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5.3.2 A ldicarb so lu tion  (IQOmM)
100 mM solution of aldicarb was made in cUTiO and was kept at 4°C till use.
5.3.3 0.5mM A ldicarb p lates
5 ml of lOOmM aldicarb was added to 1 L of NGM agar and the medium was poured 
into 6-well plates. The medium was allowed to solidify at room temperature before 15 
kul of an overnight culture of E. Coli OP50 was spotted in the centre of each well. The 
plates were incubated at 37°C overnight to allow the OP50 to grow. The plates were 
stored at 15°C.
5.3.4 B leach in g  Solu tion  for th e  egg  preparation  o f C. elesans
5 ml of 2N NaOH, 4 ml of 5% alkaline hypochlorite, and 1 ml of cffi^O were mixed
together.
5.4. Materials for Molecular Biology
5.4.1 5Ox TAE (Tris-Acetate-EDTA) buffer
242 g of Tris base, 57.1 ml of acetic acid, and 100 ml of 0.5MEDTA, pH 8.0 was mixed 
with (IH2O to a total volume of 1L and was sterilized by autoclaving.
5.4.2 1% A garose gel
1% (weight/volume) of agarose was dissolved in lx  TAE buffer.
5.4.3 6x g e l load ing buffer for DNA
0.25% (weight/volume) of bromophenol blue, 0.25% (w/v) of xylene cyanol FF, and 
30% (w/v) of glycerol in cffi^O was mixed.
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5.4.4 Solu tion s for M ini-preps
5.4.4.1 Resuspension buffer
50mM Glucose, 25mM Tris-HCl (pH8.0) and lOmM EDTA (pH8.0) were mixed to the 
final concentrations as specified, to a total volume of 50 ml, adjusted with (IH2O.
5.4.4.2 Cell Lysis buffer
1% Sodium Dodecyl-Sulphate (SDS) (pH7.2) and 0.2N NaOH were mixed to the final 
concentration as specified, to a total volume of 10 ml, adjusted with dH20.
5.4.4.3 Neutralization buffer
5.75 ml of Glacial Acetic Acid and 30 ml of 5M Potassium Acetate was mixed to a final 
volume of 50ml, adjusted with dH20.
5.4.5 Solu tion s for DNA p u rifica tion  bv ph en ol extraction:
5.4.5.1 Chloroform:isoamylalcohol (24:1)
Chloroform was mixed with isoamylalcohol to the ratio of 24:1.
5.4.5.2 Phenol:Chloroform:isoamylalcohol
The mixture of chloroform:isoamylalcohol was added to Phenol to the ratio of 1:1, to 
make the final solution of Phenol:Chloroform:isoamylalcohol to the ratio of 25:24:1. 
The mixture was kept in a bottle wrapped with aluminium foil and was stored in the 
dark at 4°C for minimum 12 hours before use.
5.4.6 lOx TE buffer (Tris-EDTA buffer)
10 ml of 1M Tris HC1 (pH7.4) and 1 ml of 1M EDTA were mixed to the total volume of 
100 ml in dH20, to give the final concentration of lOOmM of Tris-HCl and lOmM of 
EDTA. The solution was autoclaved for sterilization.
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5.5. Materials for Biochemistry
5.5.1 R unning buffer for SDS-PAGE
Final concentrations of 196mM Glycine, 50mM Tris-HCl (pH8.3) and 0.1% SDS (w/v) 
were mixed in (IH2 O.
5.5.2 T ransfer B uffer
Final concentrations of 150mM Glycine, 25mM of Tris base and 20% ethanol were 
mixed in CIH2O.
5.5.3 TBS-Tween
Final concentrations of 150mM NaCl, lOmM Tris-HCl (pH8.0) and 0.2% of Tween-20 
were mixed in (IH2 O.
5.5.4 3x L aem m li load ing  buffer for SDS-PAGE
6 mg of bromophenol blue was dissolved in 1 ml of water. 3 ml of 20% of SDS, 2.4 ml 
of 1M Tris-HCl (pH6.8), 3 ml of 100% glycerol and 1.6 ml of P-mercaptoethanol were 
added. The total volume was made up to 10 ml with and stored at 4°C.
5.5.5 20% TCA and 5% TCA
20 ml of 100% TCA was mixed with 80 ml of to prepare 20% TCA. 5ml of 100% TCA 
was mixed with 95 ml of CIH2O to prepare 5% TCA.
56
6. Methods
6.1 Methods for molecular biology
6.1.1 PCR am plification  o f  th e  b a it inserts
Primers specific for the gene of interest were designed and bought from Sigma or 
Invitrogen. ESTs specific for the genes of interest (itsn-1 and ehs-1) was kindly 
provided by Dr. Yuji Kohara from the C. elegans consortium. 50 ng of cDNA library of 
C. elegans was used as a template for the amplification of various constructs of rme-1 
and that of R10E11.6, whereas a mix of 1 pi of T0P02.1 clone containing the 5’ RACE 
and 1 pi of T0P02.1 clone containing the 3’RACE reaction of reps-1 was used as a 
template. The amplification of the insert with a polymerase was carried out using PCR 
machine (maker) in reaction mix in a total volume of 50 pi, set up as follows:
1 pi of 5’ oligo (lOpmol/pl)
1 pi of 3’oligo (lOpmol/pl)
1 pi of template (EST -  lOOng/pl)
4 pi dNTPs 2.5mM
5 pi 1 Ox buffer for polymerase 
1 pi of polymerase (Taq)
37 pi of sterile water 
Final volume of 50 pi
The protocol used for the amplification cycle was as follows:
1 cycle of 5 minutes at 94°C
25 cycles of 30 seconds at 94°C, 30 seconds at 55°C, andl .5minute at 72 °C,
1 cycle of 7 minutes at 72 °C,
and the completed reaction was kept at 4 °C until further use.
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6.1.2 A garose gel e lectrop h oresis
Inserts amplified by PCR reaction were visualised by running 10 pi of the PCR reaction 
mix in a gel electrophoresis with 1 % agarose gel, loaded alongside a DNA marker 
Lambda!Hind III and Phil74IHaeIII or lkb ladder (Promega). DNA was visualized by 
Ethedium Bromide (EtBr) under the UV light at 256 nm.
6.1.3 TA c lon in g
Once the insert of the expected size was amplified by PCR reaction, the insert was first 
cloned in a cloning vector T0P02.1, TA cloning kit, Invitrogen. TA cloning reaction 
was set up as follows:
3 pi of PCR reaction mix
1 pi of Salt solution (provided in the TA Cloning kit, Invitrogen)
1 pi of sterile water 
1 pi of T0P02.1 vector
The total volume of 6 pi was mixed and was incubated for 5 minutes at room 
temperature.
6.1.4 T ransform ation  o f  E. Coli
The chemical competent E. Coli strain TOP 10 (Invitrogen) was transformed with TA 
cloning reaction as follows. 2 pi of the TA cloning reaction was added to 50 pi of 
TOP 10 cells and was on ice for 5 minutes. The cells were then heat shocked at 42°C for 
30 seconds. 70 pi of SOC medium was added immediately and was incubated at 37°C, 
shaking at 650 rpm for 1 hour. A total volume of 120 pi of transformed cells was plated 
on a solid medium LB containing X-gal (80 pi of the stock solution 20mg/ml) and
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kanamycin to the final concentration of 50pg/ml assuming that a plate of contains 25 ml 
of LB.
6.1.5 E xtraction  o f p lasm id  -  M ini-preps
The plasmid was extracted using QIAGEN Mini-prep kit, according to the 
manufacturer’s instruction. When the commercially available kit was not used, the 
following protocol was used.
T0P02.1 clones that contain the insert were identified by the fact that the cloning 
vector is designed such that the insertion of the PCR product into T0P02.1 vector * 
results in the disruption of the gene encoding p-galactosidase present in the T0P02.1 
vector. Several white transformed colonies grown on the medium containing X-gal were 
individually inoculated in 2 ml of LB, which contains the appropriate antibiotics, and 
were incubated at 37°C, constantly shaking at 220 rpm overnight. 1.5 ml of the 
overnight culture was centrifuged at 14,000 x g for 1 minute. The pellet was 
resuspended in 250 pi of Solution I, stored at 4°C. 250 pi of the freshly prepared cell 
lysis buffer, Solution II, was added to the cell suspension and was mixed gently. 250 pi 
of the neutralization buffer, Solution III, was added and mixed gently. The mixture was 
incubated on ice for 5 minutes and was centrifuged at 14,000 x g for 10 minutes. The 
DNA present in the supernatant was extracted using the phenolrchloroform DNA 
purification protocol, which is described below.
6.1.6 Phenol:chloroform  ex traction  o f  DNA
An equal volume of phenol:chloroform:isoamylalcohol (25:24:1) was added to the 
eluate, vortexed and centrifuged. The upper later corresponding to the fraction 
containing the DNA was mixed with chloroform:isoamylalcohol (24:1). The mixture
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was vortexed and centrifuged. The DNA contained in the upper fraction was then 
precipitated with 5M sodium acetate and 100% ethanol.
6.1.7 P recip ita tion  o f  DNA w ith  Sodium  A cetate/E thanol
A 1/10 volume of 5M Sodium Acetate and a twice the volume of 100% ethanol was
added to the fraction containing DNA. The mixture was vortexed briefly and was left to 
freeze in a dry ice bath for 15 minutes. The DNA was precipitated by centrifugation at 
14,000 x g for 15 minutes at 4°C. The pellet was washed with an equal volume of 70% 
ethanol, centrifuged 14,000 x g for 10 minutes at 4°C. The pellet was left to dry for 5 to 
10 minutes and was resuspended in resuspended in 50 pi of TrisHCl lOmM pH 8.0, 
containing 0.1 mg/ml RNase A (Promega).
6.1.8 D iagn ostic  d igestion  o f  the p lasm id  extracted
200-300 ng of the plasmid and 2units of the appropriate restriction enzymes in the
suitable buffer was mixed and added up to a total volume of 20 pi with dHiO. The 
digestion mix was incubated at 37°C for 90 minutes. 4 pi of 6x loading buffer was 
added to the total volume of 20 pi and was loaded onto 1% agarose gel as described in 
the previous section 6.1.2 on the agarose gel electrophoresis.
6.1.9 P reparation  o f  th e  c lon in g  vector  and th e  in sert
The TOP02.1 clone that was found to be positive for the insert was digested with the
specific restriction enzymes used as the cloning sites to release the insert. At the same 
time, the cloning vector was digested with the same restriction enzymes to prepare the 
cloning site. 3 pg of the plasmid with insert, and 5 pg of the cloning vector was each 
digested with 3 units of the appropriate restriction enzymes in the suitable buffer at the 
optimum temperature, which was commonly 37°C, for a total of 1 hour. Usually 2 units
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of each enzyme were used in the first 30 minutes and the other unit was added in the 
second 30 minutes. The total volume of digestion was made up to 80 pi with cfflbO. 
After 1 hour of digestion, 2% of the total volume of the digestion mix was loaded in 1% 
agarose gel electrophoresis to ensure that the digestion was efficient.
6.1.10 C alf In testin a l P h osp hatase (CIP) treatm en t o f  th e  
clon in g  v ecto r
The overhanging nucleotides at the restriction sites were dephosphorylated to prevent 
the re-closure. The plasmid in the 80pl of the digestion mix was purified from the 
enzymes and the buffer by phenol:chloroform extraction and precipitated with sodium 
acetate/ethanol as described in the sections 6.1.6 and 6.1.7, respectively. To 20 pi of the 
plasmid extracted, 1 unit of CEP (New England BioLabs) was added with its appropriate 
buffer. The total volume was made to 50 pi with dHiO and was incubated at 37°C for 1 
hour. The plasmid was purified from CEP and its buffer by phenol: chloroform 
extraction, followed by sodium acetate/ethanol precipitation. The precipitate was 
resuspended in 15 pi of sterile dH^O and was stored at -20°C until used for ligation.
6.1.11 G el extraction  o f  DNA
All of the remaining digestion mix (16 pi) remaining from the step described in Section 
6.1.8, was then run in 1% agarose gel electrophoresis to isolate the insert. The band 
corresponding to the expected size of the insert was excised. The band was visualized 
with EtBr under the UV light at 70% emission, with the gel piece kept on the plastic 
tray for running the gel, in order to minimize the damage by the UV. The DNA in the 
gel band was extracted from the agarose gel piece by centrifugation through a packed 
glass wool. The DNA was further purified by phenolrchloroform followed by
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precipitation with sodium acetate/ethanol, as described in the sections 6.1.6 and 6.1.7, 
respectively. The precipitate was resuspended in 10 pi of sterile dLLO instead of 20 pi.
6.1.12 L igation
1 pi of insert and 1 pi of the cloning vector prepared were loaded in 1% agarose gel to 
quantify approximately. The cloning vector and the insert was mixed to the ratio of 1:4, 
in excess of the insert, and was kept on ice whilst the ligation buffer and 1 unit of Fast 
Ligase (Promega) was added and made to a total volume of 10 pi with dH^O. At the 
same time, a negative control was prepared by incubating the vector without the insert 
with the ligase. The mixture was shaken briefly and was incubated at room temperature 
for 5 minutes. 50 pi aliquot of chemical competent E. Coli cells Select 96 (Promega) 
was immediately transformed with 3 pi of each ligation mix by heat shock as described 
in Section 6.1.4. The number of colonies transformed by the ligation of the vector plus 
insert and that of vector only were compared. If the ratio of vector plus insert: vector 
only was more than 4:1, minimum of 4 colonies were inoculated in 2 ml of LB for mini- 
preps as described in section 6.1.5.
6.1.13 Large-scale preparation  o f  p lasm id
The clone that was confirmed to contain the plasmid of interest by diagnostic digestion 
of mini-prep was inoculated in 500 ml of LB medium with the appropriate antibiotic, 
and was incubated overnight at 37°C, shaking constantly at 220 rpm/min. 500 ml of the 
overnight culture was centrifuged at 3,000 rpm for 10 minutes. The plasmid was 
extracted using QIAGEN Maxi-prep kit, according to the manufacturer’s instructions.
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6.2. Methods for Y2H Screening
6.2.1 P reparation  o f  C om petent Y east ce lls
20 ml of YPD medium was inoculated with a single colony of MaV203 yeast cells and 
was incubated at 30°C, constantly shaking at 220 rpm for 18 hours. 480 ml of YPD was 
added and the culture was incubated at 30°G, constantly shaking at 220 rpm for 3-4 
hours. When the Optical Density at 600 nm (OD6 0 0) of the culture reached within the 
range of 0.5 ± 0.1, the culture was centrifuged at 3,0000 rpm for 5minutes. The pellet 
was resuspended in 50 ml sterile cfflbO and was centrifuged at 3,000 rpm for 5 minutes. 
The pellet was resuspended in 10 ml sterile cffi^O. The competent cells were aliquoted 
into 50 jxl per transformation.
6.2.2 Sm all-scale C o-Transform ation o f  C om petent Y east cells  
MaV203
100 ng of each plasmid (pPC86 and pDBLeu constructs) were added to 50 pi of 
competent yeast cells and were kept on ice. 1 ml of salmon sperm (Invitrogen) was 
added as a carrier DNA. 300 [il of PEG/LiAc and was mixed well. The cells suspended 
in PEG/LiAc were immediately placed a water bath at 30°C for 20 minutes, where the 
tube was shaken to mix every 10 minutes. The aliquot was transferred to a water bath 
kept at 42°C for 15 minutes. The yeast cells were collected by centrifugation at 7,000 x 
g for 30 seconds. The pellet of cells were resuspended in 100 pi of sterile dE^O, were 
plated on a selective SC medium lacking Tryptophan and Leucine, and were incubated 
at 3 0°C for 48 hours.
6.2.3 P reparation  o f  th e  m asterp la tes for te s tin g  th e  self­
activa tion  oiL acZ  gene exp ression  bv th e  ba it
Five of the co-transformants were streaked on to a plate SC -L/-W on a grid as shown 
in the schematic diagram below alongside the control strains A, B, C, D and E provided 
in the Yeast Two Hybrid (Invitrogen).
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A  Schematic diagram to show the grid on which the co-ransformants were streaked on a plate
containing the selective medium alongside the control strains:
Control
strains
pDBLeu
-bait/
pPC86
A 1
B 2
C 3
D 4
E 5
The control strain A is a negative control that is a co-transformant of an empty bait 
vector and an empty prey vector. Each of the control strain B, C, D, and E express 
interactors with the increasing strength of interaction. The control strains are described 
in Table 1. The masterplate was incubated at 30°C for 48 hours.
Table 1 Description o f  the Yeast Control strains A-E used in the Y2H Screenings 
(Taken from the protocol for ProQuestTM Two-Hybrid System, Invitrogen).
Control Strain Resident Plasmids cDNA insert Interaction strength Reference
A
pPC97
no insert none
Chevray, P. and Nathans, D . (1992) 
Proc. Natl. Acad. Sci. USA 89: 
5789pPC86
B
pPC97-RB
human RB 
Acc. No. M28419 
amino acids 302-928
weak
Vidal, M. (1997) The Reverse Two- 
Hybrid System in the Two-Hybrid 
System , (Bartel, P. and Fields, S., 
eds.),Oxford University Press, New 
York, 109 Vidal, M., etal., 
(1996) ProcNatlAcadSci.USA  , 
93:4091pPC86-E2Fl
human E2F1 
Acc. No. M96577
amino acids 342-437
C
pPC97-CYH2!jDP
Drosophila DP 
Acc. No. X79708 
amino acids 1-377
moderately strong
Du, W., Vidal, M„ Xie, J-A., 
Dyson, N. (1996) Genes and Dev . 
10:1206
pPC86-dE2F
Drosophila E2F 
Acc. No.U10184 
amino acids 225-433
D
pPC97-Fos
rat cFos 
Acc. No. X06769 
amino acids 132-211
strong
Chevray, P. and Nathans, D . (1992) 
Proc. Natl. Acad. Sci. USA 89: 
5789
pPC86-Jun
mouse cJun 
Acc. No. XI2761 
amino acids 250-325
E
pPC97-Fos
rat cFos 
Acc. No. X06769 
amino acids 132-211
very strong Fields, S., and Song, O-K. (1989) 
Nature 340:245
pPC86-Jun
mouse cJun 
Acc.No.X12761 
amino acids 250-325
64
6.2.4 S elf-activation  T est for b a it constructs bv X-gal A ssay
The masterplate prepared as described in Section 6.2.3 was replica plated onto a
nitrocellulose membrane placed on a plate of YPAD medium, and was incubated at 
30°C for 16 hours. The yeast cells grown on the nitrocellulose membrane were frozen at 
-80 °C for 20 minutes. The nitrocellulose membrane was then transferred onto a layer of 
two filter papers soaked in 5 ml X-gal assay buffer. Any excess buffer was removed and 
the membrane was incubated at 37°C for 2 hours. The expression of LacZ, which is 
detectable by the appearance of blue colonies due to the conversion of X-gal, was 
checked after 2 hours, and was left incubated at 37°C for 24 hours.
6.2.5 TCA P recip ita tion  o f  p rotein s from  y ea st liq u id  cu lture
The five co-transformants streaked onto the masterplate were inoculated in 5 ml of SC -
L/-W and were incubated at 30°C shaking for 24 hours. The cells were harvested by 
centrifugation at 3,000 x g for 5 minutes. The pellets were resuspended in 1.5 ml 20% 
TCA, were transferred to 2 ml-eppendorf tubes and were centrifuged at 14,000 x g for 1 
minute. The pellet was resuspended in 200 pi 20% TCA. 30 pi volume of acid-washed 
glass beads (425-600 pm) was added to each tube and was vortexed for 3 minutes. The 
glass beads were allowed to settle at the bottom of the tube and the supernatant was 
transferred to a clean eppendorf tube. 400pl of 5%TCA was added to each tube and 
were centrifuged at 3,000 x g for 10 minutes. The pellet was resuspended in 25 pi of 
Laemli buffer and 12.5 pi of TRIS was added to adjust the pH suitable for 
polyacrylamide gel electrophoresis. The protein extracts were denatured at 99°C for 5 
minutes and were centrifuged at 3,000 x g for 10 minutes. 20 pi of the supernatant was 
loaded in 10% polyacrylamide gel.
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6.2.6 SDS-PAGE
Polyacrylamide gel was prepared from a 40 % mix of acrylamide : bisacrylamide to the 
ratio of 30:1. 10% Ammonium persulphate (APS) and tetramethylethylenediamine 
(TEMED) were used as polymerizing catalysts. The proportions of solutions to 
prepare 8% - 15% polyacrylamide gels are shown in the table below:
Separating gel mix (ml): 8% 10% 15%
acrylamide mix 6 7.4 11.25
1.5MTrispH 8.8 7.4 7.4 7.4
dH20 15.9 15.4 10.65
10% SDS 0.3 0.3 0.3
10% APS 0.3 0.3 0.3
TEMED 0.03 0.03 0.03
TOTAL volume 30 30 30 .
(ml):
1.7 
1.25
6.8 
0.1 
0.1 
0.01
10
Stacking gel mix
Aciylamide mix 
1M Tris pH6.8 
dH20  
10% SDS 
10% APS 
TEMED 
TOTAL volume
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20 pi of TCA protein precipitation of each co-transformants were loaded in the 
polyacrylamide gel and the electrophoresis was run at 100 V for 90 minutes to 2 hours, 
until the loading dye ran out of the gel.
6.2.7 W estern B lot
The proteins in the polyacrylamide gel were then transferred onto a nitrocellulose 
membrane that was sandwiched by layers of filter paper and a transfer sponge (as 
shown in the schematic diagram below).
A  schematic diagram to show the set-up o f  the layers o f  a nitrocellulose membrane and' a 
polyacrylamide gel for the transfer o f  proteins:
Negative electrode -
Transfer sponge xxxxxxxxxxxxxxx
Filter paper
Polyacrylamide gel oooooooooooooooooooooo
Nitrocellulose membrane
Filter paper -------------------------------------------------------------------------------------------------------
Transfer sponge xxxxxxxxxxxxxxxx
Positive Electrode . +
The transfer was carried out either at 30 V overnight at room temperature, or at 100 V at 
4°C with ice block for 1 hour.
The proteins the nitrocellulose membrane were visualized by Ponceau staining to ensure 
that the transfer was efficient.
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The unspecific binding was blocked with 5% milk in buffer TBS-Tween 0.2% for 30 
minutes at room temperature. The primary antibody, anti-GAL4DBD antibody diluted 
in 5% milk/TBS-Tween to the ratio of 1:1,000 was added to the membrane and left 
incubated rocking at room temperature for 1 hour. The unbound primary antibody was 
washed off with TBS-Tween 0.2% with four changes of buffer for a total of 30 minutes. 
The secondary antibody, anti-mouse antibody diluted in TBS-Tween 0.2% to the ratio 
of 1: 20,000 was added to the membrane and left incubated rocking for 30 minutes. The 
unbound secondary antibody was washed off with TBS-Tween 0.2% with four changes 
of buffer for a total of 30 -minutes. The ECL solutions (Amersham- 
Biopharmaceuticals) were used for the detection of anti-GAL4 DBD signals.
6.2.8 3AT A ssay
3AT assay was an assay to determine the appropriate 3AT concentration required for 
titrating the basal HIS3 expression of the co-transformants. The masterplate, prepared as 
described in Section 9.3, was replica plated onto a series of SC -L/-W/-H plates 
containing varying concentration of 3AT from OmM to lOOmM. The plates were 
incubated at 30°C for 24 hours. The plates were replica cleaned until no residue of cells 
were visible, and were incubated at 30°C for 48 hours. The lowest concentration of 3AT 
at which the growth of the co-transformants was comparable to control strain A, the 
negative control, was determined as the concentration required for the Y2H screening 
with the bait.
6.2.9 P rep aration  o f  th e  cDNA library
The glycerol stock containing the cDNA library clones (purchased from Invitrogen) was 
inoculated in 500 ml of LB added with 50pg/ml of Ampicillin. The culture was 
incubated at 30°C for 16 hours. After the incubation for 16 hours, the culture was 
centrifuged and the pellet was resuspended in 30 ml of cell resuspension buffer PI
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(QIAGEN). The cDNA was purified using a protocol for the large-scale purification of 
DNA, according to the manufacturer’s instruction by QIAGEN. The purified cDNA 
library was divided into aliquots of 10 pg and the aliquots were kept at -20°C till use.
6.2.10 C o-transform ation o f  library sca le  com p eten t yeast  
c e lls  MaV203 w ith  a ba it and a cDNA library
The 500 pi aliquot of Mav203 cells (purchased from Invitrogen) that was stored at - 
80°C was placed in a water bath set at 30°C, gently shaking for 90 seconds. 250 pi was 
transferred to a 50 ml-falcon tube and was kept at room temperature. 10 pg of pDBLeu- 
bait and 10 pg of pPC86-cDNA library were added to 250 pi of competent yeast cells 
and were mixed well. 1.5 ml of PEG/LiAc was added to the cells and the mixture was 
swirled gently until the cells were suspended in PEG/LiAc homogenously. The 
suspension of yeast cells was incubated in a water bath at 30°C for 30 minutes, shaking 
every 10 minutes. The suspension of yeast cells was then heat shocked at 42°C for 20 
minutes, shaking after 10 minutes. The cells were collected by centrifugation at 4,000 x 
g for 5 minutes and were resuspended in 1.5 ml of 0.9% sodium chloride solution. 5 pi 
of the cell suspension was added to each of 95 pi of water (the dilution factor 1: 800) 
and to 995 pi of water (the dilution factor 1: 8,000). The cells were resuspended well, 
and lOOpl of each resuspensions were plated on SC -L/-W. These plates were used to 
calculate the efficiency of co-transformation. 150 pi of the suspension was plated per 16 
cm-diameter plates of SC -L/-W/-H/+3AT. The plates were incubated at 30°C for 72 
hours to 96 hours. The co-transformation with each bait used in the Y2H screening was 
repeated until the total co-transformation efficiency reached 1 x 106 colonies to ensure 
that the complexity of the whole genome represented by the cDNA library was covered.
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6.2.11 P reparation  o f  th e  m asterp lates for Y2H screen ing
The yeast co-transformants that grew on the screening plates were checked and marked
after 48 hours, 72 hours and 96 hours. The clones that grew in the selective medium for 
the screening were streaked onto masterplates in grid alongside the control strains as 
shown in the schematic diagram below. The control strains are described in detail in 
Table 1 Description of the Yeast Control strains A-E used in the Y2H screenings.
Legends:
C-: clone used as the negative control, aco-transformant of the bait and the empty prey 
vector (pDBLeu-ITSN-l/pPC86 or pDBLeu-EHSl 123/ pPC86)
C-l, C-2, C-3: Three clones used as the negative controls, which were three co- 
transformants of the bait and the empty prey vector (pDBLeu-RME-l/pPC86, pDBLeu- 
Repsl/pPC86, or pDBLeu-RlOEl 1.6/pPC86)
The clones, which were co-transformed with the bait constructs and the empty prey 
vector, were used as the specific negative control for the clones from the screenings. In 
comparison, the control strain A  which is a clone transformed with plasmids pPC97 
and pPC86, both with no insert (refer to Table 1 Description of the Yeast Control strains 
A-E used in the Y2H screenings in Section 6.2.3) was used as the general negative 
control for the X-gal assay. The other control strains B, C, D, and E, which are also 
described in detail in Table 1 in Section 6.2.3, were used as references to indicate the 
different strengths of interactions observed in the X-gal assays of the clones from the 
screenings.
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The schematic diagram to show the grids for the masterplates used in the Y2H screenings:
Masterplates for ITSN-1 and 
EHS-1 123 Y2H screenings
Masterplates for RME-1, Reps 1, 
R10E11.6 Y2H screenings
A C- 1 2 3 4
B 5 6 7 8 9
C 10 11 12 13 14
D 15 16 17 18 19
E 20 21 22 23 24
A 1 2 3 4 5
B 6 7 8 9 10 C-
1
C 11 12 13 14 15 c-
2
D 16 17 18 19 20 C-
3
E 21 22 23 24 25
6.2.12 X-gal assay  to te s t  th e  LacZ  exp ression  o f  p ositive  
clon es
The clones grown on the masterplates were replica plated onto nitrocellulose membrane 
and tested for LacZ expression by X-gal assay as described in Section 6.2.4.
6.2.13 T est for URA3 exp ression
The masterplates were replica plated onto plates lacking Uracil (SC -L/-W/-U) to test 
for the expression of URA3. The plates were incubated at 30°C for 24 hours and were 
replica cleaned until there were no residues of yeast cells visible. The plates were 
incubated at 30°C for 48 hours before the growth of each clone was observed.
6.2.14 E xtraction  o f  p lasm id  from  v e a st p ositive  c lon es
The clones, which were shown to be positive for the expression of the reporter genes,
were each inoculated in 5 mL of SC -L/-W, and were incubated shaking at 30°C for 30
hours. The cells were harvested by centrifugation at 4,000 x g for 5 minutes at room
temperature. The cell pellet was resuspended in 250 pL of resuspension buffer PI
(QIAGEN). 30 pL of acid-washed glass beads were added and the cell suspension was
vortexed for 5 minutes. The glass beads were allowed to settle and the supernatant was
transferred to another eppendorf tube. 250 pi of cell lysis buffer P2 (QIAGEN) was
71
added, mixed gently and incubated at room temperature for 5 minutes. 350 jxl of the 
neutralization buffer P3 (QIAGEN) was added to the cell lysate, mixed gently and 
centrifuged immediately at 14,000 x g for 10 minutes. The supernatant was loaded onto 
QIAGEN mini-prep column and was centrifuged through the column for DNA to bind 
to the column, at 14,000 x g for 1 minute. The column was washed with 750 pi of the 
wash buffer provided, by centrifuging through at 14,000 x g for 1 minute. The wash 
buffer was removed, and the excess wash buffer left on the column was removed by 
centrifugation at 14,000 x g for 2 minutes. The yeast plasmid bound on the column was 
eluted with 15 pi of elution buffer EB. ~
6.2.15 T ransform ation o f  E. Coli w ith  p lasm id  extracted  from  
veast.
The plasmids extracted from yeast cells were passed to E. Coli by transformation by 
heat shock in order to obtain a plasmid preparation suitable for digestion by restriction 
endonucleases. 5 pi of the yeast mini-prep prepared in Section 6.2.14 was added to 50 
pi of E. Coli Select 96 competent cells (Promega). The competent E. Coli was 
transformed as described in Section 6.1.4.
6.2.16 Id en tifica tion  o f  th e  cDNA in sert
The digestion was loaded in 1% agarose gel electrophoresis and visualised by Ethedium 
Bromide staining. The E. Coli clones with an insert were sequenced for the 
identification of the cDNA insert. The plasmid purified as described in Section 6.1.5 
was sequenced using an oligo specific to the upstream of the multiple cloning site in the 
prey vector pPC86 of the sequence as follows:
5’ TATAACGCGTTTGGAATCACT 3’
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Sequencing was carried out using only the 5’ oligo as partial sequence was sufficient for 
its identification from the non-redundant database. The partial DNA sequence of the 
cDNA was then translated using the Expasy Translate Tool that is available on the 
Internet at :http://www.expasy.ch/tools/dna.html.
In order to ensure that the cDNA fragment was cloned in-frame with GAL4AD, the 
DNA sequence was translated into amino acid sequence, starting from the DNA 
sequence that encoded the last part of the GAL4AD, as highlighted in an example of the 
following sequence:
> 6428 .7-l-p pc86f.07 .ab i 885 0 885 ABI
AGGNNATGTTTANTACCACTACAATGGATGATGTATATAACTATCTATTCGATGATGAAGATACCCCAC
CAAACCCAAAAAAAGAGGGTGGGTCGACCCACGCGTCCGGTTTGAGGCGGGGAGCAAACATGTCGATTT
CGACGATTCGCCGGCAAGTGAAGAACGTCGCCTATAATTTCTCGGATGCACAAGTAAAGGTTCGCGAAG
CCACAAGCAACGATCCATGGGGACCATCCACAGCGCTCATGTCCGAAATTGCCGACTTGACGCACAATC
CAATGGCGTTCACTGAGATTATGTCAATTGTTTGGAAGCGATTAAATGATTCTGGCAAAAACTGGCGAC
ACGTGTACAAAAGTCTGGTGCTTCTCGATTTTCTCATCAAATGCGGCCACGAGAAGGTCGCGCAACAAT
GCAGAGAGAACGTGTTCACCATTGAAACACTCAAGGATTTCCAGCATGTGGAAGACAATCGGGATCAGG
GCTTGAACATTCGAGAGAAAGCAAAGCAGATCACTTCACTGCTCTCCGACGATGAACGCTTGAAAAACG
AAAGAACACGCTTCATCCTCACAAGAAACAAATTCAAGCAAAACAATCCAGGACCGGTTGGAGCGGAAA
GTCGTCGCAGCAATCGTCATCATGTCACCGACGCGTCTCTTGACCCGAGTACGAAGATGCTCGTCCATC
TACCGCCACGAGGAAGAGATGCAGCTTCAAATTGCTCTTGCTCTTTCACGAGANGAATGCGAAAAGGNC
GACNANATGCGCAAGAGCGATGATGCNCGCCTTCAAATGGCNCNGGAAGANTCCCAAAAGCTTCAGGAT
GCCGNTCCCTCCCAACNACAANCANGGTACGTNAGCANCGGANATTAACCNATCCCC
An example of the translation of the sequence above is shown below:
5 ' 3 '  F r a m e  1
DDVYNYLFDDEDTPPNPKKEGGSTHASGLRRGANM SISTIRRQVKNVAYNFSDAQVKVREATSNDPW GPST
ALM SEIADLTHNPM AFTEIM SIVW KRLNDSGKNW RHVYKSLVLLDFLIKCGHEKVAQQCRENVFTIETLKD
FQ HVEDNRDQGLNIREKAKQITSLLSDDERLKNERTRFILTRNKFKQNNPGPVGAESRRSNRHHVTDASLD
PSTKM LVHLPPRGRDAASNCSCSFTRXMRKXRXXAQER-
CXPSNGXGRXPKASGCXSLPXTXXVRXXRXLTXP
The amino acid sequence till the end of the reading frame (-), shown highlighted in the 
sequence above was taken and was searched against the C. elegans non redundant 
database using BLASTP (Protein BLAST).
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6.2.17 R e-transform ation assay
The cDNA inserts, which were identified as a putative interactor of the bait, were re­
transformed with the bait into 50 pi of Mav203 competent cells as described in Section 
6.2.2. The yeast colonies were streaked onto masterplates of SC -L/-W, alongside the 
control strains as shown in the schematic diagram below, and the plates were incubated 
at 30°C for 48 hours. The control strains that were used are described in detail in Table 
1. The expression of the reporter gene LacZ by the re-transformants were tested using 
the X-gal assay, as described in Section 6.2.4.
A  Schem atic diagram to sh ow  the grid used to streak the yeast co lon ies on a plate  
containing the selective  m edium  alongside the control strains:
Masterplates for re-transformation assays
Control
strains
Bait/
cDNA
1
Bait/
cDNA
2
Bait/
cDNA
3
Bait/
cDNA
4
C-
A 1 1 1 1
B 2 2 2 2 C-
1
C 3 3 3 3 c -
2
D 4 4 4 4 C-
3
E 5 5 5 5
For the description and the explanation of the control strains A-E and of the 
clones used as the negative controls (C-l, C-2 and C-3) in this assay, refer to 
Table 1 Description of the Yeast Control strains A-E used I the Y2H Screenings 
in Section 6.2.3 and to Section 6.2.11.
6.2.18 Rapid A m p lification  o f  cDNA en d s (RACE) for  
Y39A6A.38 (5’RACE and  3’ RACE)
5’ RACE and 3’ RACE were carried out using the FirstChoice™ RLM-RACE Kit 
(Ambion Inc, Applied Biosystems). The reactions were set up according to the 
manufacture’s instructions, using the genomic DNA of C.elegans as template. The PCR
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products were cloned into T0P02.1 vector using the TA cloning kit, as described in the 
section 5.1.3. 50 ml of chemical competent TOPIO cells purchased from Invitrogen was 
transformed with 3ml of the inserts ligated into the T0P02.1 vector, as described in the 
section 5.1.5. The plasmid was extracted from the transformed colonies by mini-prep as 
described in the section 5.1.5. The inserts in the extracted plasmids were sequenced 
using primers specific for T0P02.1 vectors.
6.2.19 Q uantitative PCR (qPCR) am plification  o f  cDNA  
in serts from  th e  cDNA library
(The primers were designed by Dr. Loris Bernard of the Real Time PCR Unit, 
Cogentech at IFOM, Milan, Italy. The qPCR was carried out by Cogentech. The 
selection of the genes encoding NPF-containing proteins were assisted by Dr. Stefano 
Confalonieri, IFOM, Milan, Italy).
16 genes encoding NPF-containing proteins from the C. elegans genome were selected 
in order to test their level of representation in the cDNA library used in the Y2H 
screenings.
Briefly, the cDNAs of these selected genes were amplified from the cDNA library using 
specific primers and the level of fluorescence emitted by the incorporation of SYBR- 
Green® in the amplicons were quantified. Prior to the qPCR analysis by the facility, the 
concentration of the magnesium chloride in the PCR reaction buffer was optimized in 
the range OmM to 1.5mM for each set of primers in order to have specific 
amplifications. 3 genes (indicated by arrows in the Table 2) that were initially chosen 
were discarded because many unspecific bands were observed despite the various 
conditions attempted.
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Table 2 Sixteen genes selected fo r  the qPCR analysis to tes t the level o f  
representation in the cDNA library used in the Y2H screenings.
11
1
WormBase
Acc
Gene Name RefSeq Bait freq Other Bait? Freq Tot Freq Validation
Bind
motif?
Description
Fished at HI Freq.
T04C10.2 EPN-1 NM 078057 EHS-1 20 INT-1 18 38 re-trasf. 4 NPF liquid facets (51.0 kD) (XP436)
C09H6.2 UN-10 NM 059825 EHS-1 11 INT-1 4 15 re-trasf. 2 NPF
abnormal cell UNeage UN-10, amyloid beta 
precursor protein-binding family A-Ske, controls cell 
polarity (102.3 kD)(6n-10)
Y63D3A.5 TFG-1 NM 061061 EHS-1 13 INT-1 2 15 re-trasf. 1NPF human TFG related (49.7 kD) (tfq-1
F29C12.1 PQN-32 NM_064384 EHS-1 4 INT-1 5 9 re-trasf. 2 NPF
Prion-like Q/N-rich domain protein (66.0 kD) (pqn- 
32)
i i \ \ I I
Fished at LOW 
Freq.
F41G4.2 CAS-1 NMJ378313 EHS-1 1 1 re-trasf. 1NPF
adenylyl Cyclase Associated protein Homolog 
(53.0kD)fcas-1)
RQE12.1 ALX-1 NMJB66812 EHS-1 1 RME-1 1 2 re-trasf. 1 NPF
prion-like Q/N-rich domain protein PQN-58, Prion- 
Bke Q/N-rich domain protein, vertebrate ALG-2 / 
programmed ceB death 6  interacting protein 
homofoqYNKI
T05E7.5 vet-1 NM_059386 INT-1 4 4 re-trasf. 1 NPF
very Early Transcript VET-1, arrti-apoptofic factor 1 
like (vet-1)
F28H12 cprt-3 NM 058881 EHS-1 2 2 re-trasf. 1 NPF CalPoNin (cpn-3)
NEG NPF >1
M01D72 scm-1 NMJ358510 0 0 0 None 2 NPF
Caenorhabditis elegans secretory Carrier 
associated Membrane protein
R08C7.9 4F204 NM 068164 0 0 0 None 4  NPF cycEn-Iike F-box family member (4F204)
RQ6F6J2 2L78 NMJ063921 0 0 0 None 4  NPF
vacuolar protein sorting 11 (108.4 kD) (2L78) 
fCaenorhabdifis eleqans]
C32E8.1Q UNC-11 C32E8.gc10 0 0 0 None 5 NPF
AP180-Bke adaptor protein family member, 
UNCoordinated locomotion UNC-11 (60.2 kD) (unc- 
11)
1t I
NEG NPF =1
F18C122 rme-8 NMJD59821 0 0 0 None 1 NPF
rme-8 j-domain containing protein, required for 
endocytosis, Receptor Mediated Endocytosis RME- 
8 (259.2 kD) (rme-8)
R13A5.11 31680 NM 066265 0 0 0 None 1 NPF protein phosphatase family member (31680)
JC8.10 unc-26 N M J71423 0 0 0 None 1NPF
synaptojanin, UNCoordinated locomotion UNC-26, 
(123.4 kD) (unc-26)
B0285.1 3F429 NMJD65472 0 0 0 None 1 NPF
protein kinase (3F429) Putative cell division protein 
kinase 9  homolog
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6.3 Methods for In Vitro Pulldown assays
(This part of the project was carried out by Dr.Francesca Senic-Matuglia, IFOM, Milan, 
Italy)
6.3.1 E xp ression  o f  FLAG-tagged EH p rotein s
Full length C. elegans’ EH proteins were cloned in-frame with a FLAG-tag in pCDNA 
vectors. For genes such as ehs-1 and rme-1, where several isoforms are reported, the 
sequences of the isoform a of both genes were used, whereas itsn-1 and reps-1 have 
only one reported isoform each. The FLAG-tagged EH proteins in pCDNA vectors were 
expressed in mammalian HEK293T Phoenix cell line, by transfection with Calcium 
phosphate. The over-expression in mammalian cell line was chosen in order to obtain a 
large quantity of the FLAG-tagged EH proteins. 3 6 hours after transfection, cells were 
lysed in JS buffer (Hepes 50 mM pH 7.4, NaCl 150 mM, Glycerol 10%, Triton X I00 
1%, MgCL 1,5 mM, EGTA 5 mM, and Protease Inhibitor cocktail set HI EDTA free 
from Calbiochem) and clear lysates were obtained by centrifugation at 14,000 rpm. 
Expressions of the FLAG-tagged proteins were verified by Western blot using anti- 
FLAG M2 antibody (Sigma).
6.3.2 P rep aration  o f  th e  G ST-fusion con stru cts
The cDNA inserts that were isolated from the clones showing an interaction with EH 
proteins in the Y2H screenings were cloned in pGEX-6-P2 vector, in order to express 
them as GST-fusion proteins. If different lengths of DNA inserts for one putative 
interactor had been identified, the shortest insert was chosen. E. Coli strain BL21 was 
then transformed with the pGEX constructs.
A single colony of transformed E. Coli BL21 was inoculated in 50 ml of LB with
Ampicillin and was incubated overnight at 37°C, shaking at 220 rpm. 20 ml of the
overnight culture was added to 1 L of LB-Amp. Diluted culture was incubated at 37°C,
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shaking at 220 rpm, until the absorbance at 600nm (A6 0 0 ) reached 0.6. IPTG was then 
added to the culture to the final concentration of ImM to induce the expression of GST- 
fusion proteins. The culture was left to express for 5 hours at 30 °C. Bacterial cells were 
collected by centrifugation at 5,500 x g for 15 minutes at 4 °C. The supernatant was 
discarded and the pellet was washed with 50 ml cold PBS. After another centrifugation 
step, the bacteria pellet was resuspended in 10 ml of PBST (PBS, 0.1% of tween20, and 
the protease inhibitors cocktail purchased from Calbiochem). The cells were disrupted 
by sonication on ice (30 seconds at 30% of intensity for 3 cycles). Lysate was clarified 
by 30 min centrifugation at 20,000 x g at 4 ~C. GST proteins were then purified by 
incubation with 1 ml slurry of Glutathione Sepharose 4B beads (75% slurry - 
Amershampharmacia Biotech) on wheel for 2 hours at 4 °C. The beads were then 
washed 5 times with cold PBST and twice with conservation buffer (HEPES 20 mM pH 
7.4, NaCl 100 mM, glycerol 10%). The beads carrying the GST purified proteins were 
then divided into aliquots and were stored at -  80 °C.
6.3.3 P reparation  o f  th e  G lu tath ione Sepharose beads
The matrix of sepharose beads was centrifuged at 500 x g for 5 minutes, and the
supernatant was carefully removed. The beads were washed by adding 10ml of cold 1 x 
PBS and inverting gently the tube five times. The mixture was centrifuged at 500 x g 
for 5 minutes and the supernatant was removed. The washing steps as above were 
repeated three times.
6.3.4 In vitro  pu lldow n assa y s
In vitro binding assay were performed incubating 120 pmol of GST proteins (previously 
normalised on a SDS-PAGE stained with Goomassie staining) with the lysate 
harbouring the C. elegans EH proteins for 2 hours at 4 °C. The quantity of the lysates 
used in the pulldown assays were normalized on the amount of FLAG-tagged EH
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proteins detected in each lysate by the Western blotting with anti-FLAG antibody. GST- 
NPY, which is a GST fiised with a peptide sequence isolated from human Epsin, which 
contains the mutation of the NPF motif into NPY, and GST alone were used as negative 
controls. Beads were then rapidly washed three times with 1 ml JS buffer and 50 pi of 
loading buffer was added. After separation on SDS-PAGE and transfer onto 
nitrocellulose, the presence of EH proteins in the pulldowns were analysed by Western 
blot using the anti-FLAG antibody and ECL (Amersham-GE Healthcare) as Western 
blotting detection reagents.
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6.4. Methods for Caenorhabditis elegans
6.4.1 P reparation  o f  cu ltu red  w orm s prior to  th e  egg  
p rep aration
A single colony of OP50 from a plate on which the glycerol stock of OP50 was 
streaked on 18 hours prior, was inoculated in 20 ml of LB, and was incubated shaking at 
37°C overnight. 100 jil of the overnight culture of OP50 was plated on 15 plates of 
NGM agar medium. The plates were incubated overnight at 37°C. The plates were left 
to cool at room temperature for 1 hour before they were transferred at 15°C for 2 hours. 
The plates were divided into five sets of 3 plates. From a plate of mixed-stage 
population of N2 strain, 6 adult worms were placed on one plate (Plate 1), 6 worms of 
L3/L4 staged worms on the second plate (Plate 2), and 6 worms of L1/L2 worms were 
placed on the third plate (Plate 3). The procedure was repeated for the other four strains 
of C. elegans, namely; itsn-l(ok268), ehs-1 (okl46), rme-l(bl045) and repsl(tm2156). 
Plates 1, Plates 2 and plates 3 of each strain were incubated at 15°C for 5 days, 6 days 
and 7 days, respectively.
6.4.2 E gg preparation  o f  C. elegans
For each plate of five strains of C. elegans prepared, the adult worms with eggs were 
collected in 5 ml of water. 9 ml of water was added and worms were collected by 
centrifuged at 1,500 x g for 2 minutes. The pellet of worms was resuspended in 4 ml of 
water. 4 ml of bleaching solution was added to the resuspension of worms and the 
mixture was shaken vigorously for 5-6 minutes. When the bodies of adult C. elegans 
were no longer visible in the resuspension, 6ml of water was added immediately and 
centrifuged at 1,500 x g for 2 minutes. The pellet of eggs was washed with 14ml of 
water three times. The pellet was resuspended in 1 ml of sterile water and was incubated 
at 15°C for 15 hours in order to synchronize the population.
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6.4.3 RNA interference o f  p u ta tive  in teractors bv feed in g
The bacterial strain E. Coli HT115 transformed with the plasmid L4440 containing
cDNA that encodes for a putative interactor was inoculated in 10 ml of LB+Ampicilin, 
taken from the RNAz library (Geneservice Ltd), and incubated shaking overnight at 
37°C.
The overnight culture was induced with final concentration of ImM IPTG and of 
2pg/ml of tetracycline and was left incubating at 37°C, shaking for 4 hours. The induced 
culture was harvested at 4,000 x g for 7 minutes and resuspended in 500 pi of 
LB+Ampicilin. 100 pi of the resuspension was plated per feeding plate and was 
incubated overnight at 37°C. 150 pi of a resuspension of C. elegans synchronized at LI 
stage from the egg preparation was added to the feeding plate and was incubated at 
15°C for 4-5 days until the C. elegans reached young adulthood.
6.4.4 A ldicarb A ssay
20 young adult worms of each strain were transferred from an RNAi feeding plate onto 
a well on the aldicarb plates, using a platinum rod under the light microscope. 20 more 
young adult worms were transferred onto a well adjacent. A total of 40 worms, 20 per 
well, were transferred from the feeding plates for each strain, as shown in the schematic 
diagram below. Each worm placed on the aldicarb plates were touched with the tip of 
the platinum rod every 30 minutes to test check for the touch response for the total 
duration of 3 hours. The number of worms per well that responded to touch every 30 
minutes was recorded. The experiment was carried out in triplicates.
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A Schematic diagram to show the arrangement of 40 worms of each strain on an aldicarb plate:
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6.4.5 S ta tistica l analysis for th e  A ldicarb assay
(This part of the project was carried out by Mr. Giovanni D’Ario, IFOM, Milan, Italy) 
The data collected from the aldicarb assay as described in the previous section 6.3.4 
were subjected to a statistical analysis in order to represent the significance of the 
genetic interactions. The statistical significance was shown by a method described 
below, which utilized the R statistical software [137].
6.4.5.1 Description of the Data Set
The raw data set was divided into four files, one for each of the genetic backgrounds: 
ehs-1, itsn-1, rme-l, reps-1. In each of these files the following information was 
recorded:
1) block: an accessory variable used to indicate the particular comparison between a 
genetic background and a gene, which was knocked down. Such a combination 
represents the experimental unit block, hence the name.
2) replicate: a number indicating the particular replicate within the same type of
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comparison. The number of these replicates is not constant across experimental blocks 
and ranges from 2 to 6.
3) gene: a categorical variable used to indicate either the silenced gene or the control 
group within each class of comparison.
4) strain: a categorical variable indicating the genetic background, including the wild 
type group.
5) time: the time at which the animals were stimulated and the number of reacting 
animals recorded. Time zero is the time at which aldicarb was administered. 
Measurements were taken at 0.5, 1, 1.5,2, 2.5, 3 hours.
Despite the presence of 6 time points, all the animals were uncoordinated (with only one 
exception) at 2.5 hours, therefore there are only four informative time points. A further 
complication is the fact that the initial number of worms is not constant. On the other 
hand, there are no cases of censored survival times, therefore we decided to pursue a 
simple strategy focused on the individual (approximate) survival times rather than on 
the counts of worms still reacting at the tactile stimulus at each time point.
For each combination of the factors within each of the four genetic backgrounds, we 
operated as described in the example shown below:
Example 1: The first replicate of the combination of the ehs-1 genetic background and 
the silenced gene lin-10.
There were 60 worms at time 0 (T=0), 53 at T = 0.5, 20 at T = 1.0, 9 at T = 1.5 hours, 
and 0 worms at T = 2.0 onwards. We reorganized these counts creating a vector of 60 
elements, each containing the approximate survival time of a worm. In this case the 
vector would have 9 elements containing a survival time of 2.0 hours, 11 of 1.5 hours,
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33 of 1.0 hour and 7 of 0.5 hour. An approximate survival time can be calculated as T =
1.5 hours, even though the worms became uncoordinated at an unknown time in the 
interval having T = l-.O and T = 1.5 hours as endpoints. This uncertainty is compensated 
by the fact that every worm now brings a piece of information, increasing the statistical 
power of the analysis described below.
6.4.5.2 Statistical Analysis
B indicates the genetic background of worms that has been impaired. B can take values 
ehs-1, rme-l, itsn-1, reps-1.
G indicates an impaired gene, where G can be lin-10, alx-1, dab-1 etc.
N indicates the wild type phenotype.
B+G represents the combined impairment of both B and G.
Depending on the reciprocal relationships among these factors, we can have several 
possible scenarios. We defined the genetic interaction as the situation where the B+G 
phenotype differs from both B and G alone.
It is advantageous to consider the difference between the survival time of a particular 
factor (using the generic term “factor” to indicate B, G, or B + G) and the wild type 
condition, rather than the absolute survival times.
We therefore introduce the quantities:
G = G J t ; B = B _ N ;  BG_ = _B_G_N
G_N indicates the application of the knockdown genes (G) in the wildtype background
(N). Whereas B_N indicates the effect of the genetic background of the eh mutants in
the wildtype genetic background (N). The factor that contains the combination of the
previous two factors, the effect of knockdown of genes (G) and that of the mutant
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genetic background (B) is represented by __ _ B  G_, which is the combined effect of B 
and G in the genetic background of wild type (N). This notation allows us to simplify 
greatly the number of possible scenarios and to formalize our definition of genetic 
interaction.
The first condition to be tested for is:
 B_G_ = _B.
If this identity holds, there can be no genetic interaction, since it simply states that the 
phenotype of the doubly impaired class does not differ from that of the background- 
impaired one. This equality represents a sufficient but not necessary condition for the
absence of genetic interaction. Provided that the condition B _ G_ ^ _B holds, the
identity B_G_ = _G is then tested. If the latter condition is true, even though it
appears to be different from the background phenotype, the doubly impaired phenotype 
is not significantly different from the G phenotype. This suggests that the observed 
difference compared to the wild type is due to G alone, rather than to a combined effect 
of B and G. In this case, therefore, the presence of genetic interaction can be excluded.
In conclusion, the two conditions for having a genetic interaction are _ _B_G_^_B and 
_ _B_Gjj£_G. It is important to note that equality and inequality must be looked at in 
the context of a statistical inferential procedure and not in a strict algebraic sense. For
this reason, a condition that is expressed as B_G_£JB means that the null hypothesis
that these two quantities are equal is rejected, with a given level of significance level.
The scenarios discussed so far do not exclude all the possibilities, and we can further 
refine our analysis including other possibilities. In Figure I, a schematic representation 
of all the situations we have taken into account is depicted.
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6.4.5.3 Linear Models
To identify the combination of experimental factors giving rise to a genetic interaction 
we used the following linear model:
ti =  _0_  1 2 ^ 2  I3 U 3  _ 14U 4_ _
*thwhere ti is the survival time for the i worm, _ j is a random error with zero mean and 
2variance _  . An experiment, in which lin-10 was knocked down (k.d.) in the wild type
N2 and ehs-1 mutants, will be used as an example. Within the experimental block, the 
following combinations of factors can be found:
1) wild type ehs-1 / wild type lin-10.
2) k.d. ehs-1 / wild type lin-10.
3) wild type ehs-1 / k.d. lin-10.
4) k.d. ehs-1 / k.d. lin-10.
The average survival time for the worms belonging to group 1 is given by coefficient -0 , 
which is the reference against which factors such as _B, _G are computed. The 
coefficients -ik represent the change in the average survival time for the worms in the 
£th group, for k = 2,3,4 (group 1 is accounted for by -0 ). Uk is a “dummy variable”, 
which assumes a value of 1 if the worm belongs to the £*, or assumes a value of zero 
otherwise.
Once a model is fitted we obtain an estimate of the four parameters, and the associated 
standard error. Thus, the comparisons described above can be performed and a p-value 
for every single combination is obtained.
In this analysis, the averaged survival times were arranged across the replicates of the 
same experimental block. All the tests were two-sided.
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Figure I. A Tree representation o f the algorithmic procedure we have followed to 
establish the presence or absence o f genetic interaction.
D(B + G) =  DB ?
noyes
DB =  DG ? D(B +  G) =  DG ?
yesyes nono
(DB != 0) & (DG != 0) DG = 0 ?
noyes yes no
NO G.l
NOG.I There's
There's
G.l.
No G.l. but B seem s  
to be dominant
No G.l. butG seem s  
to be dominant
6.4.6 Egg lav in g  assay
24 adult w o rms of N2 and rme-l (bl045) strain that were subjected to RNAi by feeding, 
as described in Section 6.3.3, were used for this assay. After 4 days of incubation at 
15°C, an L4-staged worm was transferred onto to a small NGM agar well (in a 12-well 
plate) prepared with lawn of E.Coli OP50. For each knockdown experiment in N2 and 
in rme-l background, a total of 24 L4-staged worms were transferred to individual well. 
The worms were continuously transferred into a new well every 36 hours for a total 
period of 5-7 days, until each individual worm had stopped laying eggs. The worms 
were incubated at 15°C constantly, apart from when they were being transferred into 
new wells at room temperature. The total number of eggs laid by each worm was 
counted. The total egg counts of three worms were not included when calculating the
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average, because of an early death after 1 day, or due to two worms having extremely 
low brood sizes of 2-3 eggs in the total period of 7 days. The average for each 
knockdown experiment was calculated from the duplicated experiments with 21 worms.
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m. RESULTS
7. Y2H Screenings
The EH domains of five C. elegans EH domain-containing proteins (R10E11.6, ITSN- 
1, EHS-1, REPS-1 and RME-1) were cloned as baits (Figure 1) to screen against the 
cDNA library of C. elegans, prepared from a mixed population of all developmental 
stages.
Figure 1 The Schematic diagrams to show the regions cloned as baits for the 
Y2H screening o f ITSN-1, EHS-1, RME-1, REPS-1, and R10E11.6
a. ITSN-1 b. EHS-1
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The EH domain-containing regions were cloned in-frame with the GAL4DBD, whereas 
the cDNAs were cloned in-frame with the GAL4AD. The expression of the chimera 
proteins of GAL4DBD and the EH domain-containing regions were checked by 
Western Blots using anti-GAL4DBD antibody (Figure 2).
Figure 2 Western blots with Anti-GAL4DBD to show the expression of the bait 
constructs in-frame with GAL4 DBD.
a. REPS1 C, RME-1 Bait B, ITSN-1, EHS-1123, EHS-1 125
CO CO CO X  X  
UJ LU
—175kDa
—83kDa
62kDa
—47.5kDa
32.5kDa
Fig.2a The expected molecular weights of the Reps-1 bait, one of 
the RME-1 baits, ITSN-1 bait, and two EHS-1 baits :
Reps-1 C: 40.9kDa 
RME-1 D:34.1kDa 
ITSN-1: 47.0kDa 
EHS-1 123: 53.0kDa 
EHS-1 125: 30.9kDa
The band corresponding to RME-1 bait D was repeatedly detected 
around 37-40kDa, higher than expected. In comparison, the band 
corresponding to REPS-1 bait ran lower than expected, near 35kDa. 
The correct DNA sequences of all bait constructs were confirmed.
b. RME-1 constructs D, F and H
E250kD a 180kDa4lOOkDa
— 75kDa
50kDa
— 37kDa
.— 25kDa
20kDa
250kDa
180kDa
100kDa
75kDa
SOkDa
37kDa
25kDa
20kDa
c. R10E11.6 bait
Fig.2b The expected molecular weights of 
the RME-1 baits used in Y2H screenings: 
D:34.1kDa 
F: 35.8kDa 
H: 38.8kDa
The band corresponding to the bait D was 
detected at a molecular weight higher than 
expected, closer to 37kDa, as described also 
above in Figure 2a.
—175kDa
—B3kDa
-6 2 k D a
—47.5kDa
v -J -3 2 .5 k D a  
I —26.5kDa
Figure 2c. The expected 
molecular weight of R10E11.6 
bait:
R10E11.6 B: 35.6kDa
The cDNA library and the baits were co-transformed in Mav203 yeast strain, which has 
three reporter genes (URA3, HIS3 and LacZ) with the GAL4 promoter regions in the 
genome, as described in Section 3.2. In order to ensure that the expression of the bait
alone does not self-activate the reporter genes, the clones transformed with the bait and 
the empty prey vector were tested by X-gal assays (Figure 3 and 4).
In addition, Mav203 cells express a basal level of HIS3, which can be titrated out in the 
presence of 3 -Amino-l,2,4-Triazole (3AT). Therefore the minimum concentration of 
3AT required to sensitize the selection by HIS3 was determined for the clones 
transformed with the bait and the empty prey vector (Figure 5).
Figure 3 X-gal assays o f the co-transfonnants of each bait construct (pDBLeu- 
Bait) with an empty prey vector (pPC86) to ensure that the baits used for  
screenings did not self-activate The expression of the reporter gene, LacZ.
A,B,C,D,E: Yeast Control strains transformed with plasmids containing no inserts 
(A), or transformed w ith plasmids expressing interactors of increasing interaction 
strengths in the order of B-E, as described in detail in  Table 1 in Section 6.2.3.
1,2,3,4,5: Five different co-transformants tested in order to ensure that the self­
activation was not observed not only in one clone but in multiple clones.
The co-transformants of the EHS-1 bait 123 and pPC86 were tested alongside five co­
transformants of EHS-1 bait 117, which contains all three EH domains and had 
shown self-activation of LacZ when tested previously (Refer to the later section  
7.2.1.)
ITSN-1 EHS-1 123 EHS-1 125 RME-1 D and Reosl C R10E11.6
123 117 C
E
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Figure 4 X-gal assays of the various RME-1 bait constructs D, re-transformed 
with an empty vector pPC86 (C-) or with the cDNA encoding epn-1 (E), alx- 
1(A) and F15C11.2 (F) in-fusion with GAL4AD, alongside a negative control, 
Reps-1 C/pPC86 (Ct-).
Five co-transformants were tested to ensure that the self-activation was not observed not 
only in one clone but in multiple clones.
The co-transformants shown in this figure were transformed with the plasmids as follows
Ct-: pDBLeu-REPSl/ pPC86 
with noinsert
D/F: pDBLeu-BaitD/ pPC86- 
F15C11.2
D/A: pDBLeu-BaitD/ pPC86- 
alx-1
D/E: pDBLeu-BaitD/ pPC86- 
epn-1
D-: pDBLeu-BaitD/ pPC86 
with no insert
C: Yeast control strains A-E
Ct-: pDBLeu-REPSl/pPC86 
with noinsert
F/F: pDBLeu-BaitF/ pPC86- 
F15C11.2
F/A: pDBLeu-BaitF/ pPC86- 
alx-1
F/E: pDBLeu-BaitF/ pPC86- 
epn-1
F-: pDBLeu-BaitD/ pPC86 
with no insert
C: Yeast control strains A-E
Ct-: pDBLeu-REPSl/ 
pPC86 with noinsert
H/F: pDBLeu-BaitH/ 
pPC86-F15C11.2
H/A: pDBLeu-BaitH/ 
pPC86-alx-l
H/E: pDBLeu-BaitH/ 
pPC86-epn-l
H-: pDBLeu-BaitH/ pPC86 
with no insert
C: Yeast control strains A-E
a. Bait D b. Bait F c. Bait H
Ct- H/F H/A H/E H - CCt- D/F D/AD/E D- C
 ---  IW|«
The co-transformants of the cDNA library and the baits were tested initially for the 
expression of HIS3 in the presence of 3AT, at a concentration that was set up prior to 
the screenings. The clones that were positive for HIS8 expression were further tested for 
the expression of LacZ by X-gal assays, and of URA3 by replica plating onto minimum 
medium lacking uracil.
92
Figure 5 The replica plates o f pDBLeu-bait/pPC86 transformants onto plates 
containing increasing concentration of3ATfrom OmM to lOOmM (SC -Leur - 
Trp, -His +3AT) in assays to determine the concentration of3AT that is 
required titrate out the basal HIS3 expression by the co-transformants of every 
bait.
A,B,C,D,E: Yeast Control strains transformed with plasmids containing no inserts 
(A), or transformed w ith plasmids expressing interactors of increasing interaction 
strengths in  the order of B-E, as described in  detail in  Table 1 in  Section 6.2.3.
a. pDBLeu-ITSN-l/pPC86 and pDBLeu-EHS-1123/pPC86 co-transformants
b. pDBLeu-EHS-1125/pPC86 co-transformants
c. pDBLeu-Reps-1 C/pPc86 and pDBLeu-RME-1 D/pPC86 co-transformants
d. pDBLeu-R10E11.6/pPC86 co-transformants
In all tests used to monitor the expression of the reporter genes, the control strains A, B, 
C, D and E, provided from the Invitrogen were used as reference. The control strains 
express interactors that interact in an increasing order from A to E. The interactors 
expressed by each control strain are described in detail in Table 1, under the section
6.2.3. The control strain A was used as negative control, whereas the control strains B, 
C, D, and E were used as the positive controls.
No interactors were found for the putative EH protein, R10E11.6. On the other hand, 
the Y2H screenings identified a total of 26 proteins as the interactors of ITSN-1, EHS-1, 
REPS-1, and RME-1 in C. elegans, including several proteins, which are common 
interactors between two or three of the EH proteins.
7.1 ITSN-1 Y2H Screenings
7.1.1 P rep aration  o f ITSN-1 bait
The EH domains present in the N-terminal of ITSN-1 were cloned in-frame with 
GAL4DBD in a vector pDBLeu as the bait, as shown in Figure la. It was ensured prior 
to the screening that the bait was expressed in-frame with GAL4DBD by Western blot 
with anti-GAL4DBD antibody on the protein precipitates of the yeast culture 
transformed with the bait constructs and the empty prey vector. The expression of the 
fusion protein GAL4DBD-ITSN-1 is shown by the band, which is specifically 
recognized by an anti-GAL4DBD antibody in the Western Blot, at its expected 
molecular weight of 47.0kDa (Figure 2a).
Five colonies from the same co-transformation were used in X-gal assay in order to 
ensure that the bait is not able to self-activate the reporter gene LacZ. The clones 
expressing the ITSN-1 bait together with GAL4AD expressed by the empty prey vector 
pPC86, were shown to be negative for LacZ expression. The minimum concentration of 
3AT required to titrate out the basal expression of another reporter gene HISS for the 
yeast clone expressing the ITSN-1 bait was determined to be lOmM, as shown in Figure 
5a.
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7.1.2 Y2H screen ings w ith  ITSN-1 (I) & (II)
A total of two screenings were earned out using the bait containing the EH domain of 
ITSN-1. In the first screening (I), 88 clones were positive for the initial selection for the 
expression of HIS3 in the presence of lOmM 3AT. 43 out of these 88 clones were 
positive for the expression of LacZ  gene (Figure 6a) whereas 25 clones were positive 
for the URA3 expression (results not shown). The expression of the three reporter genes 
by each clone is summarized in Table 3.
Figure 6 X-gal Assay to test the expression o f  LacZ reporter genes by the clones 
fished for ITSN-1 Y2H screenings
A,B,C,D,E: Yeast C ontrol strains transform ed w ith  p la sm id s con ta in in g  no inserts  
(A), or transform ed w ith  p lasm id s exp ressin g  interactors o f increasing  interaction  
strengths in  the order o f B-E, as described  in  d etail in  Table 1 in  S ection  6.2.3.
a. ITSN-1 Y2H screening I: X-gal assays of a total of 48 clones that were identified 
as positive for the expression of HIS3 with lOmM 3AT. The 48 clones out of the 88 
clones were tested to be positive for growth in -HIS medium when the single 
colonies were streaked on a plate lacking HIS. The number of the clones in the 
assay refers to the initial clone number out of the 88 clones.
b. ITSN-1 Y2H Screening II: X-gal assays of a total of 100 clones that were 
identified as positive for the expression of HIS3 with lOmM 3AT.
95
Table 3 The expression of the reporter genes, LacZ and URA3, by the ITSN-1 
interacting-clones, which were initially selected for the expression ofHIS3 in 
the presence o f lOmM 3AT
The levels o f expression were compared with that o f  the control strains A-E as follows: A:-, B: 
+, C: ++, D:+++, E: ++++. Note that the intensity shown in the figure may not correspond 
exactly to that observed during the experiment as the intensity o f  the colour changed during 
storage o f  the membrane after the experiment.
(Clones # 4, #12-13, #42, #44-45, #48-54, #56-58, #62-70, #72-76, #78-79, #81-84, 
and #86-87 were omitted as they were contaminants.)
Clone # LacZ URA3 HIS3
1 +++ + ++
2 ++ + ++
3 ++ - . ++
5 + - ++ ~
6 ++ - ++
7 +++ + ++
9 ++ ++ ++
10 ++ + ++
11 + + ++
14 ++ - ++
15 + - ++
16 + - ++
17 + - ++
18 +++ ++ ++
19 +++ ++ ++
20 + - ++
21 ++ + ++
22 ++ ++ ++
23 ++ + ++
24 ++ + ++
25 ++ + ++
26 ++ + ++
27 ++ ++ ++
28 ++ + ++
30 +++ - ++
31 ++ + ++
32 ++ +++ ++
33 +++ - ++
34 ++ + ++
35 ++ - ++
36 ++ - f ++
37 ++ - ++
38 ++ - ++
40 ++ + ++
Clone # LacZ UR A 3 H IS 3
41 + + + + + + +
43 . - + + +
46 + + - + +
47 + + +/- + +
55 + + - + +
59 - ■ - + +
60 - - + +
61 - - + +
71 + + - + +
77 + + - + +
80 + + - + +
85 + - + +
88 - - + +
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In the second screening (II), 100 clones were selected for HIS3 expression in the 
presence of lOmM 3AT. As shown in Table 4, 52 out of these 100 clones were shown 
to express LacZ by the X-gal assay as shown Figure 6b. In comparison, 32 out of these 
100 clones were positive for the expression of URA3, and 22 clones, which showed a 
very weak expression of URA3 (indicated as +/- in Table 4). The expression of the 
reporter genes LacZ, URA3 and HIS3 are shown in Table 4.
Table 4 The expression o f the reporter genes, LacZ and URA3, by the ITSN-1 
interacting-clones, which were initially selected for the expression o/HIS3 in 
the presence of lOmM 3 AT.
The levels o f  expression were compared with that o f  the control strains A-E as follows: A:-, B: 
+ ,C : ++, D:+++, E: -1-+++. Note that the intensity shown in the figure may not correspond 
exactly to that observed during the experiment as the intensity o f  the colour changed during 
storage o f  the membrane after the experiment.
Clone# LacZ URA3 HIS3
1 + - 4-4-
2 -H + -H - 4-4-
3 4- 4-4- 4-4-
5 H—h - 4-4-
6 + 4- - 4-4-
7 -4-4 + - 4-4-
8 + + 4- 4-4-
9 + + - 4-4-
1 0 + + 4-4-4- 4-4-
11 + + - 4-4-
12 - 4-/- 4-4-
13 4-4- 4-/- 4-4-
14 4- 4-4-4- 4-4-
15 4- - 4-4-
16 4-4- - 4-4-
17 - - 4-4-
18 - - 4-4-
19 - ' - 4-4-
20 4- - 4-4-
21 4-4- 4-4- 4-4-
22 4- - 4-4-
23 4-4- 4-4- 4-4-
24 - - 4-4-
25 4-4-4- - 4-4-
26 4-4- - 4-4-
27 4- 4- 4-4-
28 - 4- + 4-
29 4-4- 4-4- 4-4-
30 4-4- - 4-4-
31 4-4-4- - 4-4-
32 4- - 4-4-
33 4- - 4-4-
34 ■ - - 4-4-
35 4-4- 4- 4-4-
36 4-4- 4- 4-4-
37 4-4- - 4-4-
38 4-4-4- - 4-4-
39 4-4-4- - 4-4-
40 - - 4-4-
41 4-4-4- +/- 4-4-
42 4-4- +/- 4-4-
43 4-4- +/- 4-4-
44 4-4- - 4-4-
45 4-4- - 4-4-
46 - 4- 4-4-
47 + + +/- 4-4-
48 4-4- +/- 4-4-
49 4- - 4-4-
50 4-4- +/- 4-4-
50 + 4- + / - +  +
51 - + / - +  +
52 + + + + / - +  +
53 - t - + - +  +
54 + + + / - +  +
55 - + / - +  +
56 - + / - +  +
57 - + / “ +  +
58 - - +  +
59 - - +  +
60 - + +  +
61 - + / - +  +
62 - + / - +  +
63 - - +  +
64 - + / - +  4
65 - + 4 4
66 - + / - 4 4
67 - + 4 4
68 - - 4 4
69 4  + + 4 4
70 - + / - 4 4
71 - + / - 4 4
72 - - 4 4
73 - - 4 4
74 - + 4 4
75 - + 4 4
76 + + 4 4
77 - - 4 4
78 - - . - 4 4
79 - 4- 4 4
80 4- + 4 4
81 - + 4 4
82 - - 4 4
83 - - 4 4
84 - + 4 4
85 - + 4 4
86 - 4- 4 4
87 +  + - 4 4
88 + + - 4 4
89 - + 4 4
90 + + 4 4
91 - + 4 4
92 - - 4 4
93 - + / - 4 4
94 + + + 4 4
95 - + 4 4
96 - + 4 4
97 - - 4 4
98 - - 4 4
99 + + - 4 4
100 - + 4 4
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7.1.3 In teractors o f ITSN-1
A total of 95 clones were positive for the expression of LacZ  and/or URA3. Subsequent 
sequencing of the cDNA library insert of these 95 clones identified a total of 16 distinct 
putative interactors that were translated in-frame with the GAL4AD. The DNA 
sequences of the positive clones were analysed to determine whether the cDNA inserts 
is in-frame with the GALA AD, as described in Materials and Method. Following the re­
transformation assays, 10 proteins were confirmed as putative interactors of ITSN-1, 
namely: EPN-1, LIN-10, PQN-32, TFG-1, T05E7.4, F46H5.7, F15C11.2, DAB-1, 
K04H5.2 and BE0003N10.3 (Figure 7).
Figure 7. The X-gal Assays for the Re-transfownation assay o f the putative  
positive interactors that were identified from the Y2H screenings with ITSN-1.
A,B,C,D,E: Yeast Control strains transform ed w ith  p la sm id s con ta in in g  no inserts  
(A), or transform ed w ith  p lasm id s exp ressin g  interactors o f increasin g  interaction  
strengths in  the order o f B-E, as described  in  d etail in  Table 1 in  S ection  6.2.3.
1,2,3,4/5: Five d ifferen t co-transform ants tested  in  order to ensure that the LacZ  
activation  w as not ob served  not o n ly  in  one clon e b ut in  m u ltip le  clones.
T he p o sitiv e  interactions detected  in  the X-gal assays are m arked w ith  arrows.
1) EPN-1, LIN-10, PLK-3, and
SRS-2
2) PQN-32, TFG-1, T05E7.5, 
and COL-8 ,
Q- ITSN-1 
COL-B
itsn-w rrSN-i / ITSN.,,T05E? 5 TFG-1 p™”
1 1
2 2 ' f  a
A  I f  B3 3 3 , < 3. ^
4 4
4 " 4 *  ^  D
5 5
5
3) F46H5.7, F15C11.2, DAB-1, 4) CTL-1, K04H4.2, VITA, and
BE0003N10.3
B E0003N 10.3 VIT-4 K04H4.2 CTL-1
and DLI-1.
DAB-1 F1 SC 11.2 F46H5.7
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7.2 EHS-1 Y2H Screenings
7.2.1 P reparation  o f EHS-1 b aits
Two baits containing all three EH domains present in the N-terminal of EHS-1, 
indicated as constructs 117 andll8 in Figure lb, were able to self-activate LacZ 
expression (construct 117 shown in Figure 3b). In order to avoid using baits that self- 
activate the reporter genes, several baits were constructed that separate the three EH 
domains. Bait construct 121 contained only the first EH domain, whereas Bait 122 was 
designed to contain the first EH domain and the half of the second EH. Bait 122 was 
constructed in order to include the surrounding region of the first EH domain, but not 
including the second EH domain, which starts 54 amino acids after the first EH domain, 
in case two EH domains together caused self-activation. Bait 123 containing both the 
first and the second EH domain, showed no self-activation (Figure 3b). When the third 
EH was expressed' on its own (Bait 125), the ability to self-activate LacZ was not 
observed (Figure 3 c), whereas Bait 124 containing the second and the third EH domains 
showed self-activation (Figure 3b).
Bait 123 was chosen for its complete representation of the region containing the first 
two EH domains. The bait 125 was then used in additional Y2H screenings to 
compensate for any interactions that may be mediated specifically by the third EH 
domain. The expression of Bait 123 and Bait 125 in-frame with GAL4DBD were 
detected by anti-GAL4DBD Western Blot as the bands corresponding with the expected 
molecular weight, 53.0kDa and 30.9kDa, respectively (Figure 2a). The minimum 
concentrations of 3AT appropriate for titration of HIS3 basal expression with the bait 
123 was determined to be between 20mM and 30mM (Figure 5a). In comparison, the 
appropriate concentration of 3AT for Baitl25 was determined as lOmM (Figure 5b).
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7.2.2 Y2H S c ree n in g s  w ith  EHS-1 123 (D & (II)
Two screenings with the bait 123 were performed, one in the presence of 25mM 3AT, 
and another in less stringent conditions, using lOmM 3AT. In the Y2H screening with 
bait 123 (I), 54 clones were selected for the expression of HIS3 in the presence of 
25mM 3AT. 51 out of these 54 clones expressed LacZ  as assessed by the X-gal assay 
(Figure 8a). X-gal assays were repeated to ensure reproducibility of results. Indeed, 
there was no discrepancy except for clone number 42, which was positive for the first 
X-gal assay but was negative in the second X-gal assay, although differences in the 
level of activation was observed in several clones (Table 5). In comparison, 49 out of 
these 54 clones were positive for the expression of URA3.
Figure 8 X-gal Assay to test the expression o f LacZ reporter gene by the clones 
fished for EHS-1 Y2H screenings.
A,B,C,D,E: Yeast C ontrol strains transform ed w ith  p lasm id s con ta in in g  no inserts  
(A), or transform ed w ith  p lasm id s exp ressin g  interactors o f increasin g  interaction  
strengths in  the order o f B-E, as described  in  d etail in  Table 1 in  S ection  6.2.3.
a. EHS-1 123 Y2H screening I: X-gal assays of a total of 54 clones that were 
identified as positive for the expression of HIS3 with 25mM [3AT].
^  O sy '/
/y
s/Sy/,'!iA
✓V / /  /  /  
t /N h  ti
b. EHS-1 123 Y2H screening II: X-gal assays of a total of 110 clones that were 
identified as positive for the expression of HIS3 with lOmM [3AT].
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Table 5 The expression of the reporter genes, LacZ and URA3, by the EHS-1- 
interacting clones, which were initially selected for the expression o f  HIS3 in 
the presence of25mM 3AT.
The levels of expression were compared with that of the control strains A-E as follows: 
A:-, B: +, C: ++, D:-H-+, E: I l-1 l . Note that the intensity shown in the figure may not 
correspond exactly to that observed during the experiment as the intensity of the colour 
changed during storage of the membrane after the experiment.
C lone # La1
cZ
2 UR A 3 HIS3
1 + + + + + + + + + + + +
2 + + ++ + + + + + +
3 + + + + + + + + +
4 H—h + + + +
5 + + + + + + + + + +
6 + + + + + + + ++
7 + + + + +
8 + + ++ + + ++
9 + + + + + + +
10 + + + + + + + ++
11 + + + + + +
12 + ++ + + ++
13 ++ + + + ++
14 + + + + + + + +
15 + + + + + + + + + + +
16 + ++ - + + +
17 + + + + + + + ++
18 + + + + + + + + + + + +
19 + + + + + +
20 + + + ++ + + + ++
21 + + + + + + + + +
22 + + + ++ + + + + + +
23 + + + /- + +
24 + + + + + + ++
25 + + + + + + + + H—H
26 + + + + + + + ++
27 ++ + + + +
28 + + + + + + +
29 + + + + + + + +
30 + + + + + + + ++
31 ++ + + + + + +
32 + + + + + + + + + + +
33 - - - ++
34 + + + ++ + + + + +
35 + + +' +
36 + + + + + +
37 + ++ + + + + +
38 + + + + + + + + + +
39 + + + +
40 + /- + /- + /- +
41 + + + -
42 - + + +
43 ++ + + + + + H—h
44 + + + + + + + + + ++
45 + + + + +
46 - - - -
47 + + + + + /-
48 - + /- - +
49 + + + + + ++
50 + + /- + /- +
51 + ++ +H—
52 - - + /- -
53 + + + H—h H—h + +
54 ++ ++ + + + + /-
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In the second less stringent screening with bait 123 (II) in the presence of lOmM of 
3AT, 110 clones were positive for the initial selection of #753 expression. 102 out of 
these 110 clones were also positive for the expression of LacZ gene for at least one of 
the duplicated X-gal assays (Figure 8b), whereas 96 clones were positive for the URA3 
expression (results not shown). The expression of the three reporter genes: LacZ, URA3 
and HIS3, by the individual clones are summarized in Table 6.
Table 6 The expression of the reporter genes, LacZ and URA3, by the EHS-1 
interacting-clones, which were initially selected for the expression o/HIS3 in 
the presence o f lOmM 3AT in EHS-1 Y2H.
The levels of expression were compared with that of the control strains A-E as follows: 
A:-, B: +, C: ++, D:+++, E: I ri-K Note that the intensity shown in the figure may not 
correspond exactly to that observed during the experiment as the intensity of the colour 
changed during storage of the membrane after the experiment.
56 - 4 4 -4 - 4 4
57 - 4 4 4 -4 - 4 4 4
58 4 4 4 -4 - 4 4
59 4 4 4 4 4 -4 -4 - 4
60 - * 4 4 4- 4
61 - - - 4
62 4 4 4 -4 -4 - 4 / -
63 4 4 4 4 4 *4 *4 - 4 4 4
64 4 4 4 - - 4
65 4 - - -
66 - 4 4 + / - 4 4
67 4 - - 4 / -
68 4 + / - 4- 4
69 4 4 4 4 4 4 4- 4 4 4
70 - 4 4 4 4 -4 - 4 4
71 4 4 4 4* 4
72 4 4 -4 -4 - - -
73 4 4 4 4 4 -4 -4 - 4
74 4 4 4 4 4 + / - -
75 4 + / - 4 - 4
76 4 4 4 4 4 4 -4 -4 - 4 4 4
77 - 4 4 4-4 - 4 4 4
78 -I—1—b 4 4 4 -4 - 4 4
79 4 4 4 4 -4 - 4 4 4
80 4 4 4 4 4 -4 -4 - 4 4 4
81 4 4 4 4 4 -4 -4 - 4 4 4
82 - - 4- -
83 4 - 4- 4
84 4 4 4 4 4 4 -4 -4 - 4 4 4
85 4 4 -4 -4 - 4 -4 -4 - 4 4
86 4 - - -
87 4 4 4- - 4
83 - 4 - + 4 *4 *4 * 4 4 4
89 4 4 4 4 -4 -4 - 4 -4 - 4 4 4
90 - - - -
91 4 4 4 4 -4 -4 - + / - 4 4
92 4 4 4 4 -4 - 4 - 4 4 4
93 4 4 4 -4 - 4 -4 - 4 4
94 4 4 4- 4- 4 4
95 4 4 4 -4 -4 - 4 + / -
96 - - - 4
97 4 4 4-4 - 4 4 4 4
98 4 4 4 -4 - 4 4 4 4 4
99 4 4 4- 4 4 4 4
100 4 4 4 4 -4 -4 - 4 4 4 4 4
101 4 4 4-4 - 4 4 4 4 4 4
102 4 4 -4 -4 - 4 4 4 4 4
103 4 4 4 -4 -4 - 4 4 4 4
104 - 4 -4 -4 - 4 4 4 4
105 4 4- 4 4
106 4 4- 4 4 4
107 4 4 4 -4 - 4 4 4 4
108 - - - 4
109 4 4 4 4 -4 -4 * - 4 4
110 4 4 4-4 - 4 4 4 4 4
Clone # Lbi
c Z
2
U R A 3 H JS 3
1 4 4 4 4 4 4 4 4 4
2 4 4 4 4
3 4 4 4 4 4 4 4 4 4 4 4
4 4 4 4 4 4 4 4 4 4 4 4
5 4 4 4 4 4 + / -
6 4 4 4 4 4 + / -
7 4 4 4 4 + / -
8 4 4 4 4 4 4 4 4 4 4
9 4 4 4 4 4 4 4 4 4
10 4 4 4 4 4 4 4 4
11 4 4 4 4 4
12 4 - 4 4 + / -
13 4 4 - 4 4
14 4 4 4 4 4 4 4 4 4
15 4 4 4 4 4 4 4 4
16 4 4 4 4 4 4 4 + +
17 4 4 4 4 4 4 4 4
18 4 4 4 4 4 + / -
19 4 4 ' 4 4 4 + / -
20 4 + / - 4 4 + / -
21 4 4 4 4 4 4 4
22 4 4 4 4
23 4 4 4 4 4 4 4 4 4 4
24 4 4 4 4 4 4
25 4 4 4 4 4 4 4 4 4 4
26 4 4 4 4 4 4 4 4 4 4 4 4
27 4 4 4 4 4 4
28 4 4 4 4 4 4 4 4
29 4 4 4 4 4 4
30 4 + / - - -
31 - - - -
32 4 4 + / - 4 4
33 4 4 4 4 4 4 4 4 4
34 - 4 4 4 4 4 4
35 - - 4 4
36 4 4 4 - 4 4
37 - + / - 4 -
38 4  ' 4 4 4 4 4 4 4
39 4 4 4 4 4 4 4 4 4 4 4
40 4 4 - 4 4
41 4 4 4 4 4 4
42 4 4 4 4 4
43 4 4 4 4 4 4 4 4 4
44 4 4 4 4 4 4 4 4 4 4
45 - * 4 4 4 -
46 4 4 4 4 4 4
47 4 4 4 4 4 4
48 4 4 4 4 4 4 4 4
49 4 4 4 4 -
50 4 4 4 4 4 4
51 4 4 4 4 4 4
52 - 4 4 4 4 4 4
53 - 4 4 4
54 4 4 4 4 4 4
55 4 4 4 4 4 4 4 4
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7.2.3 Y2H S creen ings w ith  EHS-1 125 (I) & (ID
The first Y2H screening with bait 125 resulted in 50 clones, which were found to be 
positive for HIS3 selection in the presence of 5mM 3 AT. 7 out of these 50 clones were 
shown to express LacZ by the X-gal assay, as shown in Figure 9a. In comparison, 4 out 
of these 50 clones were positive for the expression of URA3, which appeared to show a 
level of growth slightly higher than the negative controls, the bait alone and control 
strain A (results not shown). The expression of the three reporter genes: LacZ, URA3 
and HIS3, by the individual clones are summarized in Table 7.
In the second more stringent screening with bait 125 in the presence of lOmM of 3AT, 
25 clones were positive for the initial selection for the expression of HIS3. 13 out of 
these clones were positive for the expression of LacZ gene (Figure 9b) whereas only 3 
clones were positive for the URA3 expression (results not shown). The expression of the 
three reporter genes: LacZ, URA3 and HIS3, by the individual clones are summarized in 
a table in Table 8.
Table 7 The expression of the reporter genes, LacZ and URA3, by the EHS-1 
interacting-clones that were initially selected for the expression o f  HIS3 in the 
presence o f 5mM 3AT.
The levels of expression were compared with that of the control strains A-E as follows: 
A:-, B: +, C: ++, D:+++, E: -H - H -. Note that the intensity shown in the figure may not 
correspond exactly to that observed during the experiment as the intensity of the colour 
changed during storage of the membrane after the experiment.
26 - - +
27 + - +
28 + - + -
29 + - +
30 - + /- +
31 - - +
32 - - +
33 - + /- +
34 - + /- +
35 - + /- +
36 - - +
37 - - +
38 - - +
39 - - +
40 - - +
41 - - +
42 - - +
43 - - +
44 + + + + +
45 - - +
46 - - +
47 - - +
48 - - +
49 - - +
50 - - +
Clone # LacZ U RA3 H IS 3
1 - + • +
2 - + +
3. - + +
4 ++ - +
5 - ++ +
6 + + +
7 - +
8 - - ■ +
9 - - +
10 - - +
11 - - +
12 - - +
13 - - +
14 - - +
15 - - +
16 - • +
17 - - +
18 - - +
19 - - +
20 - - +
21 + ++ +
22 - - +
23 - - +
24 - - +
25 - - +
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Figure 9 X-gal Assay to test the expression ofha.cZ reporter gene by the clones 
fished for EHS-1125 (3rd EH domain) Y2H screening
A,B,C,D,E: Yeast Control strains transformed with plasmids containing no inserts 
(A), or transformed w ith plasmids expressing interactors of increasing interaction 
strengths in the order of B-E, as described in  detail in  Table 1 in Section 6.2.3.
a. EHS-1125 Y2H screening I: X-gal assays of a total of 50 clones that were 
identified as positive for the expression of HIS3 with 5mM [3AT].
A  . . M -  A  - .
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b. EHS-1 125 Y2H screening II: X-gal assays of a total of 25 clones that were 
identified as positive for the expression of HIS3 with the determined [3AT].
Table 8 The expression of the reporter genesf LacZ, and URA3, by the EHS-1 
interacting-clones that were initially selected for the expression of HIS3 in the 
presence of lOmM 3AT.
The levels of expression were compared with that of the control strains A-E as follows: 
A:-, B: +, C: ++, D:+++, E: M i l.  Note that the intensity shown in the figure may not 
correspond exactly to that observed during the experiment as the intensity of the colour 
changed during storage of the membrane after the experiment.
Clone # LacZ URA3 HIS3
1 - - +
2 + + +
3 - + + +
4 - +
5 + + - +
6 + - +
7 + +
8 ++ +
9 ++ +
10 ++ +
11 + +
12 + -
13 + - +
14 - - +
15 + - +
16 + - +
17 - + /- +
18 - + /- +
19 - - +
20 - - +
21 + - +
22 - - +
23 - - +
24 - - +
25 + - +
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7.2.4 In teractors o f EHS-1
A total of 31 putative interactors of EHS-1 were identified as cDNA inserts in-frame
with GAL4AD. Following the re-transformation assays, 14 proteins were confirmed as 
putative interactors of EHS-1: EPN-1, TFG-1, D1081.7 (1J65), LIN-10, DAB-1, PQN- 
32, F15C11.2, Y45F10D.13, F46H5.7 (also referred to as XH858), B0041.2, C50C3.8, 
CAS-1, Y11D7A.12 and ALX-1 (Figure 10).
Figure 10. The X-gal Assays used as an assay for the Re-transformation assay 
o f the putative positive interactors that were identified from the Y2H 
screenings with EHS-1.
A,B,C,D,E: Yeast Control strains transformed with plasmids containing no inserts (A), 
or transformed with plasmids expressing interactors of increasing interaction strengths 
in the order of B-E, as described in detail in Table 1 in Section 6.2.3.
1,2,3,4,5: Five different co-transformants tested in order to ensure that the LacZ- 
activation was not observed not only in one clone but in multiple clones.
The nositive interactions detected in the X-eal assavs are marked with arrows.
1) EPN-1, TFG-1: 
D1081.7 (1J65) and
2) LIN-10, DAB-1, CPR-1. 
and Y47G6A.4
1  1
3) PQN-32, F15C11.2, 
Y45F10D.13 and T23G7.3
EhS-l /  EHS
T23G7.3 Y45F10 F15CU.
4) F46H5.7, B0041.2, 
R05G6.7 and C50C3.8 
 * ------* —*-------
5) CAS-1, Y11D7A.12,
F44E7.4, and T1 OB 10.2 
 ------
6) CPN-3, RPL-4, 
C55C3.3 and EFT-4
7) ALX-1, COL-165, 
COL-3, and CUT-2
8) 123/ALX-l (positive control), R09E12.3 
(with 125), Y24D9A.4 (withl25), COL-166 
(with 123)
c -  S K ' S f i' S t l i  f tf”  \ - C- EHS-1 E„s., E„,„, < 1 2 5 )3 ^  «”« » £ , , ,  S i
’ ’ 1 ’ f f  A
(123) 1 1  1 , A
2 2 2 - ^  B 1 2 2 2 2 d® ? B
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7.3. RME-1Y2H screenings
7.3.1 P reparation  o f  RME-1 B a it D
The bait to be used for the Y2H screenings for RME-1 was initially cloned to contain 
the restricted region surrounding the EH domain at the C-terminus (Bait B, Figure lc). 
However, this construct was not expressed and another bait, Bait D was constructed. 
Bait D contains an extension of 49 amino acids in the region N-terminal to the EH 
domains (Bait D, Figure lc). Bait D was expressed in-frame with the GAL4DBD, as 
detected as the band at the expected molecular weight of 35.1kDa, recognized by an 
anti-GAL4DBD Western Blot (Figure 2a). Bait D was also confirmed not to self- 
activate LacZ gene, as shown in Figure 3d. The concentration of 3AT required to titrate 
out the basal HISS expression in the co-transformants of bait D and the empty prey 
vector was determined to be lOmM (Figure 5c).
7.3.2 Y2H screen in g  w ith  R M E-lBait D
In spite of the fact that the total co-transformation efficiency for Bait D had reached 
more than the required level of 1 x 106 colonies, only 1 clone was selected for HIS3 
expression in the presence of lOmM 3AT. This clone was shown to express LacZ 
(Figure 11) but not URA3 (result not shown). Two plasmids were isolated from this 
clone, and sequencing of each plasmid identified ASP-1, ALX-1, and GLY-8. Two 
rounds of re-transformation assays confirmed only ALX-1, although the expression of 
LacZ detected by the X-gal assay was very weak (Figure 12).
7.3.3 P reparation  o f  o ther RME-1 b a its
In an attempt to find a bait that might act as a functional EH domain of RME-1 without
having to resort to using the full-length protein, 8 more constructs, containing different
regions of RME-1, were prepared (see baits A, C, E, F, G, H, I, J in Figure lc). In order
to test whether the EH domains contained in these baits successfully interacted with a
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putative interactor, they were co-transformed with cDNAs inserts that were identified to 
interact with the other EH domains of ITSN-1 and EHS-1 in the previously described 
screenings. This approach was chosen because it requires only small-scale 
transformations of yeast, rather than a library-scale screening.
Figure 11. X-gal Assay to test the expression o f  LacZ reporter gene by the clone 
fished by RME-1 Y2H Screenings.
The clone marked as RME-1 Y2H #1 is the only clone to be concerned in  this figure. 
The other unlabelled clones are unrelated clones from the ITSN-1 Y2H screenings.
A,B,C,D,and E are the control strains co-transoformed w ith two Y2H plasmids with  
no inserts (A), ot with Y2H plasmids expressing interactors of increasing strengths 
from B to E. The details of each strain is described in  Table 1 in  the section 6.2.3.
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Figure 12. Re-transfonnation assay o f the putative positive interactors that 
were identified from the RME-1 Y2H screening I  using bait D.
The level of expression of LacZ by the re-transformed clones observed was very 
weak. The interaction was considered positive nonetheless, for the fact that the 
expression positive with respect to the control strain A (A), the control strain B 
which should be expressing a weak interaction, and the negative control of the bati 
D alone (D).
A,B,C,D,and E are the control strains co-transoformed with two Y2H plasmids with  
no inserts (A), ot with Y2H plasmids expressing interactors of increasing strengths 
from B to E. The details of each strain is described in  Table 1 in the section 6.2.3.
1,2,3,4,5: Five different co-transformants tested in order to ensure that the self­
activation was not observed not only in one clone but in multiple clones.
c -
(bait D)
RM E-1 D /
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The cDNAs of interactors that were used to test the various RME-1 baits were: epn-1, 
F15C11.2 and alx-1. The first two were chosen as they had been frequently identified 
from the cDNA library by both ITSN-1 and EHS-1. The cDNA encoding ALX-1 was 
used as it was the only interactor identified from the Y2H screening with the RME-1 
bait D. Furthermore, all of them contained at least one NPF motif, which is a known 
interacting motif of EH domains [11].
Each bait was co-transformed with the empty prey vector or with the EH-interacting 
cDNAs. The co-transformants were tested for the activation of LacZ reporter gene by 
X-gal assay (Figure 4). The co-transformations were carried out also with EHS-1 Bait 
123 as a positive control. The expression of each bait in-frame with GAL4DBD was 
checked by anti-GLA4DBD Western Blot. RME-1 Bait D, F and H showed successful 
binding to ALX-1.
Bait J also interacted with ALX-1, but was considered unsuitable for the screenings, 
because of the presence of the coiled-coil region, which could identify interactors that 
are not specific for the EH domain. Nonetheless, in view of the efficiency in interacting 
with NPF containing proteins, Bait J was used in the re-transformation assays with the 
putative clones identified from a screening with EH domain only. Bait J was preferred 
to other baits for the purpose of confirmation, in the hope that the extended region N- 
terminal to the EH domain may facilitate the correct folding of the bait.
The expression of Baits F, H and J in-frame with GAL4DBD detected by anti- 
GAL4DBD Western blot is shown in Figure 2b. The concentration of 3AT required to 
titrate out the HIS3 gene for bait F was also found to be much higher than that of the 
other baits, between 60mM and 75mM. In comparison, the concentration of 3AT
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required for the selection of HIS3 expression during the screening was determined to be 
in the range of 30mM to 40mM. Unfortunately, Bait F showed self-activation of LacZ 
gene whereas Bait H did not
The fact that Bait F represented the minimal region that interacted with all the NPF- 
containing cDNAs made Bait F still more favourable to Bait H. Following the progress 
of the X-gal assay closely every hour suggested that the self-activation of LacZ would 
take place after 5-6 hours of incubation at 37°C, approximately when the control strain 
C become positive. Using this information, an attempt at an Y2FL screening was made.
7.3.4 Y2H screen in gs w ith  RME-1 b a it F (D
A total of 175 clones were picked for the expression of HIS3 in the presence of 60mM 
3 AT. 20 out of these expressed LacZ earlier than the bait alone (C-) started to self- 
activate the expression of LacZ. The positive clones were marked with red spots on the 
membrane in order to distinguish them from the others that turned blue due to the self­
activation by the bait (results not shown). Unfortunately no clones were selected for 
URA3 expression.
7.3.5 Y2H screen in g  w ith  RME-1 bait F (II)
In the presence of 75mM of 3AT, 50 clones were selected HIS3 expression under 
75mM 3 AT. The X-gal assay of these clones showed that only 1 clone, #22 expressed 
LacZ, but very slightly. No clone expressed URA3 (results not shown) The sequencing 
clone #22 identified ncam-1, but was out-of-frame with respect to GAL4AD. The 
cDNA was checked by re-transformation, but did not show interaction with RME-1 bait 
J.
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7.3.6 Y2H screen in g  w ith  RME-1 bait H (D
Co-transformation of the bait construct H with the cDNA library identified 75 clones 
for HISS expression in the presence of 30mM of 3AT. However, no clone expressed 
LacZ expression that could be detected by X-gal assays (results not shown), and no 
clones showed the expression of URA3 more than that shown by the bait alone (C-) 
(results not shown).
7.3.7 Y2H screen in g  w ith  RME-1 B ait H (II)
A more stringent round of screening with Bait H was selected for HIS3 expression in 
the presence of 40mM 3 AT. A total of 40 clones were selected for HISS expression. 1 
clone out of 40 showed a weak expression of LacZ (results not shown), but no clone 
showed the expression of URAS (results not shown). Sequencing of the clone #32 
showed that the cDNA insert encoded CYN-6. However, CYN-6 was not confirmed in 
the re-transformation assays.
7.3.8 In teractor o f  RME-1
21 putative interactors that were identified from a total of five Y2H screenings with 
three different bait constructs of RME-1, Bait D, F, and H were re-transformed with 
Bait J. The only protein, which was identified and confirmed, was ALX-1. The co­
transformant of ALX-1 and bait J was also used as the positive control for each 
membrane of X-gal assays (Figure 13).
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Figure 13The X-gal Assay used as an assay for the re-transformation assay o f  
the putative positive interactors that were identified from the RME-1 Y2H 
screenings I-VI w ith  bait J.
The re-transformation with ALX-1 with Bait J was used as a positive control (One 
example is indicated with an arrow). ALX-1 was used as it was already shown to be a 
positive interactor with shorter bait, Bait D in the previous section (Figure 12). 
A,B,C,D,E: Yeast Control strains transformed with plasmids containing no inserts (A), 
or transformed with plasmids expressing interactors of increasing interaction strengths 
in the order of B-E, as described in detail in Table 1 in Section 6.2.3.
1,2,3,4,5: Five different co-transformants tested in order to ensure that the LacZ 
activation was not observed not only in one clone but in multiple clones.
1) ALX-1, ASP-1, 
Y53GAL.2, Y55B1BR.3, 
and GLY-8
________________y
2) ALX-1, W09H1.5, 
F17C11.9, C47B2.5, 
and C02D5.3
3) ALX-1, C05D9.7, 
W01B11.3, H17B01.1, 
and ZK721.2
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7.4. REPS-1 Y2H screenings
7.4.1 P reparation  o f  REPS-1 baits
Three baits were constructed in total for the EH domain of REPS-1. The 3 AT assay for 
Bait A indicated that 20mM of 3 AT was sufficient to titrate the background expression 
of HIS3 gene. However, once the bait was co-transformed with the cDNA library in two 
attempted screenings, a large number, over a thousand colonies per plate (10 cm diam.) 
were found even in the presence of 40mM, suggesting the background expression of 
HIS3. Bait B, which was designed to contain a limited but a different region around the 
EH domain, starting at 30bp‘downstream closer to the EH domain but contains 13'4bp 
more after the domain in comparison to Bait A (Figure Id. REPS-1 Bait B). 
Unfortunately, an attempt at a screening with Bait B exhibited the same problem as Bait 
A.
7.4.2 REPS-1 R apid A m plification  o f  th e  cDNA Ends (RACE!
Despite the immense information available on thousands of genes in C. elegans, REPS-
1 gene was poorly characterised at the time of screening. No expression pattern was 
known, and there was no EST available that corresponded to the full-length sequence of 
REPS-1. The sequences that were publicly available on the database at 
http://www.wormbase.org. were ambiguous, as they were modified a several times even 
though the exon encoding the EH domain remained constant. Therefore, in order to 
determine the 5’ and the 3’end of REPS-1 sequence, 5’RACE and 3’ RACE was carried 
out to determine the sequence of REPS-1 present in the genomic DNA extracted from 
C. elegans.
Combining both of the amplified sequences of the 5’ end and the 3’ end suggested two
isoforms of REPS-1. The amino acid sequences of two isoforms are shown in Figure 14,
alongside the amino acid sequence that is currently available on the Wormbase.
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Figure 14 The amino acid sequence found in the Wormbase and two possible 
amino acid sequences o f Reps-1 tha t was determined by the combination o f the 
translated sequences identified by 5' RACE and 3' RACE.
(The region identified as the EH domain by the NCBI Conserved Domain search at: 
http://www.ncbi.nlm.nih. gov/Structure/cdd/wrpsb.cgi is shown in red)
1 .  WORMBASE SEQUENCE:
> W P :C E 3 7 8 5 6
MTENDKKSQYFSNGDFEKVAADIISSPRRLKHTSPADSNADSLFKITEKQ  
QEYYTKCFRHLIKTTQGAADLCGALCGADQRIVAFFKRSSLDMSSLSKIW  
SLADVNEDGWLDLNEFSIAMHLVVLKVKGEVPIPDVLPGFARPPLTEPRA 
P S TVAATP S PAGAGHVEADGPVKNWANQP11KQFSDTPPLLVDSRPTAIK  
HSALLALKSPLGPPPIPPVRPQQQQRGHNRSASLDLKLIALNKTKASAES 
Q L PPTTLSLW SSH SD PTA Q SISTTTTTTTFA SFPA TPD SIPPPIPQ R ITP  
SPLPRVIEEEKRITTTDSSTQTTELLYSEEDVKSFFSKIGHQIDDLIGEE  
IQATDGQGIERWKERCTALRTQNSELEAERARLAQVRIQLEIRIQEFEER  
SKTACSSSTL
2 .  LONG ISOFORM:
3 7 1 a a
MTENDKKSQYFSNGDFEKVAADIISSPRRLKHTSPADSNADSLFKITEKQQ
EYYTKCFRHLIKTTOGAADLCGALCGADQRIVAFFKRSSLDMSSLSKIWSL
ADVNEDGWLDLNEFSIAMHLVVLKVKGEVPIPDVLPGFTRPPLTEPRAPST
VAATPSPAGAGHVEADGPVKNWANQPIIKQFSDTPPLLVDSTPTAIKHSAL
LALKSPLGPPPIPPVRPQQQQRGHNRSASLDLKLIALNKTKASAESQLPPT
TLSLW SSH SD PT A Q SIST TT T T TT FA SFPA T PD SIPPPIPQ R IT PSPLPR V
IEKKRTYSESY
3 .  SHORT ISOFORM:
1 8 1 a a
MTENDKKSQYFSNGDFEKVAADIISSPRRLKHTSPADSNADSLFKITEKQQ  
EYYTKCFRHLIKTTQGAADLCGALCGADQRIVAFFKRSSLDMSSLSKIWSL 
ADVNEDGWLDLNEFSIAMHLVVLKVKGEVPIPDVLPGFTRPPLTEPRAPST 
VAATPSPAGAGHVEADGPVKNVGVFEII
7.4.3. P reparation  o f  REPS-1 B ait C
Bait C, a larger construct which contains a region surrounding the EH domain, was 
amplified by PCR using the mixture of 5’RACE reaction and the 3’ RACE reaction as the 
template. The expression of Bait C in-frame with the GAL4DBD was demonstrated by the 
anti-GAL4DBD Western Blot (Figure 2). The concentration of 3AT required to titrate out 
the background expression of HIS3 for Bait C was determined to be lOmM, and the bait 
was used in a total of two screenings under the presence of lOmM 3 AT.
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7.4.4 Y2H sc re e n in g s  w ith  REPS-1 B a it C
A total of 140 clones were selected for HIS3 expression in the presence of lOmM 3AT. 77 
out of these clones were positive for LacZ reporter gene expression (Figure 15a), whereas 
44 clones expressed URA3 (results not shown). The expression of three reporter genes by 
the clones isolated in this screening is summarised in Table 9.
A less stringent screening in the presence of 5mM of 3AT resulted in the selection of 120 
clones for HIS3 expression. X-gal assays of the clones identified 38 positive clones (Figure 
15b), whereas the selective medium lacking Uracil identified 26 clones (results not shown). 
The expression of three reporter genes by the clones isolated in this screening is shown in 
Table 10.
Figure 15X-gal Assay to test the expression o f LacZ reporter gene by the clones 
fished by Reps-1 Y2H screenings.
A,B,C,D,E: Yeast Control strains transform ed w ith  p la sm id s co n ta in in g  no inserts (A), 
or transform ed w ith  p lasm id s exp ressin g  interactors o f in creasin g  interaction  strengths  
in  the order o f B-E, as described  in  detail in  Table 1 in  S ection  6.2.3.
a. Reps-1 Y2H screening I: X-gal assays of a total of 140 clones that were 
identified as positive for the expression of HIS3 with lOmM [3AT].
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b. Reps-1 Y2H screening II: X-gal assays of a total of 120 clones that 
were identified as positive for the expression of HIS3 with 5mM [3 AT].
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Table 9 The expression of the reporter genes, LacZ, and URA3, by the REPS-1 
interacting-clones that were initially selected for the expression of  HIS3 in the 
presence oflOmM 3AT.
The levels of expression were compared with that of the control strains A-E as follows: 
A:-, B: +, C: ++, D:+++, E: I j-l I. Note that the intensity shown in the figure may not 
correspond exactly to that observed during the experiment as the intensity of the colour 
changed during storage of the membrane after the experiment
71 +/- - +
72 ++ + +
73 + - +
74 ++ - +
75 + - +
76 + + +
77 + - +
78 +++ + +
79 - +/- +
80 - + +
81 - - +
82 +++ ++ +
83 ++++ +++ +
84 ++ ++ +
85 ' - +
86 - - +
87 - - +
88 +/- - +
89 +/- - +
90 ++++ +++ +
91 + - +
92 + - +
93 + - +
94 - - +
95 + - +
96 - - +
97 +++ ++ +
98 - - +
99 +++ ++ +
100 +++ +++ +
101 ++ + +
102 - - +
103 ++ +++ +
104 - +/- +
105 - - +
106 ++ +/- +
107 +++ +++ +
108 - - +
109 +++ ++ +
110 - - +
111 - - +
112 + - +
113 - - +
114 +++ +++ +
115 - - +
116 ++ - +
117 +++ + +
118 ++ - +
119 - - +
120 ++ +++ +
121 - - +
122 + - +
123 ++ +++ +
124 - + +
125 + +/- +
126 - - +
127 - - ++
128 - - +
129 - - +
130 - - +
131 + ++ +
132 + - +
133 +/- - +
134 - +/- +
135 - - +
136 - - +
137 - - +
138 +/- + /- +
139 - +/- +
140 - - +
Clone # LacZ U R A 3 H IS 3
1 + - ++
2 +++ +++ ++
3 + ++
4 + - ++
5 - - ++
6 - - ++
7 ++ ++ ++
8 - - ++
9 - +/- ++
10 + - ++
11 + - ++
12 + - ++
13 +++ ++ ++
14 +++ - ++
15 + - ++
16 ++ - ++
17 + /- - ++
18 + - ++
19 +++ +++ ++
20 + - ++
21 ++++ ++++ ++
22 + - ++
23 ++++ ++++ ++
24 - - ++
25 +++ - ++
26 ++++ +++ ++
27 ++ + ++
28 - - ++
29 - - ++
30 +++ + ++
31 - - ++
32 +++ + +
33 + - +
34 ++ ++ +
35 - - +
36 - - +
37 - - +
38 ++ - +
39 +++ - +
40 +++ +++++ +
41 - +/- +
42 ++ +/- +
43 ++ + +
44 +++ +++ +
45 ++ ++ +
46 - - +
47 +++ ++ +
48 - - +
49 +++ ++ +
50 + - +
51 - - +
52 + ++ +
53 - +
54 - - +
55 +++ + +
56 ++++ +++ +
57 - - +
58 ++ - +
59 +++ + +
60 + - +
61 - - +
62 - - +
63 - - +
64 +/- +
65 +/- - +
66 - - +
67 +++ +++ +
68 - - +
69 - - +
70 ++ +++ +
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Table 10 The expression of the reporter genes, LacZ and URA3, by the REPS-1 
interacting-clones that were initially selected for the expression of HIS3 in the 
presence o f 5mM 3AT.
The levels of expression were compared with that of the control strains A-E as follows: 
A:-, B: +, C: ++, E: ++++. Note that the intensity shown in the figure may not
correspond exactly to that observed during the experiment as the intensity of the colour 
changed during storage of the membrane after the experiment.
Clone 4t LacZ URA3 HIS3
1 - + ++
2 - + ++
3 + ++ +++ + ++
4 - - ++
5 + - ++
6 - - ++
7 - - ++
8 ++ +++ ++
9 - - ++
10 - - ++
11 - - ++
12 - - ++
13 - - ++
14 + - ++
15 ++ - ++
16 - ++ ++
17 + /- - ++
18 - - ++
19 + - ++
20 - - ++
21 + /- + ■ ++
22 - - ++
23 - + ++
24 + /- - ++
25 - - ++
26 - - +/-
27 - - ++
28 - - ++
29 - - ++
30 + +/- ++
31 - - ++
32 + /- - ++
33 + - ++
34 - - ++
35 + ++ ++
36 - - ++
37 - - ++
38 - - ++
39 - - ++
40 - ++ ++
41 - +/- ++
42 + ++ ++ ++
43 + - ++
44 - - ++
45 + - ++
46 +++ +++ ++
47 + ++
48 ++ - ++
49 - - ++
50 + - ++
51 - - ++
52 + /- - ++
53 + /- - ++
54 - - ++
55 +++ +++ ++
56 - - ++
57 + /- - ++
58 ++ - ++
59 + ++ +++ ++
60 - ++
61 ++ - ++
62 + -  ■ ++
63 - + ++
64 - - ++
65 + /- - ++
66 ++ ++ ++
67 - + ++
68 - - ++
69 + + ++
70 - + /- ++
71 - - ++
72 - ++
73 - - ++
74 - - +
75 - - +
76 - - +
77 + - +
78 - + +
79 - - +
80 + - +
81 - - +
82 - - +
83 - - +
84 +/- - +
85 - - +
86 + + +
87 + + +
88 + - +
89 - - +
90 - - +
91 +/- - +
92 + /- - +
93 +++ +++ +
94 + - +
95 +++ +++ +
96 - - +
97 - - +
98 + - +
99 - - +
100 + - .+
101 - +
102 - - +
103 - - +
104 - - +
105 - - +
106 ++ + +
107 +++ + +
108 - - +
109 ■ - - +
110 - - +
111 - - +
112 - - +
113 + + + + + +
114 - - +
115 - + + + + +
116 +++ - +
117 - - +
118 + /- - +
119 + - +
120 + /- - +
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7.4.5 In teractors o f  REPS-1
A total of 63 distinct interactors were identified from the two Y2H screenings with REPS-1 
EH domain. Following the re-transformation, a total of 14 proteins were confirmed as 
putative interactors of REPS-1, which are: F15C11.2, EPN-1, SEL-5, T05F1.4, PCN-1, 
VAB-19, ALH-9, LIN-10, DAB-1, B0041.2, T23G11.7 (11257), M03A8.3 (XH423), 
F23B12.5 (50926) and Y37E3.11 (1C653), as shown in Figure 16.
Figure 16. The X-gal Assays used as an assay fo r the Re-transformation assay o f 
the putative positive interactors that were identified from the Reps-1 Y2H 
screening.
The co-transformants o f EHS-1 with DAB-1 cDNA were used as positive controls on each 
membrane, whereas co-transformants o f the Reps-1 bait B was used as the negative controls. 
A,B,C,D,E: Yeast Control strains transformed with plasmids containing no inserts (A), or 
transformed with plasmids expressing interactors o f increasing interaction strengths in the order o f  
B-E, as described in detail in Table 1 in Section 6.2.3.
1,2,3,4,5: Five different co-transformants tested in order to ensure that the LacZ activation was not 
observed not only in one clone but in multiple clones.
The positive interactions detected in these X-gal assays are indicated with arrows.
1) EHS-l/DAB-1 (Positive 2) Positive control, F01G10.1, 3) Positive control, SEL-5,
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7.5. R10E11.6 Y2H Screenings
Although y-synergin was classically thought to be a mammalian specific protein, when the 
gene R10E11.6 was reported to encode for an EH domain, the BLAST search of its amino 
acid sequence identified other sequences homologous to y-synergin in various species. The 
species ranged from a sea urchin species, Strongylocentroutus purpuratus, bird species 
(Gallus gallus), and primates (Macaca mulatta, and Pan troglodytes) to human.
7.5.1 P reparation  o f  R10E11.6 b a it
The EH domain of R10E11.6 was estimated in the region between 75aa to 120aa, 
corresponding to 225bp-360bp by the conserved domain search engine available on the 
website of the NCBI fhttp://www.ncbi.nlm.nih. gov/Structure/cdd/wrpsb.cgi). Even though 
the region of 45 amino acids detected as EH domain was much smaller than what is usually 
expected of other EH domains, which is approximately of 100 amino acids, the region 
restricted to the area from 225bp to 462bp was cloned as the first bait (Bait A in Figure 
le). However, the expression of the bait in-frame with the GAL4DBD could not be 
detected successfully by anti-GAL4DBD Western Blot. When the conserved domain 
search was repeated, the alignment with the other known EH domains identified EH 
domain region started from 58aa up to 118aa. Therefore, another bait (Bait B) was cloned 
containing the region from 166bp till 770bp corresponding to the larger area recognized as 
an EH domain. The expression in-frame with GAL4DBD was detected successfully and 
the X-gal assay of the co-transformants with an empty prey vector showed that the bait did 
not self-activate the expression of LacZ (Figure 3e). The minimum concentration of 3 AT 
required to titrate out the basal HIS3 expression of the R10E11.6 bait was determined to be 
lOmM (Figure 3d).
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7.5.2 Y2H screen in gs w ith  R10E11.6 B ait B
From the first round of co-transformation, 25 clones were selected for HISS expression in 
the presence of lOmM 3AT. Only the clone #1 was found to be positive for LacZ 
expression (Figure 17), and no clone expressed URA3 (results not shown). From two 
additional rounds of screenings, a total of 100 clones were selected for HIS3 expression. 
Only one clone, #57 from the second screening was shown to express URA3, but not LacZ 
(Figure 17b). As a result, three screenings identified two clones.
The clone #1 from the first screening was identified to encode for ZK822.5. Two plasmids 
were isolated from the clone #57, and both were sequenced. One plasmid was found to 
encode for pdi-3, whereas the other plasmid encoded for a peptide sequence 
unrecognizable as any specific C. elegans protein. All three cDNAs were re-transformed 
with the EH domain of R10E11.6 but none of them showed positive LacZ expression 
(Figure 18).
7.5.3 The EH dom ain  o f  R10E11.6
Y2H screening during this project identified no putative interactors of R10E11.6. As 
mentioned previously in Section 2.5, Y-synergin binds to SCAM-1 through an EH-NPF 
interaction. In order to check whether the EH domain of R10E11.6 is able to perform an 
interaction similar to that shown by the EH domain of the mammalian y-synergin, the C. 
elegans homologue of SCAMPI (Secretory Crier Membrane Protein 1), SCM-1, was 
cloned in-frame with the GAL4AD. No interaction was found between the R10E11.6 EH 
domain and the SCM-1 using the Y2H approach (Figure 19). The fact that the EH domain 
of R10E11.6 was not shown to interact with any protein, including the predicted interactor 
SCM-1, raises the question of whether the R10E11.6 gene product contains a bona fide EH 
domain-containing protein, and requires further investigation.
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Figure 17. X-gal Assay to test the expression o f LacZ reporter gene by the clones 
fished in R10E11.6 Y2H Screenings.
A,B,C,D,E: Yeast Control strains transformed with plasmids containing no inserts (A), or 
transformed with plasmids expressing interactors of increasing interaction strengths in the order of 
B-E, as described in detail in Table 1 in Section 6.2.3.
Three yeast clones co-transformed with the bait construct pDBLeu-RlOEl 1.6 and the empty prey 
vector pPC86 were used as the negative control, as well as the control strain A.
a. R10E11.6 Y2H screening I: A total of 25 clones that were identified as 
positive for the expression of HIS3 with lOmM [3AT].
b. R10E11.6 Y2H screening II: A total of 75 clones that were identified as 
positive for the expression of HIS3 with lOmM [3AT].
This figure shows Clone #57, the only clone identified in this screening. 
Clone #57 expressed of URA3 but not LacZ.
c. R10E11.6 Y2H screening III: A total of 25 clones that were identified as 
positive for the expression of HIS3 with lOmM [3AT]
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Figure 18. The X-gal Assays used as an assay fo r  the Re-transformation assay o f 
the putative positive interactors tha t were identified from the R10E11.6 Y2H 
screening I  w ith  bait B under the presence oflO m M  3 A T fo r the initial HIS3 
selection.
A,B,C,D,E: Yeast Control strains transformed with plasmids containing no inserts (A), or 
transformed with plasmids expressing interactors o f  increasing interaction strengths in the order o f  
B-E, as described in detail in Table 1 in Section 6.2.3.
Five yeast clones co-transformed with the bait construct pDBLeu-RlOEl 1.6 and the empty prey 
vector pPC86 were used as the negative control, as well as the control strain A.
1,2,3,4,5: Five different co-transformants tested in order to ensure that the LacZ 
activation was not observed not only in one clone but in multiple clones.
1) ZK822.4, (11)57-1, "
and PDI-3
Figure 19. The X-gal Assay o f the co-transformants o f the bait R10E11.6 Bait B 
and GAL4AD-SCM1.
A,B,C,D,E: Yeast Control strains transformed with plasmids containing no inserts (A), or 
transformed with plasmids expressing interactors o f  increasing interaction strengths in the order o f  
B-E, as described in detail in Table 1 in Section 6.2.3.
Three yeast clones co-transformed with the bait construct pDBLeu-RlOEl 1.6 and the empty prey 
vector pPC86 were used as the negative control, as well as the control strain A.
1,2,3,4,5: Five different co-transformants tested in order to ensure that the LacZ activation was not 
observed not only in one clone but in multiple clones.
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8. “Criss-Cross” Transformation
A total of 26 proteins were identified in Y2H screenings with the EH domains of four EH 
proteins in C. elegans: ITSN-1, EHS-1, RME-1, and REPS-1 (indicated by the + in white 
boxes in Table 10). The list of all the interactors of the four EH proteins in C. elegans 
indicated that there were several proteins that were common between two or in some cases 
three EH protein. In order to better understand the specificity of the interaction of each EH 
domain-containing proteins, all the putative interactors were tested for possible interactions 
with all five of the EH-domain containing proteins. This approach will herein be referred 
to as “criss-cross transformation”.
Yeast strain MaV203 was co-transformed with each EH bait construct and different prey 
constructs containing cDNA inserts encoding the putative interactors identified in the Y2H 
screening of the other three EH proteins. The co-transoformants were tested heir 
expression of the reporter gene, LacZ, by X-gal assays. When there were several clones 
encoding the same gene, for example, epn-1, dab-1 and F15C1L2, the shortest encoding 
cDNA inserts that were identified during the screenings were used. LacZ was chosen 
rather than the other reporter genes as it was shown to be more sensitive than URA3 by 
many examples of clones during the Y2H screenings. In addition, LacZ showed more 
specificity in comparison to HIS3 expression, considering the fact that many clones, which 
were positive for HIS3 expression at the initial selection of clones for the Y2H screening 
were found to be negative for LacZ or URA3 expression. Interactions were considered to 
be positive only when the results of the X-gal assays were confirmed from two 
independent transformations. Only one example of X-gal assay is shown for each putative 
interactor. The results of X-gal assays for the criss-cross transformations are shown 
separately for each EH protein: ITSN-1 (Figure 20), EHS-1 (Figure 21), RME-1 (Figure 
22), REPS-1 (Figure 23) and R10E11.6 (Figure 24).
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Figure 20. ITSN-1 Criss-Cross Transformation:
The X-gal Assays of clones that were transformed with ITSN-1 bait A and the cDNAs of 
the putative interactors that were identified from the Y2H screenings of EHS-1, RME-1, 
and Reps-1.
A,B,C,D,E: Yeast Control strains transformed with plasmids containing no inserts (A), or 
transformed with plasmids expressing interactors o f increasing interaction strengths in the order o f  
B-E, as described in detail in Table 1 in Section 6.2.3.
Three yeast clones co-transformed with the bait construct pDBLeu-ITSN-1 and the empty prey 
vector pPC86 were used as the negative control, as well as the control strain A.
1,2,3,4,5: Five different co-transformants tested in order to ensure that the LacZ  activation was not 
observed not only in one clone but in multiple clones.
Five co-transformants o f the ITSN-1 bait and the prey expressing T05E7.5, a putative interactor o f  
ITSN-1 previously identified in the Y2H screenings, were used as the positive control for each 
membrane.
The positive interactions are indicated with arrows.
1) T05E7.5, CAS-1, ALX-1, D1081.7 
(1J65), and Y45F10D.13
c-
2) T05E7.5, Y11D7A.12, 
C50C3.8, B0041.2, and T05F1.4
c-
INT-l/ I NT-1/ INT-l
TOSfl.4 60041.2 C50O.6 YUD7A.12 T0S7E.5
‘ A 2
B
3 ZP
■4 £ /  A
5 5C‘
3) T05E7.5, SEL-5, PCN-1, VAB-19, 
and ALH-9
4) T05E7.5, Y37E11.3 (1C653), 
M03A8.3 (XH423), F23B12.5 
(50926), and T23G11.7 (T25195)
INT-l/ I NT-1/ INT-l/ I NT-1/ INT-l/
T25195 50926 XH4Z3 1C653 T05E7.5
C-
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%
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Figure 21 EHS-1 Criss-Cross Transformation:
The X-gal Assays of clones that were transformed with EHS-1 bait 123 and the cDNAs of 
the putative interactors that were identified from the Y2H screenings of ITSN-1, RME-1, 
and REPS-1.
A,B,C,D,E: Yeast Control strains transformed with plasmids containing no inserts (A), or 
transformed with plasmids expressing interactors o f increasing interaction strengths in the order o f  
B-E, as described in detail in Table 1 in Section 6.2.3.
Three yeast clones co-transformed with the bait construct pDBLeu-EHS-1 123 and the empty prey 
vector pPC86 were used as the negative control, as well as the control strain A.
1,2,3,4,5: Five different co-transformants tested in order to ensure that the LacZ  activation was not 
observed not only in one clone but in multiple clones.
Five co-transformants o f  the EHS1-1 bait and the prey expressing CAS-1, a putative interactor o f  
ITSN-1 previously identified and confirmed in the Y2H screenings, were used as the positive 
control for each membrane.
The scanned images o f the membranes 2) and 3) appear as i f  there was a strong background 
activation o f  LacZ  gene, as the negative controls are also coloured. However, the colour o f  the 
negative control clones during a total o f 24 hours for the X-gal assay was equivalent to that shown 
by the negative control clones in the membrane 1). The difference in the colour o f the clones in the 
membranes 2) and 3) is thought to be due to the fact that the membranes were not dried well when 
they were stored prior to the scanning o f the images.
The positive interactions are indicated with arrows.
1) CAS-1, K04H4.2, 
BE0003N10.3, T05E7.5, 
and T05F1.4
2) CAS-1. SEL-5, PCN-1, 3) CAS-1, Y37E3.11
c-
VAB-19, and ALH-9
aim's EHS_1/ EHS-1/ EHS-1/ EHS-1/
~  7  ^
i i
1 2  2 y u 12 2 B
2 3  3 ■> > % (& .
3 4  4 . -i / /
L  5 5
(1C653), M03A8.3 
(XH423), F23B12.5 
(50926), and T23G11.7
125
Figure 22. RME-1 Criss-Cross Transformation:
The X-gal Assays of clones that were transformed with RME-1 bait D and the cDNAs 
of the putative interactors that were identified from the Y2H screenings of ITSN-1, 
EHS-1, and REPS-1.
A,B,C,D,E: Yeast Control strains transformed with plasmids containing no inserts (A), or 
transformed with plasmids expressing interactors of increasing interaction strengths in the order 
of B-E, as described in detail in Table 1 in Section 6.2.3.
Three yeast clones co-transformed with the bait construct pDBLeu-RME-1 and the empty prey 
vector pPC86 were used as the negative control, as well as the control strain A.
1,2,3,4,5: Five different co-transformants tested in order to ensure that the LacZ activation was 
not observed not only in one clone but in multiple clones.
Five co-transformants of the RME-1 bait and the prey expressing ALX-1, a putative interactor 
of RME-1 previously identified and confirmed in the Y2H screenings, were used as the positive 
control for each membrane.
The co-transformants of the RME-1 bait and the prey fused with ALH-9 showed the activation 
of LacZ gene once (as shown in membrane 7)), but when the X-gal assay was repeated on 
clones frorn two different co-transformations, the activation of LacZ  was not observed. In 
comparison, the LacZ activation was confirmed the interactions of RME-1 with Y37E3.11 and 
with Y11D7A.12.
The positive interactions are indicated with arrows.
1) EPN-1 LIN-10 PQN-32 2) F15C11.2, DAB-1, K04H4.2, 3) T05E7.5, CAS-1, B0041.2,
and TFG-1 ’ ’ and BE0003N10.3 and SEL-5
c-
4) PCN-1, VAB-19, T05F1.4, 
and Y45F10D.13
c-
5) ALX-1, D1081.7(1J65), 
Y11D7A.12, and ALH-9
c-
c-
6) ALH-9, Y37E3.11, XH423, 
and F23B12.5 (50926)
r '
C -
M t - l /  RM E-1/RM E-1/ RME-1/ r m h ,, ^  
0 9 ? 6  XH423 1C653 ALH-9 ALX_ /  '
1 1 1 1 IA A
l 2 2 2 2 ; . 2 B
2 3 3 3 3 3 f / c
3 4 4 4 4 4 ^
L .  s •
7) ALX-1, Y37E3.11 (1C653), 
Y11D7A.12, and ALH-9
c-
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Figure 23 Reps-1 Criss-Cross Transformation:
The X-gal Assays of clones that were transfonned with Reps-1 Bait C and the cDNAs 
of the putative interactors that were identified from the Y2H screenings of ITSN-1, 
EHS-1, and RME-1.
A,B,C,D,E: Yeast Control strains transformed with plasmids containing no inserts (A), or 
transformed with plasmids expressing interactors o f increasing interaction strengths in the order 
o f B-E, as described in detail in Table 1 in Section 6.2.3.
Three yeast clones co-transformed with the bait construct pDBLeu-REPS-1 and the empty prey 
vector pPC86 were used as the negative control, as well as the control strain A.
1,2,3,4,5: Five different co-transformants tested in order to ensure that the LacZ  activation was 
not observed not only in one clone but in multiple clones.
Five co-transformants o f  the REPS-1 bait and the prey expressing SEL-5, a putative interactor 
o f REPS-1 previously identified and confirmed in the Y2H screenings, were used as the positive 
control for each membrane.
The scanned images o f the membranes appear as i f  there was a strong background activation o f  
LacZ  gene, as the negative controls are also coloured. However, the colour o f  the negative 
control clones during a total o f 24 hours for the X-gal assay was equivalent to that shown by the 
negative control clones in the membranes from the Criss-Cross Transformation o f ITSN-1. The 
difference in the colour o f the clones in the membranes in this assay is thought to be due to the 
fact that the membranes were not dried well when they were stored prior to the scanning o f the 
images.
The positive interactions are indicated with arrows.
1) SEL-5, PQN-32, TFG-1, 
K04H4.2, and BE0003N10.3 
 *  1
REPS-1/  REPS-1/ REPS-1/ REPS-l/REPS-1/ 
6EC003N20.3 K04H4.2 TFC-J PQN-32 SEL-5
2) SEL-5, T05E7.5, CAS-1, 
ALX-1, and Y37E3.11 (1C653)
*
REPS-i/ REPS-1/ REPS-1/REPS-1/REPS-1/ 
1C653 ALX-1 CAS-1 T05E7.S SEL-5
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Y11D7A.12, and C50C3.8
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Figure 24. R10E11.6 Criss-Cross Transformation:
The X-gal Assays of clones that were transformed with R10E11.6 Bait B and the 
cDNAs of the putative interactors that were identified from the Y2H screenings of 
ITSN-1, EHS-1, RME-1, and REPS-1.
A,B,C,D,E: Yeast Control strains transformed with plasmids containing no inserts 
(A), or transformed with plasmids expressing interactors of increasing interaction 
strengths in the order of B-E, as described in detail in  Table 1 in Section 6.2.3.
1,2,3,4,5: Five different co-transformants tested in order to ensure that the self­
activation was not observed not only in one clone but in  multiple clones.
Re-transformation o f  EHS-1 with DAB-1 was used as a positive control for the X-gal assay o f  
each membrane, streaked above the negative control. Re-transformation o f R10E11.6 bait with 
SEL-5, PCN-1, VAB-19 and F23B12.5 did not give any colonies and were not tested.
1) EPN-1, LIN-10, PQN-32, TFG-1, 2) DAB-1, F46H5.7, K04H4.2,
and F15C11.2 . BE0003N10.3, and T05E7.5
9 D
R10U1.6/ R10E116/ R10E11.6,' R10E11.6/IMCF11 fi/ 
T05E7.5 8E0003NIO 3 K04H4 2 F46H5 7 DAM
3) CAS-1, ALX-1, D1081.7 (1J65), 4) C50C3.8, T05F1.4, and
Y45F10D.13, and Y11D7A.12 T23G11.7
5) ALH-9, Y37E3.11 and 
M03A8.3,
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The EH proteins, for which several bait constructs had been used in Y2H screenings, 
such as EHS-1 and RME-1, were tested by criss-cross transformation using only one of 
the baits. Bait 123 was used for EHS-1 rather than Bait 125, for two main reasons. 
Firstly, Bait 123 encodes a more complete EH domain-containing regions of EHS-1, as 
it contains first and the second EH domain whereas Bait 125 contains only the third EH 
domain. Secondly, the Y2H screenings carried out with Bait 125 did not identify any 
proteins that had not been found by the screenings with Bait 123.
Table 11 The interactions identified in Y2H screenings and by the criss-cross 
transformations
Protein INT-1 EHS-1 REPS-1 RME-1
1 EPN-1 + + + _
2 LIN-10 + + +
3 PQN-32 + + -
4 TFG-1 + + _
5 F15C11.2 + + + _
6 DAB-1 + + + -
7 F46H7.5 + + -
8 K04H4.2 + + 4- .
9 BE0003N10.3 + - - -
10 T05E7.5 + - r _ .
11 CAS-1 + + -f _
12 ALX-1 + + - +
13 D1081.7 _ + _ _
14 Y45F10D.13 + -
15 Y11D7A.12 _ + .
16 C50C3.8 _ + _ _
17 B0041.2 + + + .
18 T05F1.4 . -f + _
19 SEL-5 - + -
20 PCN-1 . - + .
21 VAB-19 _ - + -
22 ALH-9 . - + -
23 Y37E3.11 . _ + +
24 M03A8.3 . - + _
25 F23B12.5 . - + _
26 T23G11.7 . - + -
+ Found positive in the Y2H screenings and confirmed by re-transform ation assays 
New ly Found positive by the criss-cross transform ations for the LacZ expression 
Found negative in the criss-cross transform ation for the LacZ expression_
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Y2H screenings for RME-1 interactors were carried out using bait constructs D, F and 
H. Bait F was considered to be unsuitable for criss-cross transformation, as the bait 
alone was able to self-activate the expression of LacZ and required a tight monitoring of 
the reaction time for the X-gal assay. Similarly, Bait H was could self-activate URA3. 
Despite the fact that only LacZ expression was monitored in the criss-cross 
transformations, construct H was not used in order to reduce the risk of false positives. 
Although Bait D may indicate a restricted range of interactions mediated by the EH 
domains of RME-1, it was considered as the best out of all constructs available, as it 
had been shown to bind to an NPF-containing protein, ALX-1, which was also the only 
protein repeatedly confirmed to interact with RME-1 EH domain. Construct J, which 
was used for a re-transformation assay, or a whole-length RME-1 were not used in 
criss-cross transformation in order to be specific to the interactions mediated by the EH 
domain, and not to include baits with regions such as coiled-coil domain that may 
provide other interaction surfaces.
The interactions that were identified in the Y2H screenings and in the criss-cross 
transformation assays are summarized in Table 11 and in the Y2H column in Table 12.
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Table 12 The summary o f interactions found between a total o f 26 proteins 
identified by the Y2H screenings and the 4 EH proteins: ITSN-1, EHS-1, Reps-1 
and RME-1.
Gene 
Names of 
putative 
interactors
Bind.
motif
ITSN-1 EHS-1 REPS1 RME-1
Y2H with 
INT-1
IVB with 
Full- 
length 
ITSN-1
genetic 
interaction 
by RNAI7
Y2H with 
EHS-1
IVB with 
Full- 
length 
EHS-1
genetic 
interaction 
by RNAI?
Y2H with 
Repsl
IVB with 
Full 
length 
REPS1
genetic  
interaction 
by RNAI?
Y2H with 
RME-1
IVB with 
Full- 
length 
RME-1
IVB with FL 
RME-1, with 
mutated EH 
domain
genetic 
interaction 
by RNAI?
EPN-1 4 NPF ++++ + + + - + + + + +♦ + +++ - + - ++ - -
LIN-10 2 NPF ++ ++ + ++++ ++++ + +++ - - - +++++ +++ -
DAB-1 2 NPF + ■M-+ + +++ +++++ ♦ +++ - + - +++++ —
F15C11.2
(1H603) 2 NPF
+ + + ++ +f- * ++++ - + - +/- - -
ALX-1 1 NPF +* ++ - + + - - - + + +/- -
CAS-1 1NPF +* +++ - + +++ ~ - +* - - +++ ++ -
Y45F10D.13 
(40533 ) 1HSF -
++ ♦  I +++++ ♦ - - - - - -
Y11D7A.12
(4K28)
1 FWR - + + + + + + + + - - + +/- +
C50C3.8
(3J252) None -
+++ + + +/- ♦ - - ++++ +++ +
BE0003N10 
.3 (3C136)
None/ 
NPW / 
NPY
+ +++ - - +/- - - - + ++++ +++ •
T05E7.5
(1G778) 1 NPF
+  + - - +* + + - - - + +++++ +++++ -
PQN-32 2 NPF + + ++ - ++ + - ♦* - + ++ - -
TFG-1 1NPF + + - ++++ +/- ♦ - - + - - -
F46H5.7
(XH858)
1N P F/1
WW N/A -
++ N/A + - N/A N/A N/A +
B0041.2 
(1F227 ) 1 NPF
+* N/A - + N/A - N/A + N/A N/A -
D1081.7 
(1J65)
1 HTF/1  
FWR - N/A •
++++ N/A - N/A N/A N/A -
K04H4.2
(3K438) 1 NPF
+ + - +* ++ + - + ++++ +++ -
T05F1.4
(1K209) 1 NPF
++ - - ++ + ++ • +++ + -
s e l- 5
1 N P F /1  
HSF +/-
+ - + - - + - - -
pcn-1 None - + - - - + - - - +
vab-19 None N/A - - N/A - -M-+ N/A + N/A N/A +
alh-9
(F01F1.6) None N/A
+ - N/A + + N/A + N/A N/A -
Y37E3.11
(1C653) 1 DPF N/A - - N/A
+ + N/A - +* N/A N/A -
M03A8.3
(XH423) None N/A
+ N/A • + N/A - - N/A N/A -
F23B12.5
(50926) None N/A - N/A
+ + N/A - - N/A N/A •
T23G11.7 
(11257 ) None - - -
+ + - - - - - -
__________: 13 in te ra c tio n s  co n firm ed  by  Y2H, IVB an d  g e n e tic  a s s a y s
__________: 12 p h y s ica l in te rac tio n s  confirm ed  (Y2H a n d  IVB)
__________: 16 in te rac tio n s  co n firm ed  p h y sica l and  g e n e tic  (Y2H o r  IVB, a n d  gen e tic )
The levels of e x p re s s io n  w ere  c o m p a re d  w ith th a t  o f th e  co n tro l s tr a in s  A-E a s  fo llow s:
A:-, B: +, C: ++, D:+++, E: ++++
A,B,C,D,E: Y e a s t C on tro l s tr a in s  tra n sfo rm ed  with p la sm id s  c o n ta in in g  no  in se r ts  (A), o r  t ra n s fo rm ed  w ith  p la sm id s  e x p re s s in g  in te rac to rs  o f 
in c re a sin g  in te rac tio n  s tr e n g th s  in th e  o rd e r  of B-E, a s  d e s c r ib e d  in de ta il in T ab le  1 in S e c tio n  6.2.3.
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9. Representation of cDNAs encoding NPF-containing 
proteins in the cDNA library
The level of representation of genes encoding the NPF-containing proteins in the cDNA 
library was of interest because a few of the interactors identified in the screening were 
identified from multiple clones. Therefore, it was important to ensure that there was no 
bias in the cDNA library used during the screening that could have affected the 
frequency of the cDNAs identified.
A total of 16 proteins were selected for the qPCR analysis. 4 proteins were chosen for 4 
groups of proteins using the following criteria. The first group consists of NPF- 
containing proteins that had been identified from the Y2H screenings with high 
frequencies. The second group consists of the NPF-containing proteins that were 
identified once in EHS-1 screening. The third and the fourth groups represent random 
C. elegans proteins containing multiple NPF motifs, or a single NPF-motif, 
respectively. They were checked for their presence in the cDNA library in order to 
indicate that there was no bias in the screening by the skewed representation of the 
library. After the set-up of the conditions and testing the specificity of the pimers, 3 
genes were removed and a total of 13 genes were quantified by QPCR. There are a total 
of 863 genes that encode amino acid sequences containing at least one NPF motif [18]. 
13 genes out of 863 genes account only for 1.5% of the total number of genes encoding 
NPF motifs. Therefore, this QPCR analysis was carried out with the aim of indicating 
whether there is a correlation between the number of clones from which a specific NPF- 
encoding cDNA is isolated (frequency) and the level of cDNA present in the library.
The genes encoding the NPF-containing proteins selected are summarized in Table 13, 
with the arrows indicating the three genes that were discarded for the QPCR analysis.
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Table 13 Sixteen genes encoding NPF-containing proteins selected for QPCR 
on cDNA library used in the Y2H screenings.
No.of NPF refers to the number of NPF motifs present in the primary sequence of the 
genes.
Frequency refers to the umber of clones from which the cDNAs encoding the gene of 
interest were extracted.
Genes No. of NPF Frequency
Epn-1 4 High
Lin-10 2 High
Pqn-32 2 High
Tfg-1 1 High
Cas-1 1 Low
Alx-1 1 Low
T05E7.5 1 Low
Cpn-3 1 Low
Scm-1 2 Never
Fbxb-75 (4F204) 4 Never
R06F6.2 (2L78) 4 Never
Unc-11 5 Never
Rme-8 1 Never
R13A5.11 (31680) 1 Never
Unc-26 1 Never
B0285.1 (3F429) 1 Never
A correlation between the frequency with which a cDNA encoding a protein was
identified in the Y2H screenings and the level at which it is represented in the cDNA
library was found only for EPN-1, whilst for the other proteins, no such correlation was
found. A group of NPF-containing proteins were selected from the C. elegans genome,
representing some that were identified from several clones during the Y2H screenings
in this study, and some that were never identified in the screenings. The qPCR
amplification of these NPF-containing proteins suggested that the frequency with which
the NPF-containing proteins were identified in the screenings is not dependent on the
level of the cDNAs present in the library, with the exception of one gene, epn-1 (Figure
25). The qPCR results also suggest that the whole genome had been covered by the
cDNA library used in the screenings, because a small percentage (1.5%) of the genes
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encoding NPF-containing proteins in the C. elegans genome that were chosen were all 
detected in the cDNA library.
Figure 25 A graph to show the quantification o f the cDNAs encoding NPF- 
containing proteins amplified from the cDNA library by qPCR.
The expression level: 13 genes whose expression levels were detected by the qPCR 
(blue). Total Frequency: the number of clones from which the cDNAs encoding the 
specified gene was identified during the Y2H screenings (red).No. of NPF motifs: the 
numbers indicate the number of NPF motifs present in the amino acid sequence encoded 
by the specified gene.
Estimated am ount of cDNA copies p resen t in the  cDNA library show n in an arbitrary 
unit se t to 100r with respect to epn-1 cDNA.
80,0
2 5 ■  Expression Level
■  Total Frequency  
No. o f  NPF m otifs
40,0
20,0
0,0
N am e o f  th e  g e n e s  o f  th e  N P F-contain in g p ro tein s  en co d ed  by th e  cDNA in ser ts
As a further proof-of-principle of the Y2H screenings, UNC-26, a C. elegans 
homologue of Synaptojanin that interacts with mammalian Epsl5 and Intersectin, was 
cloned in-frame with GAL4AD and tested for interaction with ITSN-1, EHS-1, RME-1 
and REPS-1 by re-transformation assays. None of the re-transformed clones showed 
LacZ  expression (results not shown). Furthermore, the cDNA encoding SCM-1 was also 
cloned in-frame with the GAL4AD, and it was checked for its putative interaction with 
R10E11.6, but no interaction was found. These results, showing that the theoretical 
interactors of C. elegans EH proteins that were not identified in the Y2H screenings 
indeed do not to interact, support the accuracy of the Y2H screening.
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10. GST Pull-down Assays
(These experiments were carried out by Dr. Francesca Senic-Matuglia, IFOM, Milan, 
Italy)
The putative interactions identified by Y2H were validated by in vitro pull-down 
assays. In the first round of pull-down assays, 18 out of 26 interactors were selected 
to represent a range of EH interacting motifs found in the amino acid sequences. 12 
proteins contained multiple or single NPF motifs (Class I), 1 protein each for Class 
II (Y45F10D.13) and Class III (Y11D7A.12) peptide motifs, and two proteins with 
no known interacting motifs, namely C50C3.8 and BE0003N10.3. The Y2H results 
indicated that BE0003N10.3 is an interactor specific to ITSN-1, whereas 
Y45F10D.13 and C50C3.8 are specific interactors of EHS-1. Therefore, not all of 
the eighteen proteins, which were cloned as GST-fiision proteins, interacted with all 
four EH proteins in Y2H. However, the pull-down assays were performed against 
all four EH proteins, in order to detect the interactions that were not detected by the 
“criss-cross” transformations.
The shortest cDNA identified in the screenings for each interactor was cloned in 
pGEX vector and was expressed as a GST-fusion protein. The C. elegans EH 
proteins were over-expressed as FLAG-tagged full-length proteins in Phoenix cells. 
The full-length proteins were used in order to provide the proteins in conformations 
that resemble the physiological conditions, and also to detect the interactions that 
are mediated by the EH domains but assisted by other regions of the EH proteins, 
especially in the case of RME-1, which will be discussed in the section 15.4. Anti- 
FLAG antibody was used to recognise the EH proteins as there are antibodies 
available only against ITSN-1 and EHS-1 and not against RME-1 and REPS-1. The 
amount of the EH proteins used in the pull-down assays were checked and were
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controlled to be approximately equivalent to each other by anti-FLAG Western blot 
as shown in Figure. 26.
Figure 26. Anti-FLAG Western Blot to show the normalization of the 
quantities o f FLAG-tagged EH proteins used in the GST Pull-down assays.
EHS-i RME-i rrsN -i rrsN -i refs- i
2S0
ITS100
10.1 ITSN-1 Pull-dow n assay
As shown in Figure 27 and summarized in Table 12, 10 interactors of ITSN-1 that 
had been identified by Y2H screenings were confirmed by in vitro pull-down assay 
(Figure 27 Itsnl, Table 12). ITSN-1 recognised by anti-FLAG for the pull-down by 
F15C11.2 was identified only by a very weak signal, indicating that the strong 
interaction found in the Y2H system may not represent the actual interaction 
strength. In comparison, C50G3.8 and Y45F10D.13, which were thought to interact 
only with EHS-1 were demonstrated to interact at a level comparable to that of 
ALX-1 and LIN-10 (Figure 27 Itsnl, Table 12). In addition, Y11D7A.12 (4K28), 
which was found to interact with EHS-1 and RME-1 in the Y2H system, also 
interacted with full-length ITSN-1 by the in vitro pull-down assays (Figure 27 
Itsnl, and the column for ITSN-1 In Vitro Binding (IVB) assays in Table 12).
10.2 EHS-1 Pull-dow n assay
In vitro pull-down assays for EHS-1 validated 13 out of 16 interactors of EHS-1 
that were identified by Y2H screenings. As it was seen for the interaction between 
ITSN-1 and F15C11.2, the latter interacted with EHS-1 with much less binding 
efficiency with respect to the other NPF-containing proteins, for example, CAS-1,
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LIN-10 and DAB-1. (Figure 27 Ehsl, and the column for EHS-1 IVB assays in
Table 12). Unlike ITSN-1, which interacted also with the other proteins that had not 
been identified previously in the Y2H system, EHS-1 did not interact with 
BE0003N10.3, which is an ITSN-1 specific interactor.
Figure 27 Anti-FLAG Western B lo t o f  the pull-down assays:
18 putative interactors cloned as GST-fusion proteins: CAS-1, LIN-10, DAB-1, EPN-1, 
F15C11.2 (Ubiquilin), ALX-1, T05E7.5, PQN-32, TFG-1, K04H4.2, T05F1.4, SEL-5, 
Y45F10D.13 (40533), Y11D7A.12 (4K28), C50C3.8 (3J252), BE0003N10.3 (3C136), 
PCN-1, T23G11.7 (11257). 3 negative controls (CPN-3, GST-NPY peptide, and GST 
alone). . . . .
120 pmol o f  GST-fusion proteins were incubated with varying amount o f  total lysates o f  
Phoenix cells over-expressing the FLAG-tagged EH proteins, in order to have equivalent 
amount o f  each FLAG-tagged EH proteins, as normalized by the anti-FLAG Western blot 
showin in Figure 26.
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10.3 RME-1 P ull-dow n assay
Amongst the eighteen GST-fusion proteins tested by in vitro pull-down assays, 
there were two RME-1 interactors, which had been identified in Y2H screenings, 
and they were both confirmed by the pull-down assays (Figure 27 RME1 and the 
column for RME-1 TVB in Table 12).
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In addition, ten proteins were identified to interact with the full-length RME-1 by 
the in vitro assays (Figure 27, RME1). Proteins such as CAS-1, LIN-10, DAB-1, 
EPN-1, T05E7.5, PQN-32, K04H4.2, and T05F1.4 are NPF-containing proteins, 
whereas C50C3.8 and BE0003N10.3 do not contain any known interaction motifs. 
The in vitro binding assays repeated with the mutated EH domain showed that the 
majority of these novel interactions were reduced but not disrupted. In comparison, 
three interactors, namely EPN-1, F15C11.2 (Ubiquilin) and PQN-32, were shown 
to be specifically mediated by the EH domain. In spite of the presence of an NPF- 
motif in its sequence, T05E7.5 was shown to interact with both constructs of full- 
length RME-1 with the comparable efficiency, indicating that it interacts with 
RME-1 at a region outside of the EH domain.
10.4 REPS-1 Pull-dow n assay
The expression of the FLAG-tagged REPS-1 was detected, although at a slightly 
lower level than the other EH proteins, no interactors were observed in the pull­
down assays.
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11. Genetic interactions 1: Aldicarb treatment of EH mutant 
strains
As discussed in the Introduction (Section 3.2.2), the mutant strain of ehs-1 (okl46) is 
hyposensitive [19] to aldicarb treatment, whereas itsn-1 (ok268) is hypersensitive [63] 
to aldicarb, with respect to the response displayed by the N2 Bristol strain. The average 
length of time that the worms were responsive to touch was referred to as the average 
“survival” time in this analysis. The hypersensitive phenotype of itsn-1 mutants 
demonstrated by the shorter average survival time (B) with respect to the wild type (N), 
in Figure 28a and 28b. Whereas the ehs-1 mutant showed an aldicarb-hyposensitive 
phenotype, indicated by the longer average survival time for ehs-1 (B) than that of the 
wild type (N) in Figure 29a and 29b.
In addition, a recently identified reps-1 mutant strain was characterized in this study for 
its sensitivity to aldicarb. Under 0.5mM aldicarb, a batch of 40 reps-1 mutants (B), 
repeated at least three times (n=40, in triplicates), have been found to be hypersensitive 
to aldicarb at a level similar to that of itsn-1, with respect to the wild type N2 Bristol 
strain (N) (Figure 30a and 30b). This observation is suggestive of a role of reps-1, 
which is still uncharacterized, in neurotransmission. The function of reps-1 in synaptic 
transmission is currently under investigation.
In comparison, rme-1 (bl045) (B) showed no sensitivity to aldicarb, a phenotype very 
similar to that of the wild type (N), indicating that it does not have a phenotype related 
to aldicarb (Figure 31a and 31b). The mutant strain of rme-1 has been reported to have a 
reduced brood size with respect to N2 [99]. The effect of knock-down of the putative 
interactors on the average brood size of rme-1 mutants was also tested.
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The mutant strain available for R10E11.6 (ok619) was not used, because the only 
mutant that is currently available also includes the deletion of the upstream gene, vha-2.
Figure 28. The average survival time (hours) under treatment w ith  O.SmM 
aldicarb of  itsn-1 mutant worms in which 26 genes were knocked-down by 
RNAi. N2 Bristol (N), N2 (RNAi) (G), itsn-1 (B), and itsn-1 (RNAi) (B+G).
(n=40, in triplicates)
X-axis: The average survival time in hours under the treatment with 0.5mM aldicarb 
Y-axis: N: wild type, B: itsn-1 mutant, B+G: itsn-1 mutant in which the specified gene was 
knocked down by RNAi, G: wild type in which the specified gene was knocked down by RNAi.
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Figure 29. The average survival time under treatment w ith 0.5mM aldicarb of 
ehs-1 mutant worms in which 26 genes were knocked-down hy RNAi. N2 
Bristol (N), N2 (RNAi) (G), ehs-1 (B), and ehs-1 (RNAi) (B+G).
(n=40, in triplicates)
X-axis: The average survival time in hours under the treatment with 0.5mM aldicarb 
Y-axis: N: wild type, B: itsn-1 mutant, B+G: itsn-1 mutant in which the specified gene was 
knocked down by RNAi, G: wild type in which the specified gene was knocked down by RNAi.
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11.3 A ssays for Touch R esp onse under th e  A ldicarb  
T reatm ent
Each EH mutant strain was subjected to the knock-down of 26 genes in parallel with the 
N2 worms. 60 young adults per strain were then placed on aldicarb plates containing 
0.5mM aldicarb and the touch response by each worm was checked every 30 minutes 
for a total of three hours. The average time of “survival” when treated with 0.5mM 
aldicarb, meaning the average duration in hours that the worms were responsive to 
touch, was calculated for both N2 and each EH mutant worms, in control condition and 
in the knock down. The average time of “survival” for N2 fed with RNAi empty vector 
(N), for N2 worm in which the putative interactor was knocked down (G), for the EH 
mutants fed with RNAi empty vector (B), and for the EH mutants in which the putative 
interactors were knocked down (B+G), were compared. When the effect of the knock 
down (G), had an effect on the average time of “survival” of the EH mutant genetic (B), 
such that the average time of “survival” of the knock-down EH mutant (B+G) was 
either extended or shortened, the effect was considered to indicate genetic interactions.
A total of 20 putative interactors out of 26 proteins found from the Y2H screenings of 
ITSN-1, EHS-1, REPS-1 and RME-1, were tested across all four respective EH 
mutants, even though some combinations had not been shown to interact physically by 
Y2H or by GST pull-down assays. The remaining 6 interactors were not tested because 
the preparation of the reagents required for RNAi specific for these genes failed.
11.3.1 itsn-1 gen etic  in teraction s
Itsn-1 was found to genetically interact with a total of 9 genes; lin-10, dab-1, F15C11.2, 
C50C3.8, Y11D7A.12, pcn-1, sel-5, F01F1.6, and M03A8.3 (Figure 28a). No 
interaction was determined for the cases of F23B12.5 and T05F1.4, but the phenotype
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of itsn-1 mutants appeared to be more dominant over that of the RNA-interfered worms 
(Figure 28b).
11.3.2 ehs-1 g en etic  in teraction s
The aldicarb experiments indicated that ehs-1 could interact genetically with 16 genes. 
The plots of the average “survival” time for 15 interactions are shown in Figure 29a. 
The fifteen genes that were identified to interact with ehs-1 are: Y37E3.11, D1081.7 
(1J65), C50C3.8, epn-1, F01F1.6, F15C11.2, F23B12.5, T05F1.4, T23G11.7, tfg-1, 
Y11D7A.12, Y45F10D.13, F46H5.7 (XH858), lin-10, and K04H4.2.-In addition, knock 
down of dab-1 in ehs-1 mutants resulted in severe phenotypes of ehs-1, such as larval 
lethality, molting and egg laying, to an extent that no worms were available for aldicarb 
experiments, indicating a genetic interaction between ehs-1 and dab-1.
11.3.3 rme-1 gen etic  in teraction s
Even though rme-1 mutants did not demonstrate a phenotype related to aldicarb 
sensitivity, several genetic interactions were revealed, before the knock down 
experiments were carried out for its specific phenotype of reduced brood size. A total of 
six genes, which were identified as interactors by the other three EH proteins, and were 
not shown to interact with RME-1 by criss-cross transformation (Table 2), were found 
to interact with rme-1 genetically. The RNAi of dab-1, pcn-1 and vab-19 caused the 
average “survival” time of rme-1 mutants to be reduced more dramatically than what 
was observed in the RNAi of C50C3.8, F46H5.7 (XH858), whereas the knock down of 
Y11D7A.12 appeared to increase the average “survival” time (Figure 30a).
11.3.4 reps-1 G enetic in teraction
Reps-1 was found to interact with 10 genes out of 20 genes tested. It was observed that 
the time of “survival” decreased even more than reps-1 on its own when the putative
152
interactors were knocked down. The ten genes that were found to interact genetically 
with reps-1 are as follows: B0041.2, BE003N10.3, epn-1, F I5Cl 1.2, K04H4.2, pqn-32, 
sel-5, T05E7.5, tfg-1, and vab-19 (Figure 31a).
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Figure 30. The average survival time under treatment w ith  0.5mM aldicarb o f  
rme-1 m utant worms in which 26 genes were knocked down by RNAi: N2 
Bristol (N), N2 (RNAi) (G), rme-1 (B), and rme-1 (RNAi) (B+G). (n=40, in 
triplicates)
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Figure 31. The average survival time under treatment with 0.5mM aldicarb of 
reps-1 mutant worms in which 26 genes were knocked-down by RNAi. N2 
Bristol (N), N2 (RNAi) (G), reps-1 (B), and reps-1 (RNAi) (B+G).
(n=40, in triplicates)
X-axis: The average survival time in hours under the treatment with 0.5mM aldicarb 
Y-axis: N: wild type, B: itsn-1 mutant, B+G: itsn-1 mutant in which the specified gene 
was knocked down by RNAi, G: wild type in which the specified gene was knocked 
down by RNAi.
a. reps-1: genetic interactions found 
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b. reps-1: No genetic interaction found
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12. Genetic interaction 2: Brood size assay for RNA/in rme-1 
mutant strain
In order to test rme-1 genetic interactions using a phenotype that is more appropriate for 
rme-1 mutant (bl045), the effect of RNAz of the putative interactors on the brood size 
of rme-1 was analyzed. Three putative interactors that were identified by criss-cross 
transformation were knocked down in N2 and rme-1 worms using RNAz by feeding. 
The change in the brood size apparently caused by the RNAi in rme-1 was comparable 
to that observed in N2 wild type worm. Thus we concluded that no genetic interactions 
were confirmed by monitoring the phenotype of decreased brood size of rme-1. The* 
average brood sizes of the knock- down animals of ALX-1, Y37E3.11, and Y11D7A.12 
in the genetic background of N2 and rme-1 are shown as bar charts in Figure 32. The 
brood sizes of 21 worms for each experiment used to calculate the average brood size 
are shown in Table 14.
Table 14 The average brood sizes of the N2 and rme-1 mutant worms in which 
alx-1, Y37E3.11, or Y11D7A.12, were knocked down by RNAi.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Average st dev
N2 Ctrl 246 258 260 263 270 286 292 300 308 312 316 318 319 320 327 330 330 331 335 338 346 305.00 30.09
rme-1 Ctrl 136 140 177 198 202 206 208 214 219 223 225 228 228 229 233 236 236 237 245 248 250 215.14 31.24
N2 alx-1 188 230 241 246 247 252 256 256 257 263 266 269 271 278 279 279 291 292 304 310 312 266.05 28.78
rme-1 alx-1 123 126 132 152 160 160 189 190 194 194 201 207 216 218 221 225 228 234 241 245 262 196.10 40.43
N2 Ctrl 246 258 260 263 270 286 292 300 308 312 316 318 319 320 327 330 330 331 335 338 346 305.00 30.09
N2
Y37E3.11 109 143 151 162 168 170 176 180 194 202 210 216 226 230 239 242 244 252 258 267 267 205.05
44.71
rme-1 Ctrl 136 140 177 198 202 206 208 214 219 223 225 228 228 229 233 236 236 237 245 248 250 215.14 31.24
rme-1
Y37E3.11 169 176 197 199 199 201 203 204 205 208 212 218 227 234 235 235 238 238 243 244 245 215.71
22.34
N2 Ctrl 246 258 260 263 270 286 292 300 308 312 316 318 319 320 327 330 330 331 335 338 346 305.00 30.09
N2
Y11D7A.12 183 201 206 208 210 211 216 223 223 229 230 230 236 242 243 250 254 259 273 281 294 233.43 27.96
rme-1 Ctrl 136 140 177 198 202 206 208 214 219 223 225 228 228 229 233 236 236 237 245 248 250 215.14 31.24
rme-1
Y11D7A.12 113 136 140 149 152 156 157 158 160 161 162 163 164 165 169 171 180 191 195 196 225 164.90
23.73
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Figure 32. The average brood sizes o f 21 rme-1 mutants and rme-1 mutants in 
which alx-1, Y37E3.11, or Y11D7A.12 were knocked down.
The effect of RNAi of these genes in the wild type background of N2 Bristol strain is 
shown for each experiment.
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13. Summary of interactions identified and the construction of 
the Interactome map
13.1 ITSN-1 in teractors
13 proteins out of 26 interact with ITSN-1 physically in the Y2H system, of which 10 
were validated by the in vitro binding assays. Probably for the fact that a full-length EH 
proteins were used in the in vitro binding experiments, some proteins that were 
identified to interact with one EH protein in the Y2H system were also found to interact 
with the other EH proteins in the in vitro pulldown assays. For example, Y11D7A.12, 
which was thought to interact only with EHS-1 and RME-1 by the Y2H system, was co­
purified with the full-length ITSN-1.
13.2 EHS-1 in teractors
EHS-1 was found to interact with 16 proteins by the Y2H screenings, of which 13 were 
confirmed by the in vitro pull-down assays. As observed in the pull-down assays for 
ITSN-1, two proteins, T05F1.4 and SEL-5, which were identified as a specific 
interactor of REPS-1 by the Y2H screenings in this study, were shown to interact also 
with EHS-1 by the pull-down assays. A genetic interaction was shown between 
T05F1.4 and ehs-1, in addition to confirming the genetic interactions for 11 out of 16 
physical interactors of EHS-1. The other five interactors that were found not to interact 
with ehs-1 genetically could be explained by the fact that the protein interactions are not 
involved in the pathway that results in the phenotype detectable by the aldicarb 
sensitivity assay.
13.3 RME-1 in teractors
The fact that the number of interactors found by RME-1 screening is so small may be
due to the fact that the EH domain of RME-1 requires other domains in the protein. For
example, it has been reported that ATP-binding to the p-loop located in the N-terminus
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of the protein plays a role in oligomerization, which is suggested to be important for the 
functions of RME-1, and it may also promote interactions with other proteins, although 
the report does not investigate the interactions mediated solely by its EH domain [121]. 
An attempt to use a bait containing the p-loop together with the EH domain was not 
carried out because it would be a full-length bait Such bait would include the coiled- 
coil region, located in the middle of the protein, and hence interfere with the aim to 
specifically identify EH-mediated interactors. Indeed, the full-length RME-1 expressed 
as a GST-fusion protein in the in vitro pull-down assays detected an array of interactors 
- that were shown by Y2H system to interact only with the EH domains of ITSN-1, EHS- 
1, and REPS-1, such as EPN-1, DAB-1, and LIN-10.
13.4 REPS-1 in teractors
The Y2H screenings of REPS-1 identified 17 proteins of which 8 were confirmed to 
interact genetically. In addition, 2 proteins that were shown to interact with ITSN-1 and 
EHS-1 by Y2H system and 1 protein which had been identified as an interactor specific 
to ITSN-1 was shown to interact genetically with REPS-1. Unfortunately the in vitro 
pull-down assays of REPS-1 did not identify any GST-fusion proteins of the putative 
interactors.
13.5 The EH Interactom e m ap
Innteractome maps that represent the putative interactions found by Y2H screenings, in 
vitro pull-down assays and by genetic analysis were created using the software Osprey 
1.2.0, and is shown in Figure 33. The interactions found by the three different 
approaches are also summarized in Table 12. The putative mammalian homologues of 
the interactors identified, where known or predictable, will be discussed later in Section 
16 (See Table 14).
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Figure 33 Map o f interaction o f EH domain-containing proteins identified by 
Y2H screening, criss-cross re-transformation, In-vitro binding, and genetic 
interaction, generated using the software Osprey _1.2.0.
Four EH proteins, ITSN-1, EHS-1, REPS-1 and RME-1 are labelled with the largest cirles, in 
the interactome map. The interactors of the EH proteins identified in this study are shownwith 
the medium-sized circles in the map, right above the bottom layer. The methods by which the 
interactions were identified in this study are indicated by different colours of the lines; red lines: 
Y2H screening; pink lines: Criss-cross re-transformation; green lines: In-vitro binding; and blue 
lines: genetic interactions. Where there are more than one colour per interaction, the colours 
indicate different methods by which the interactions were confirmed. The proteins notated with 
smaller circles and the interactions notated in grey are the known interactors of the interactors 
found in this project, or of the EH proteins [138].
The circles representing each protein are colour-coded automatically by the Osprey 1.2.0, to 
represent the general function of the proteins, where known, as follows: Purple: Transport,
Blue: Metabolism, Light blue: Signal Transduction, Brown: Protein phosphorylation, Bright 
pink: Protein transport, Beige: Protein degradation, Green: RNA processing, Dark beige: DNA 
repair, Light pink, DNA damage response, Violet: Cell organization and Biogenesis. Note that 
these annotations were applied automatically in the function within the Osprey 1.2.0, based on 
the information available from the Gene Ontology (GO) Consortium.
The mammalian homologues of the EH interactors, where known, are summarized later, in 
Section 16 and in Table 14.
MG3A8.3
BE0003N1
a. An Interactome map to show the four EH proteins and their interactors 
identified in this study.__________________________________________
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IV. DISCUSSION
This project identified a total of 26 interactors by the Y2H approach, of which 17 
were validated to bind to at least one of the EH proteins in C. elegans by either in- 
vitro pulldown or assays for monitoring genetic interactions. It was the first approach 
to identify the interactors of EH proteins on a genome-wide scale. It appears clear, 
from an overall look at the list of the EH interactors identified during this project, as 
demonstrated in the interactome map in Figure 33 (and in Table 15 in the later 
section) that many of the interactors are found in various intracellular events, holding 
together a network of adaptor proteins involved in all the major processes of the 
protein sorting events in intracellular signalling.
Our results implicate EH proteins and their interactors in sorting events such as 
receptor maturation, secretion, receptor internalization, multivesicular endosome 
(MVE) and multivesicular bodies (MVB) sorting, vesicle recycling, nuclear- 
cytosolic shuttling, protein degradation. Furthermore, the results from this study 
indicate that the EH network is involved in various signalling pathways at a more 
global level.
In the first part of the discussion, the previous knowledge on EH interactors in C. 
elegans will be addressed in the light of what was found in this study. In the second 
part, the future experiments that will help to answer the questions on C. elegans EH 
proteins raised in this study will be proposed. The final part of the discussion will 
look at some of the EH interactors identified in this study, or their homologues in 
other species, to build a speculative model on the role of EH network in intracellular
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signalling, and diseases such as cancer, human immunodeficiency virus-1 (HIV-1) 
infection and neurodegenerative diseases.
14. Previously known and predicted EH interactors in C. 
elegans confirmed by this study
14.1 P reviou sly  kn ow n EH in teractors in  C. elesans 
confirm ed bv th is  stu d y
Apart from a few interactions that had already been demonstrated previously by others, 
mostly in mammalian systems, most of the proteins identified as putative interactors of - 
C. elegans EH proteins during this project are novel. Two EH-mediated interactions 
discovered in this study have been reported for C. elegans EH proteins, namely the 
interaction between alx-1 and rme-1 [101] and the interaction between ehs-1/itsn-1 with 
dab-1 [139], supporting the validity of our screening. The interaction between alx-1, or 
dab-1, with the other EH proteins has not been reported to date.
14.2 P red icted  EH in teractors confirm ed bv th is  study
Two C. elegans proteins had been previously predicted (but not demonstrated) to
interact with EH proteins and both were identified in this project [18]. LIN-10 is part of 
a trimeric complex LIN-2/LIN-7/LIN-10, which plays a role in the basolateral 
localization of EGFR LET-23 in vulval epithelial cells [140]. In addition, its 
mammalian homologue Mint-1 (Muncl8 interacting protein i )  is essential for synaptic 
vesicle exocytosis [141, 142]. LIN-10 was a possible candidate for an EH interactor as 
it contains 2 NPF motifs and its functions are related to trafficking [18]. The prediction 
of LIN-10 as an EH interactor was confirmed in this project, as it was demonstrated to 
interact with ITSN-1, EHS-1 and REPS-1 by the Y2H screenings.
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The other predicted EH-binding protein SEL-5, was also identified in this study as an 
interactor of REPS-1. SEL-5 also contains one NPF motif as well as a class II EH- 
interacting motif, HSF. SEL-5 is a serine-threonine kinase that facilitates the LIN- 
12/Notch receptor activity [143, 144]. Notch in Drosophila had been shown to require 
an endocytic protein dynamin for its function [145, 146]. The interaction between 
REPS-1 and SEL-5 further supports a role for endocytosis and the EH proteins in the 
Notch signalling pathway. Conversely, Numb, a Notch antagonist, is able to interact 
with Epsl5 through its NPF motif [11, 147], even though C. elegans Numb was not 
identified in our screenings. Indeed, the C. elegans homologue of Numb, num-1 does 
not contain any EH interacting motif, proving the specificity of the screening.
In addition, the mammalian homologues of two interactors identified in this study have 
already been described as EH interactors. Epsin is known to interact with Epsl5 [13], 
Intersectin [14] and Repsl [148]. Ubiquilin (hPLIC), the predicted human homologue 
of F15C11.2, has been shown to interact with Epsl5. The EH domains are not essential 
for binding between mammalian Epsl5 and Ubiquilin [149]. However, this study has 
indicated that, in C. elegans, the interactions between F15C11.2 and different EH 
proteins is mediated by the EH domain: the baits designed for EHS-1 and ITSN-1 
contained only restricted regions of EH domains, yet both baits were able to interact 
with F15C11.2. Moreover, the EH-mediated interaction with F15C11.2 is likely to be 
facilitated by the regions surrounding the EH domain, since the REPS-1 bait that 
contained an extended region around the EH domain used in this study demonstrated a 
stronger interaction with F15C11.2 than EHS-1 or ITSN-1.
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15. Further experiments to be done on C. elegans EH proteins
15.1 Is R10E11.6 an  EH p rotein  ?
R10E11.6 is a gene that was recently identified as an EH-domain containing protein. 
The gene is uncharacterized, and despite its sequence similarity to the mammalian y- 
synergin family, as discussed in Section 11.5, the predicted EH domain of the C. 
elegans homologue did not show any interaction with NPF-containing proteins. The 
NPF containing proteins tested were those that were identified as the interactors of the 
other three EH proteins in this study, in addition to SCM-1, which was predicted to 
interact with R10E11.6, as discussed in Section 11.5.3. The lack of a mutant worm for 
R10E11.6 renders an appropriate analysis of its function in nematode difficult. 
However, R10E11.6 is in an operon with vha-1 and vha-2, encoding subunits of the 
vacuolar proton-translocating ATPase, suggesting that it might be required for 
lysosomal biogenesis.
To date, this study was unable to verify whether R10E11.6 is a true EH domain- 
containing protein. This study investigated whether the EH domain of R10E11.6 was 
able to interact with any of the interactors of the other C. elegans EH proteins, and no 
interaction was observed. Furthermore, the EH domain of R10E11.6 did not show 
interaction with SCM-1, a homologue of an interactor of y-Synergin in a re­
transformation assay in this study.
The EH domain of R10E11.6 did not interact with any of the C. elegans NPF-
containing proteins that bind to the EH domains of the other proteins. In addition, to the
co-transformants of the bait of R10E11.6 with the prey containing a putative interactor
SCM-1 did not show any activation of the reporter gene LacZ. These observations
suggest that R10E11.6 may not be an EH protein, and therefore it may not be a true
homologue of y-synergin. Functional characterization of R10E11.6 mutant, once
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available, will enable us to determine whether R10E11.6 acts as a homologue of y- 
Synergin. In addition, interactions with other proteins that bind to y-Synergin, mediated 
by regions outside of the EH domain, such as Aftiphilin and p200 [129], will also help 
to answer whether R10E11.6 is a homologue of y-Synergin. Moreover, the region 
recognized as the EH domain of R10E11.6 can be tested by in vitro binding assay with 
GST-fusion peptides containing NPF motifs, which was shown in a previous study to 
interact with the EH domain of Epsl5 [11]. However, the GST-NPF-containing 
peptides were taken from the sequences of the mammalian proteins, Hrb/Hrb-1 and 
Numb/Numb-1, and if the EH domain was unable to" interact with the C. elegans NPF- 
containing proteins in this study, it might not interact with the mammalian NPF- 
containing peptides.
15.2 In teraction s s till to  be confirm ed bv in vitro  pu ll-dow n  
assays
8 proteins out of a total of 26 identified in our screenings were not cloned in-frame as 
GST-fusion proteins. These are marked as “N/A” in the column for the pull-down 
experiments in Table 12. Therefore the pull-down assays in this study were considered 
as validations only for the interactions between the EH proteins and the 18 proteins 
cloned; most of these may be mediated by a NPF/DPF motif. Validation by in-vitro 
binding assay of an EHS-1 specific interactor, D1081.7, which contains a class II EH- 
interacting motif (HTF) and a class III EH-interacting motif (FWR), will help to 
confirm the interactions mediated by these other classes of interacting motifs. In this 
context, it is worth noting that Y45F10D.13, an HSF-containing protein, was validated 
as an interactor of EHS-1. Y11D7A.12, which contains an FWR motif, was also 
confirmed to interact with ITSN-1, EHS-1 and RME-1 by in vitro binding assays.
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15.3 REPS-1 sp ec ific  in teraction s
Of the eight proteins that were not validated by in vitro pull-down assays, five were 
REPS-1 specific interactors (two of the seven REPS-1 interactors were validated). 
However, it must be pointed out that none of the in vitro pull-down assays for REPS-1 
showed binding to any putative interactors, in spite of the fact that the FLAG-tagged 
REPS-1 did interact with a GST-fusion peptide containing the NPF motif (which 
suggests that the EH domain in the fusion protein was folded correctly enough to 
recognize the peptide motif). The fact that no GST-fusion proteins larger than the 
peptide motif were shown to interact with REPS-1 could lead to two speculations. One 
is that the interactions identified by the EH domain of REPS-1 in Y2H screenings are 
artefacts of Y2H system. However, this does not explain the numerous genetic 
interactions observed in the mutant background of REPS-1 that validate the Y2H 
interactions identified in this study. The second is that the folding of the FLAG-tagged 
REPS-1 was not efficient enough to recognise the binding region in the GST-fusion 
contest. Since the sequence of REPS-1 present in the Wormbase was not constant 
during the period of this project, FLAG-tagged REPS-1 was expressed as the same 
fragment used as the bait REPS-1 in the Y2H screenings, as the exon coding for the EH 
domain was found constant in all sequences of REPS-1 found to date. The fact that a 
fragment of REPS-1 was expressed in a heterologous system, could have prevented the 
correct conformation of FLAG-REPS-1 and the binding, even though the bait was 
functional in another heterologous system, that of yeast in the Y2H.
The analysis of reps-1 gene is further complicated by the lack of ESTs available,
suggesting three possibilities about REPS-1 protein expression in C. elegans: 1) the
expression is at a very low level, 2) the expression is in few specific cells or 3) the
expression is limited within a specific time frame during development. Further
experiments, such as studying the expression pattern of REPS-1 in C. elegans by using
173
GFP-fusion proteins of REPS-1 expressed under the reps-1 promoter, will indicate 
when and where REPS-1 is expressed in the nematode, thereby facilitating isolation of 
the ESTs of REPS-1, and cloning the full-length endogenous REPS-1 to elucidate its 
currently ambiguous sequence.
In the Y2H screenings, the REPS-1 bait contained regions outside of the EH domain. 
Seven interactors that do not contain NPF or other known EH-interacting motifs were 
identified in REPS-1 Y2H screenings. The extra region surrounding the EH domain is 
likely to be responsible for binding with these REPS-1 specific interactors. This is also 
supported by the fact that none of the other baits used (from the other EH-containing 
proteins screened) were able to interact with these REPS-1 specific interactors when 
criss-cross re-transformations were performed. A bait containing a mutated EH domain 
of REPS-1 should clarify whether these REPS-1 specific interactions are EH-mediated. 
No common motifs were identified in the sequences of these 7 REPS-1 specific 
interactors in this study, but if the interaction is indeed mediated by the EH domain, 
then a closer analysis of the sequences to identify new EH-interacting motifs is 
warranted.
15.4 RME-1 in teractors
A number of recent findings on the EHD family of proteins (of which RME-1 is a 
member) indicated that nucleotide-binding to the EHD proteins is required for the 
interactions mediated by its EH domain (Refer to the sections 2.5.1 and 2.5.4). In 
addition, oligomerization of the EHD proteins, which also requires the nucleotide- 
binding, is thought to be critical for the EH interactions.
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The Y2H screenings of RME-1 in this study was carried out using the C-terminal EH 
domain alone as the bait This means that the bait lacked both the oligomerization 
domain located in the coiled-coil region in the central portion and the nucleotide- 
binding domain in the N-terminal of the protein. Full-length proteins were not used in 
the Y2H screenings in this study to avoid the interactions mediated by non-EH regions. 
Indeed, a strong interaction was observed in the X-gal assay between ALX-1 and RME- 
1 only when ALX-1 was co-transformed with the bait J, which contains the coiled-coil 
region. It is probable that the bait J was able to oligomerize to some extent even without 
nucleotide-binding, and therefore assisted the interaction with ALX-1, in comparison to 
other baits such as bait D and F. Despite the risk of identifying non-EH interactors, use 
of the full-length bait to perform an Y2H screenings, should therefore reveal further 
novel interactors of the EH domain of RME-1.
16. Roles of the extensive intracellular EH network based on 
the EH interactors identified
The EH network that has been uncovered in this study appears to span diverse 
intracellular compartments from which different signalling pathways are conducted. 
Although many of the C. elegans EH interactors identified in the screenings are 
uncharacterized or do not have clear homologues in other species, the functions of 
protein families such as the Epsin family, Disabled family, Lin-10/Xll/Mintl 
family, Alix family, and SEL-5/GAK1 family have been reported. The C. elegans 
homologues of these families, EPN-1, DAB-1, LIN-10, ALX-1 and SEL-5 were 
identified as interactors of more than one EH protein in this study. By looking at the 
previously known functions of these protein families, the extent of the EH network 
can be visualized, and help to speculate on the intracellular role of the EH network.
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Furthermore the screening identified novel interactors, adding complexity to the EH- 
network.
The range of proteins identified to interact with EH proteins in this study show that 
the EH network contains several signalling pathways such as EGFR/Ras/MAPK 
pathway, Notch/LIN-12 pathway, and Hedgehog signalling pathway. The adaptor 
proteins Epsin, LIN-10, and CAS-1/CAP that interact with EH proteins and 
participate in the endocytic protein sorting or actin cytoskeleton organization in the 
EGFR/Ras/MAPK signalling pathway will be discussed. In addition, several 
components of Notch/LIN-12 pathway have been identified as EH interactors, such 
as SEL-5, EPN-1, and ALX-1. The interaction identified in this study between EHS- 
1 with C50C3.8, which is most likely to be a homologue of Drosophila roadkill, is 
the first example of an EH protein being implicated in Hedgehog signalling.
In the following section, the EH interactors identified in this study in C. elegans, of 
their homologues in other organisms will be discussed, divided into sub-sections 
according to their functions in the intracellular trafficking. The C. elegans proteins 
and their homologues that will be discussed in the following sections are shown in 
Table 15 below.
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Table 15 The EH interactors and their homologues tha t have been implicated in 
various intracellular processes.
Protein Names
Intracellular
processes C.elegans H. Sapiens S. cerevisiae D.melanogaster
Endocytosls
EPN-1
[**see below]
Epsins
[13]
Entlp/Ent2p
[150] Iqf
F15C11.2 Ubiquilins (PUC  1/-2) [149, 151] Dsk2p CG14224
ALX-1
[101]
Alix
[152] Brolp ALiX
DAB-1 Dabl/Dab2 [154- 156] - Dab
Actin
cytoskeleton
dynamics
CAS-1 Capl [158] Srv2p [157] CG33979
F15C11.2 Ubiquilins (PUC1/-2) [159,160] Dsk2p CG14224
Receptor
maturation
LIN-10 [140,161- 
163] M intl Muclp X llLbeta
Ligand
sorting EPN-1 Epsins Entlp
Iqf
[164,165]
Ligand
secretion
DAB-1
[167] D abl/Dab2 - Dab
TFG-1
(COPII
complex?)
[170]
Vrplp CG7709
Early
endosome
trafficking
SEL-5
[144]
GAK1
[173]
A rklp /P rk lp
(Paklp)
[171]
Nak
MVE/MVB
sorting
ALX-1
[174]
Alix
[175,176] Brolp ALiX
Receptor
recycling
ALX-1
[101] Alix Brolp ALiX
Nuclear
functions
EPN-1 Epsins[181] Entlp Iqf
C50C3.8 Speckle-type POZ protein -
Rdx
[182]
Protein
degradation
F15C11.2 Ubiquilins (PLIC 1 /-2 )
Dsk2p
[184] CG 14224
BE0003N10.3 FBX11? - FBX11?
[ * * ]  Personal communication from Dr. MG Malabarba
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16.1 EH in teractors in  E n docvtosis
The canonical function of EH domain-containing proteins to date is the endocytic 
function. Proteins that belong to Epsl5 family, Intersectin family, EHD family and 
Reps/POB family have each been shown to participate in endocytosis or in endocytic 
recycling processes. Mammalian Epsl5 and Epsin were shown to interact via an EH- 
NPF interaction, and their role in endocytosis has been demonstrated [13]. In this 
study, C. elegans Epsin homologue EPN-1 was shown to interact with EHS-1, C. 
elegans Epsl5, as well as with ITSN-1 and REPS-1. The yeast epsins, Entlp and 
Ent2p are also essential for endocytosis, particularly the epsin N-terminal homology 
(ENTH) domain, found conserved in Epsin homologues in C. elegans to mammals. 
In addition, the C-terminal region of Entlp was shown to bind clathrin [150]. The C. 
elegans EPN-1 contains an ENTH domain, two Ubiquitin interacting motifs (UIMs), 
several AP2-binding motifs, in addition to two clathrin-binding consensus sequences 
and four NPF motifs (Dr. MG Malabarba, personal communication). The 
conservation of the domains identified in the Epsin protein family suggests that the 
C. elegans homologue would also display an endocytic function.
F15C11.2, an as yet uncharacterized C. elegans gene is thought to be homologous to 
mammalian PLIC proteins (Ubiquilins), in particular to PLIC-2. Mammalian 
Ubiquilinhas been shown to interact with the UIM domain of Epsl5 and of Epsin 
[149]. This study confirmed the F15C11.2 (ubiquilin)-EHS-l (epsl5) interaction in 
C. elegans. A very recent study on PLIC-2, has distinguished its function from that 
of PLIC-1 in the negative regulation of GPCR (G-protein coupled receptor) 
signalling. PLIC-2 was demonstrated to inhibit the agonist-induced internalization of 
GPCR by delaying the receptor co-clustering with arrestins, which are adaptor 
proteins required for GPCR endocytosis [151]. Given the implication of mammalian
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Ubiquilin in GPCR endocytosis, and the role of EHS-1 in the endocytic processes, 
FI 5C11.2 might also play a similar role in C. elegans.
ALX-1, the known interactor of RME-1 [101] as mentioned Section 2.4.1, was found 
to interact also with EHS-1 in the Y2H screenings. In addition, ALX-1 was shown to 
interact with the EH domains of ITSN-1 and REPS-1 by the criss-cross 
transformations. The mammalian homologue of ALX-1, Alix, was also identified as 
an interactor of CIN85/SETA/Ruk [152], which regulates the endocytosis of EGFR 
through its interaction with Endophilin. Endophilin interacts with dynamin, and is 
essential for the negative membrane curvature in vesicle formation from the plasma 
membrane. Endophilin itself also interacts with Alix [153]. Therefore, the interaction 
between ALX-1 and EHS-1 identified in this study, may point to a role for them in 
vesicle formation in C. elegans. EHS-1 has also previously been shown to play a role 
in synaptic vesicle recycling together with dynamin, dyn-1 [19].
C. elegans Disabled protein, DAB-1 was identified to interact with ITSN-1, EHS-1 
REPS-1, and RME-1 in this study. While DAB-1 in C. elegans is a unique 
component of the Dab family, two members exist in mammals. Disabled-1 (Dabl), 
plays a role in Reelin signalling, and affects the positioning of cells during the 
neuronal development [154]. On the other hand, Disabled-2 (Dab2) has been 
described as a cargo-selective adaptor protein for endocytosis of the lipoprotein 
receptor family [155, 156].
16.2 EH in teractors in  A ctin  cvtosk eleton  dynam ics
CAS-1, which is a novel interactor of EH proteins identified in this study, has not yet
been characterized in C. elegans. However, its sequence is homologous to Cyclase-
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associated protein 1 (Cap 1) in yeast, Drosophila and human. Capl has been 
implicated in vesicle trafficking and endocytosis as well as actin cytoskeletal 
organization [157, 158]. The total sequence homology of 38%, but observed 
throughout the sequence of the entire protein between CAS-1 (especially the shorter 
isoform b and c) with the yeast and the mammalian Capl suggests that CAS-1 could 
share the same functions in C. elegans, although this still needs to be explored. The 
interaction of Capl with the EH proteins has not been reported and analysis of this 
interaction in mammalian system could extend the link between the EH protein and 
the cytoskeleton dynamics. *
F15C11.2, an EH interactor that may be involved in GPCR endocytosis as described 
in Section 16.1, may also play a role in actin dynamics, considering the functions 
demonstrated by its mammalian homologues. PLICs have been identified as a partner 
of integral membrane protein CD47, which is involved in adhesion and migration 
and also as a component of the actin cytoskeleton [159]. Consistent with this finding, 
PLIC-1 was found to play a role in the regulation of Gi-coupled receptor activity, 
which has been implicated in the migration of cells in chemotaxis [160], in addition 
to another study, which implicated PLIC-2 in the endocytosis of GPCR described in 
Section 16.1. Although the interaction between Epsl5 and PLIC-2 has been reported 
[151], no data are available regarding a possible role in actin organization or in the 
connection of PLIC-1/2 with other EH proteins.
16.3 EH in teractor  involved  in  R eceptor m aturation
LIN-10 was shown to interact with the EH domains of EHS-1, ITSN-1 and REPS-1
in this study. LIN-10 was demonstrated as a part of LIN-2/LIN-7/LIN-10 complex,
which plays a role in the basolateral localization of EGFR/LET-23 [140, 161].
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Intriguingly, LIN-10 in neurons was recently shown to direct the localization of 
glutamate receptor, GLR-1 in C. elegans. [162, 163] These findings suggest that 
LIN-10 is involved in the receptor sorting process in a cell-type specific manner. It is 
the first time that LIN-10/Mint-1 has been proven to interact with the EH proteins 
and it will be of interest to further investigate the role of the EH network in receptor 
localization in mammalian cells.
16.4 EH in teractor in vo lved  in  ligan d  sortin g
EPN-1, identified to interact with ITSN-1, EHS-1, and REPS-1 in this study, is a C. 
elegans homologue of Epsin protein family, as mentioned in the earlier section 16.1. 
EPN-1 in C. elegans was reported to participate in the maturation of the ligand for 
Notch receptor, GLP-1 in the development of the germline distal tip cells [164]. 
Apart from this study, most of what we know about the Epsin family comes from 
studies on the Drosophila homologue, Liquid facets (Iqf). Lqf plays a role in the 
endocytic processes that take place in the signal-sending cells in Notch pathway 
[164, 165], which is consistent with the role of EPN-1 in promoting the Notch 
signalling, as mentioned earlier in this subsection. The ligand maturation process in 
the signal-sending cells is a pre-requisite for the activation of the Notch signalling 
pathway. The Notch ligand Delta of DSL (Delta Serrate LAG-2) ligand family is 
ubiquitinated by Neuralized (in Drosophila and Mindbomb in Zebrafish) and 
undergoes subsequent dynamin-mediated endocytosis, before the ligand is re­
expressed on the cell surface as activated ligand. The trans-endocytosis of Delta- 
bound extracellular domain of Notch receptor was shown to be necessary for the 
proteolytic release of the Notch intracellular domain [166]. Therefore, endocytosis is 
a critical process for Notch activation, because without it, the Notch ligand cannot be 
activated. The interactions of EH proteins with EPN-1, lend support to the fact that
endocytosis-dependent Notch ligand activation pathways in Drosophila and in C. 
elegans are conserved, and further confirm the involvement of the EH network in 
endocytosis.
16.5 EH in teractors in  E ndocytosis o f  m em brane receptors  
and ligrand secretion
DAB-1, which was previously mentioned in Section 16.1, was recently shown to be a 
clathrin-binding protein, that is involved in the secretion of EGL-17, the fibroblast 
growth factor (FGF) in C. elegans [167]. The clathrin-binding adaptor protein function 
of DAB-1, its sequence alignment with mammalian homologues, and the recent reports 
implicating it in endocytosis [167-169] indicate that C. elegans DAB-1 is more similar 
to the adaptor-protein Dab2, than to Dabl. To date, evidence on possible interactions 
between DAB family and EH proteins in mammals are not available.
Another putative component of the secretory pathway that was found to interact with 
EHS-1 and ITSN-1 in this study is TFG-1 (Trk-fused gene-1). TFG-1 is referred to as 
COPII complex, which takes part in the protein traffic from ER to Golgi apparatus
[170].
Interestingly, in support of the functions of DAB-1 and TFG-1 in protein trafficking, 
both proteins were recently identified in a genome-wide RNAi screening for genes 
involved in membrane traffic in C. elegans [170].
16.6 EH in teractors in  E arly endosom e traffick ing
SEL-5 is an NPF motif-containing protein, which had been predicted to be an EH
interactor, as mentioned in the section 14.2 of this discussion, and was confirmed to
interact with REPS-1 in this study. SEL-5 was initially identified in a screening for
the suppressor/enhancer of LIN-12, one of the Notch receptors in C. elegans [144].
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The yeast homologues of SEL-5, Arklp and Prklp (Paklp) are Serine/Threonine 
(S/T) kinases. Prklp was initially shown to regulate the actin cytoskeleton 
organization by modulating yeast EH domain-containing proteins Panlp (a 
hypothetical homologue of intersectin) and End3p (an yeast homologue of Epsl5)
[171]. More recently, the function of Prklp was further elaborated as it was shown 
that the phosphorylation of Panlp by Prklp inhibits the fusion of vesicles to 
endosomes by inhibiting the Arp2/3-mediated actin polymerization on endocytic 
vesicles [172]. Of note, the findings that Prklp, the yeast homologue of SEL-5 
phosphorylates an EH-domain containing protein Panlp lends confidence to the 
validity of the interaction between SEL-5 and the EH domain of REPS-1 identified in 
this study.
Further implication of SEL-5 in early steps of endocytic trafficking comes from the 
knowledge on its mammalian homologue. The S/T kinase domain of Cyclin C- 
associated Kinase 1 (GAK1) is thought to be the most similar to the kinase domain 
identified in the N-terminal portion of SEL-5 [144]. GAK1 was is a co-factor of the 
chaperone protein Hsc70 during uncoating of clathrin-coated vesicles during 
endocytosis [173]. However, the sequence homology between SEL-5 and GAK is 
restricted to the S/T Kinase domain in their amino-terminal region, and while the 
region similar to auxillin that is attributed to the clathrin-uncoating activity is not 
conserved. Therefore, caution is warranted in suggesting that SEL-5 might act in a 
similar way to GAK1 as a clathrin-uncoating protein.
16.7 EH in teractors in  MVE/MVB sorting
ALX-1, which was identified as an interactor of EHS-1, RME-1 and ITSN-1 in this 
study and was the only protein that had already been demonstrated to interact with
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RME-1, as discussed in Section 14.1. ALX-1 takes part in the post-internalization 
trafficking of the Notch receptor LIN-12 [174]. The knock-down of ALX-1 in C. 
elegans resulted in the accumulation of internalized LIN-12 in intracellular puncta, 
demonstrating that ALX-1 is not required for internalization of LIN-12, but rather 
that it plays a role in the trafficking of LIN-12 at a step subsequent to the 
internalization. Furthermore, the yeast homologue of ALX-1, Brolp and the 
mammalian Alix were both shown to promote MVB sorting pathway as they were 
shown to interact with the endosomal complexes ESCRT-I and ESCRT-IQ [175, 
176] To date, the interaction of mammalian alix with the EH proteins has mot been 
reported.
Intriguingly, mammalian Alix has also been described as an adaptor protein that 
controls the function of lysobiphosphatidic acid (LBPA) in the biogenesis of 
endosomes [177]. LBPA is a phospholipid found in the late endosomes. Additional 
evidence suggests that Alix is able to regulate the intracellular positioning of 
endosomes in an actin cytoskeleton-dependent manner [178].
16.8 EH in teractors in  R eceptor recyclin g
As mentioned in the previous section 16.7, ALX-1 was recently reported to be an 
interactor of RME-1 (this was confirmed in this project), and to function in receptor 
recycling from the endosomes to the plasma membrane [101]. EHS-1, another EH 
protein that was demonstrated in this project to interact with ALX-1 was shown to 
play a role in synaptic vesicle recycling, suggesting a role for ALX-1 in this process.
16.10 The EH p rotein s and the EH in teractors in  th e  n u cleu s
Although Epsl5 and Epsl5R are classically found to interact with AP-2 and clathrin
and are localized at the coated pits, a significant fraction of Epsl5R in the nucleus has
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been reported [179, 180]. Epsl5R lacks the Nuclear Export Signal (NES), which is 
found in the C -terminal of Epsl5. The sequence homology between the human Epsl5 
and its C. elegans homologue EHS-1 is not found in their C-terminal regions, and the 
sequence particularly rich in Leucine residues is not found in EHS-1, as in the case of 
Epsl5R. However, the function of Epsl5R or of EHS-1 in the nucleus, is yet to be 
elucidated.
Mammalian Epsin (which is an established interactor Epsl5), and its C. elegans 
homologue EPN-1 (that was shown to interact with several C. elegans EH proteins in 
this study), have been found localized in the nucleus together with Epsl5 and CALM 
(clathrin assembly lymphoid myeloid leukaemia). The ENTH domain of Epsin has 
been shown to interact with a PLZF (promyelocytic leukaemia Zn2+ finger protein) 
transcription factor [181], a nuclear protein and therefore further supporting the 
nuclear localization and a possible nuclear function of Epsin.
One of the three specific interactors of EHS-1 identified in this study is the 
uncharacterized protein C50C3.8. This protein is similar to the Drosophila protein 
roadkill (rdx), which is expressed in response to Hedgehog (Hh) signaling. Rdx is 
localized in the nucleus and thought to act as an adaptor protein for Cullin 3, an E3 
ubiquitin ligase that promotes the degradation of the transcription factor, Cubitus 
interruptus (Ci) [182]. Roadkill homologue 1/HIB (Hedgehog induced BTB domain 
containing protein) is found also conserved in human, and the negative feedback loop 
that serves to attenuate Hh signalling is thought to be conserved.
It is interesting to note that the sequence of C50C3.8 contains a region recognized as 
a POZ/BTB domain. This domain is found common in transcription factors such as
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PLZF and Kaiso. PLZF, as mentioned earlier in this section, is an interactor of 
ENTH domain in Epsin, whereas Kaiso interacts with the ENTH-like armadillo 
repeat domain of catenin pl20 [183]. Even though Rdx is an adaptor protein 
involved in the degradation of a transcription factor and does not seem to act as a 
transcription factor (such as, instead, PLZF or Kaiso), the presence of a POZ/BTB 
domain in C50C3.8 further suggests that this uncharacterized protein may be a 
nuclear protein.
16.11 EH in teractors in  P ro te in  d egradation
F15C11.2 was shown to interact with ITSN-1, EHS-1 and REPS-1 in this study. Its 
possible functions in endocytosis and in the regulation of the actin cytoskeleton 
dynamics implied by the mammalian homologues Ubiquilin/PLICs have been 
discussed previously in Section 16.1 and 16.2. An additional possibility for 
F15C11.2, which is still uncharacterized in C. elegans, is that it may be involved in 
proteasome degradation as inferred from the function of its yeast homologue Dsk2p. 
Dsk2p, the single yeast PLIC protein, was shown to interact with poly-ubiquitin 
chains and with the proteasome[184]. Furthermore, Dsk2p was also identified in the 
genetic screen for components essential in the ER-associated degradation of mal- 
folded proteins.
BE0003N10.3 is another uncharacterized protein identified in this study as an 
interactor of ITSN-1 that may be predicted to play a role in protein degradation. 
BE0003N10.3 was identified as the only specific interactor of ITSN-1. The amino 
acid sequence contains similarity to proteins in Drosophila and in mammals that are 
involved in ubiquitin ligase activity, such as the F-box only protein 11 (FBX11) 
family. These proteins are a part of E3 ubiquitin ligase complex, SCF (Skpl-Cull-F-
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box) complex. FBX11 contains different domains such as cyclin-like F-box domain 
and CASH (carbohydrate-binding and sugar hydrolysis), Pectin lyase-fold and Zinc 
finger domain. The sequence similarity between FBX11 and BE0003N10.3 is found 
in the CASH domain and pectin lyase-fold region, rather than in the F-box domain. 
Therefore, whether BE0003N10.3 is a true homologue of FBX11, as stated in the 
Wormbase, is still to be investigated.
16.12 The EH in teractors at th e  cross-roads o f  sign a llin g  
path w ays
16.12.1 At the cross-roads of EGFR-Ras signaling and Notch signaling pathways
The study on the role of ALX-1 in Notch/LIN-12 down-regulation, which was
previously mentioned in Section 16.7, also shed light on the cross-talk between 
Notch pathway and EGFR-Ras-MAPK pathway that occurs during vulval 
development in C. elegans [174]. Cell-fate determination of vulval precursor cells 
(VPC) depends on the activation of either the EFGR-Ras-MAPK signaling cascade 
or the LIN-12 signaling pathway in each VPC. It was shown that EGFR-Ras-MAPK 
activation in the primary VPC promotes the endocytosis and the subsequent 
degradation of LIN-12. The degradation of LIN-12 in the primary VPC in turn 
activates LIN-12 signaling pathways in the neighbouring secondary VPC cells. 
ALX-1 was found to play a role in LIN-12 degradation after its internalization in the 
primary VPC cells.
Another EH interactor identified in this study that may be involved in the LIN-12 
pathway of vulval development is LIN-10. LIN-10 has been commented on earlier in 
Section 16.3 for its function in receptor maturation of EGFR/LET-23 and 
GluR/GLR-1. The C. elegans lin-10 mutant strain manifests a vulvaless phenotype
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[185], commonly seen for genes involved in Notch/LIN-12-mediated cell-fate 
determination.
16.12.2 At the cross-roads of EGFR/Ras signalling pathway and actin dynamics
LIN-10 was identified in this study as an interactor of three EH proteins, ITSN-1, 
EHS-1, and REPS-1. LIN-10 forms a trimeric complex with LIN-2 and LIN-7 that 
determines the basolateral localization of EGFR/LET-23, as described previously in 
Section 16.3 [139]. Recently, EPS-8, an actin-binding protein, was reported to be 
part of LIN-2/LIN-7/LIN-10 complex [186]. Mammalian Eps8 was initially 
identified as a substrate of the tyrosine kinase domain of EGFR, and was suggested 
to play a role in mitogenic signalling [187]. Subsequently, Eps8 was shown to 
interact with F-actin and both the mammalian and the nematode Eps8 were 
demonstrated to have actin barbed end-capping activity [188, 189]. The finding that 
EPS-8 interacts with the heterotrimer LIN-2/LIN-7/LIN-10 implicates LIN-10 in 
coupling the actin organization and the activation of EGFR signalling via this 
multimeric complex.
CAS-1 is another EH interactor identified in this study that may act in between 
EGFR/Ras signalling pathways and actin re-arrangement. Although no specific 
function of CAS-1 has been reported in C. elegans to date, its homologues that are 
implicated in actin organization have been discussed in Section 16.2. Caplp/Srv2, 
the yeast homologue of CAS-1, binds to Adenylyl Cylase (AC) and acts as an 
effector of Ras signalling pathways (reviewed in [190]). AC is an enzyme 
responsible for the formation of cyclic-AMP (cAMP), a key effector in Ras 
signalling pathways. Cyclase-associated proteins (CAPs) are thought to act as a link 
between Ras signalling pathway and actin polymerization.
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16.12.3. At the cross-roads of Apoptosis, Ras activation and actin dynamics
The CAP proteins, the protein family of CAS-1 as described in the previous section
16.13.2, were recently reported not only as a molecular link between the actin 
dynamics and Ras-activation, but also as a link between these processes and 
apoptosis [191]. Ras signalling activation was found to correlate with the 
accumulation of reactive oxygen species (ROS), the aggregation of F-actin, and the 
activation of apoptotic pathway.
Fascinatingly, Gourlay and Ayscough created the accumulation of F-actin in yeast 
stationary cells by using the yeast mutants of End3p, the Epsl5 homologue, and an 
SH3 domain-containing protein Slalp. End3p and Slalp interact with each other in a 
heterotrimeric complex with another EH protein Panlp. The trimeric complex 
consists of multiple EH domains and SH3 domains, a structure that is similar to that 
of the heterodimer formed between the mammalian Intersectin and Epsl5. It was 
demonstrated that in end3 and slal mutants, CAP/Srv2p is required for the co­
localization of the GTP-bound Ras protein on F-actin aggregates, as well as for the 
ROS accumulation, thus for the subsequent apoptosis. The study placed CAP 
proteins at the intersection of Ras proteins on actin dynamics and the activation of 
apoptosis. Furthermore, the observation that the yeast homologue of CAS-1 is 
needed for the apoptosis of cells which lack an EH protein (End3p) and its interactor 
(Slalp), supports the finding in this study that CAS-1 is in the EH network.
16.12.4 EH in teractors in  EGFR sign allin g  and ap op tosis
Alix, the mammalian homologue of ALX-1, which was shown to interact with RME-
1 by others and with other EH proteins in this study, is also thought to be involved in
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apoptosis. The other functions of Alix proteins such as those in MVB sorting, 
endosomes biogenesis and recycling have been discussed previously in Section 16.7 
to 16.9. Alix was originally identified as an interactor of apoptosis-linked gene 2 
(ALG-2), a gene that was shown to be necessary for cell death [192]. Subsequently, 
Alix was directly implicated in apoptosis as it was shown to induce cell death when 
overexpressed. Interestingly, the C-terminal region of Alix is required for the binding 
with ESCRT complex, and the interaction between Alix and ESCRT complex is 
necessary for the inhibition of cell death [193,194].
It would be interesting to investigate whether the interactions between EH proteins 
and Alix could affect the further interactions between Alix with other proteins, such 
as ALG-2. Interactions mediated by Alix could determine the EGFR signalling to 
continue or could instead activate the apoptotic pathway. Such studies would allow 
us to better understand the role of EH proteins as adaptor proteins that transport their 
interactors, such as Alix, to specific locations within the cell to determine particular 
outcomes (for example, growth vs. cell death).
17. The EH network implicated in diseases
The EH domain was initially recognized as the repeated domains in the N-terminal 
domain of Epsl5, a protein that was identified as the substrate of the tyrosine kinase 
domain of EGFR. Increased activation levels of EGFR signalling in quiescent cells 
promotes cell cycle re-entry; such increased and uncontrolled cell division is the first 
step of tumorigenesis.
The process of endocytosis is an important mechanism by which the continued 
activation of EGFR is attenuated by receptor internalization. The EH domains
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located in Epsl5 and in other endocytic proteins mediate protein-protein interactions 
required not only for endocytosis at the plasma membrane, but at different steps of 
intracellular trafficking. The new interactors of EH domains identified in this study 
support the view that the EH network proteins function at diverse level of protein 
trafficking downstream of EGFR signalling, ensuring the efficient attenuation of 
EGF signal. The various functions of EH network proteins in signalling pathways 
other than EGFR, that have also been implicated in oncogenesis, such as Notch 
signalling have been examined in the previous section 16.
17.1 The EH p rotein s and th e ir  in teractors in  HIV-1 in fected  
cells
The usual mechanism of the release of virus is by cell lysis of the host cells. In 
contrast, retroviruses, such as HIV-1, release their virions by budding from the 
membrane of the host cells. Some EH interactors, such as Hrb and Hrbl and Alix 
participate in the protein trafficking required for the replication of HTV-1. The 
mammalian Epsl5 family proteins interact with Hrb and Hrbl (Hrb-like), which are 
co-factors of viral Rev proteins [195]. Hrb proteins interact with Rev proteins, 
encoded by the HIV-1, and assist the nucleo-cytosolic shuttling of the viral RNA in a 
necessary process for the assembly of viral particles.
Another EH interactor reported to assist the virus budding process is Alix, the 
mammalian homologue of ALX-1 that was identified in this study and by Shi et al 
[101]. Alix, together with TSG101, are the host endosomal proteins that are “hi­
jacked” during the HTV-1 infection. Gag polyprotein encoded by HIV-1 orchestrates 
the viral assembly and the budding. There are several motifs referred to as the “late 
domains” found on the retroviral protein; P(T/S)AP, PPxY, and YPxnL (where x is
any residue and xn is any sequence). “Late domains” are found in the viral proteins
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that are expressed after the early proteins, at a stage of infection promoting the 
release of the virions [196]. The YPxnL-type domain was shown to bind the V 
domain of Alix, which was found to form a conformation similar to a letter V [196]. 
Alix interacts with both TSG101 in ESCRT-I complex and CHMP4 in ESCRT-III 
complex. The structural study on Alix showed that the Brol domain of Alix that is 
responsible for the interaction between Alix and an ESCRT III complex protein, 
CHMP4, is crucial for the function of Alix in vims budding. A recent study on the 
structure of Alix presented a banana-shaped Alix [196], which supports its role in 
inducing the membrane curvature during vims budding.
Recently it was shown that the HIV-1 gp41, which is an important player in the 
fusion between the viral and the target cell membranes, binds to the Epsin NPF 
motifs and that a synthetic peptide containing the Epsin-1 (470-499) sequence blocks 
the entry of HTV-1 virions into SupTl T cells via the endocytosis pathway. These 
results suggest that interaction between Epsin and the gp41 core, which may be 
present in the target cell membrane, is probably essential for endocytosis of HTV-1, 
an alternative pathway of the HTV-1 entry into the target cell [197]. The participation 
of EH proteins in the process required for the entry of HTV-1 into cells is so far 
completely unexplored.
17.2 E H  p ro te in s  im p lic a te d  in  n e u ro d e g e n e ra tiv e  d ise a ses  
As mentioned in the introduction of the EHD proteins (Section 2.4.6), an EHD family
protein, Pincher is involved in the retrograde signalling of NGF in the neurons isolated
from postnatal day 1 and embryonic (El 8) rat [124]. The retrograde signalling may play
a critical role in the pathogenesis of neurodegenerative diseases. The hallmarks of
neurodegenerative diseases are the loss of neurons and synapses. The failure to
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transport the signal from the axonal terminals to the cell bodies results in the loss of the 
cell survival signal, therefore resulting in the degeneration of neurons.
Proteins that are implicated in neurodegenerative diseases, such as Amyloid Precursor 
Protein (APP), which gives rise to beta-amyloid peptides (AJ3), and poly-glutamine 
(polyQ)-containing proteins, have been shown to be neurotoxic. Recently, the EH 
protein Intersectin was reported to increase the formation of aggregates by mutant 
huntingtin protein (Htt) through activation of the c-Jun-NH(2)-terminal kinase (JNK)- 
MAPK pathway [210]*. Conversely, silencing ITSN or inhibiting INK attenuated 
aggregate formation. Using a Drosophila model for polyQ repeat disease, Intersectin 
was found to enhance polyQ-mediated neurotoxicity, suggesting a broader involvement 
of Intersectin in neurodegenerative diseases through destabilization of polyQ-containing 
proteins. Moreover, human Intersectin gene is located on chromosome 21, and its 
overexpression in Down Syndrome and its potential role in the early onset of 
Alzheimer’s Disease (AD) pathogenesis observed in DS patients has been discussed in a 
recent review [198].
In addition, AD is frequently mentioned in conjunction with the mammalian 
homologues of some of the proteins that were identified in this project as the EH 
interactors. In the following section the implication of EH interactors in AD will be 
discussed.
17.2.1 The EH interactors implicated in Alzheimer’s Disease
Alzheimer’s Disease is one of the most common neurodegenerative diseases that
manifests in dementia in the elderly. The mechanisms that are involved in the pathology 
of AD are very complex, though it is evident to date that the degeneration of neurons is
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preceded by the failure of efficient synaptic transmission [199]. Extracellular 
accumulation of fibrillar Ap peptide forming the amyloid plaques is one of the 
hallmarks of AD and the neurotoxicity of Ap accumulation has been demonstrated. Not 
only extracellular but more recently, intracellular Ap is also thought to contribute to the 
increased neuronal death. Ap is a peptide of 39 to 43 residues generated from the 
proteolysis of APP by secretases and other proteases.
In this context it is important to note that some EH interactors (EPN-1, ALX-1 and 
SEL-5) are involved in Notch'signaling pathway, which recently received attention for 
its link with AD. Notch receptor has been shown to interact with APP and it was shown 
that Notch 1 and APP are able to trans-activate each other’s target genes [200]. 
Furthermore other EH interactors (Lin-10/Mint-1, Disabled and PLICs/Ubiquilin), have 
been implicated in AD, as reported below.
LIN-10 and DAB-1 are both phosphotyrosine binding (PTB)-domain containing 
proteins. The PTB domains of the mammalian LIN-10 and DAB-1 interact with APP or 
with the members of APP family [201, 202]. The Lin-10 mouse orthologue promotes 
the stability of APP, and thus downregulates the production of A-beta (A(3) production 
[203, 204]. In comparison, mouse Dabl (mDabl) has been implicated in increasing the 
production of Ap [203]. The PDZ domain of Lin-10 interacts with Presenilin-1, which 
is a component of y-secretase, the protease responsible for the cleavage of APP. The 
interaction between Xll/Lin-10 and Presenilin-1 is suggested as the mechanism by 
which X I1 promotes the stability of APP.
PLICs/Ubiquilin was also identified as an interactor of presenilin [205], and it has been 
implicated in AD by several studies. For example, Ubiquilin was shown to be localized
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in the neurofibrillary tangles and Lewy bodies, which are found in AD affected brains 
[205]. The knockdown of Ubiquilin accelerated the maturation and trafficking of APP 
from the intracellular compartments to the cell surface [206]. More recently, the 
evidence of genetic interaction between ubiquilin and presenilin in Drosophila has also 
been reported [207, 208].
Intriguingly, the UBL domain of PLIC-1 interacts with the UIM domain of Epsl5, and 
both PLIC-1 and Epsl5 are recruited to the poly-glutamine (polyQ) aggresomes [209]. 
PolyQ aggresomes are different from-Ap plaques. PolyQ are involved in another type of 
neurodegenerative diseases often referred to as prion diseases, in which plaque 
formation is characteristic. In addition, the toxic polyQ peptide is approximately 42 
residues, similar to the length of Ap in the range of 39-43 (as specified earlier in this 
section), suggesting that a similar mechanism is involved in causing the neurotoxicity.
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18. Closing Remarks
In summary, the EH proteins and the protein-protein interactions mediated by the EH 
domains are involved in the regulation of numerous intricate intracellular cross-talking 
signalling pathways.
The EH network seems to provide a web of platforms through which different 
signalling molecules travel. Once the signalling molecules are brought together with the 
adaptor proteins, signalling events such as phosphorylation or ubiquitination can occur. 
The fact that the EH interactions act as transient platforms for divergent pathways is 
supported by the finding that some adaptor protein such as ALX-1, EPN-1, LIN-10, 
DAB-1 or PLIC-1, identified in this screening as EH interactors often act at 
intersections of different signalling pathways.
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